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Abstract
Aim: The aim of this study was to investigate the patients’ perspective of migraine 
and chronic daily headache (CDH) management.
Methods; The study used a combination of qualitative (Phase 1) and quantitative 
methods (Phase 2). Both phases were conducted in the UK in adults (aged 18-65), 
who suffered either from migraine according to the International Headache Society 
criteria or from CDH. Phase 1 used semi-structui'ed interviews (n=13) that were 
analysed according to the grounded theory methodology. Phase 2 was based on a 
postal survey that was administered to migraine, migraine with aura and CDH 
patients (ri=438), who were members of the Migraine Action Association (UK).
Findings: The qualitative findings revealed the patients’ decision-maldng to treat and 
prevent headaches, their perceptions of headache and headache management and the 
holistic set of strategies used for headache management. Patients were highly 
involved in their headache care and perceived themselves as a key resource to 
management. The survey showed that a high proportion of headache patients use 
strategies from 4 areas of management including health care consultations, 
medication use, general management and social support. The sur'vey also showed that 
the use of some strategies differs between different types of headaches. Overall, it 
was generally the CDH patients, who were more active in their headache 
management than migraine and migraine with aura patients, and some of these 
findings were statistically significant.
Conclusion: Both the qualitative and quantitative findings of this study showed the 
patients’ high level of involvement in their headache care. Combining the two 
methodologies helped to confirm and reinforce the findings. The results of this study 
can be used to identify headache patients as a key resource to management. Their 
high level of activity in this study shows the patients’ willingness to be involved in 
their own headache care. However, since headache patients still report considerable 
suffering, it may be necessary to educate headache patients to maximise the outcome 
of their management efforts.
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Chapter 1 : Introduction
1.1. Migraine and Chronic daiiy headache management
Migraine and chronic daily headache (CDH) affect 12 % (Breslau and Rasmussen,
2001) and 3.2 % (Lu et al., 2001) of the general population respectively. Migraine 
and CDH significantly reduce the sufferers’ quality of life (QoL), with QoL being 
more severely reduced in CDH patients than in migraine sufferers (Meletiche et ah, 
2001; Lanteri-Minet et al., 2003). Due to their chronic natuie, migraine and CDH 
need to be managed over a prolonged period of time. A multitude of effective 
strategies to treat and prevent these headaches is available, but migraine and CDH 
patients continue to experience high morbidity. Due to a lack of use of effective 
treatments, often patients do not benefit from current treatments. Research has 
predominantly focused on migraine, although an increasing number of scientific 
articles have been published in the last 2 years on CDH.
As fai* as migraine is concerned, to date, patients remain under-diagnosed and under­
treated (Lipton et al., 1992; Lipton et al., 2000). Under-treatment in migraine has 
been attributed to several factors: 1) the patients having a fatalistic attitude, 2) 
patients using Over the Counter (OTC) medications rather than prescription drugs 
(Michel et al., 1996), 3) low consultations rates with doctors (Lipton et al., 1998) and 
4) ineffective doctor-patient communication, particularly about headache-related 
disability (Lipton et al., 1994). Twenty-four studies, using survey design, have been 
published on migraine and CDH patients’ use of management strategies, but these 
studies have predominantly focused on consultations with doctors and medication 
use (Appendix 1). While research into the clinical and phaimacological aspects of 
migraine management is important, it does not provide the whole picture of migraine 
and CDH, and the patients’ management of these headaches. A study of the members
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of the Dutch Society of Headache Patients showed that although the most frequently 
reported reason for a reduction in headache-related impact was a change in 
medication (77%); factors such as a change in life-style (56%), more relaxed coping 
(42%), and support from family (46%) were also considered to contribute to the 
reduction of headache related-impact by a large proportion of patients (Vos and 
Passchier, 2003). But studies on the patients’ perspective remain rare, and apart from 
anecdotal reports, there is little evidence about the use of non-pharmacological 
management of migraine and CDH. A comprehensive review of the literature of 
migraine and CDH and their management is presented in Chapter 2.
1.2. The expert patient
With clii'onic disease having become the principal medical problem, the patients’ 
opinions have become increasingly important. The patient must become a paitner, 
who contributes at almost every decision and action level of the management of their 
disease (Holman and Lorig, 2000). The patient becoming a partner and expert in 
care is an idea whose time has come, and this idea has the potential to create a new 
generation of patients who are empowered to take action to improve their own health 
(Donaldson, 2003). The Icnowledge and experience of the patient has been an 
untapped resource for too long and in the UK, the Department of Health considers 
the expert patient a new approach to chronic disease management for the 21®^ century 
(Depai'tment of Health, 2001). The Disease Management Association of America 
(2002) defines Disease Management (DM) as a system of co-ordinated health caie 
interventions and communications for populations with conditions in which self­
management efforts are significant. Components of DM programmes include patient- 
self management education and patient empowerment (Disease Management 
Association of America, 2002).
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Patient self-management and decision-making in their chronic disease management 
introduce a new chronic disease paradigm: the patient and health care professional 
relationship involving collaborative care and self-management education 
(Bodenheirner et ah, 2002). This paradigm implies that the health professional is the 
expeid about the disease, whilst the patients are the experts about their own lives. 
Such an approach means that the patients are empowered, i.e. they accept of 
responsibility to manage their own condition and they are encouraged to solve their 
own problems with information, but not orders, from health professionals 
(Bodenheirner et ah, 2002). Patients make decisions about their condition everyday 
(Bodenheimer et ah, 2002) and can become key decision-malcers (Department of 
Health, 2001).
1.3. Patient seif-management
Patient self-management is an inevitable outcome of the process of being or 
becoming an expert patient. Self-managernent of chronic illness implies monitoring 
and managing symptoms, adhering to treatment regimens, keeping a healthy life­
style and managing the impact of illness on daily functioning, emotions and social 
relationships (Schreui's et ah, 2003). As far as headaches are concerned, migraine 
patients have reported a desire for collaborative relationships with their doctors and a 
team approach to treatment involving both the patient and doctor (Cottrell et ah,
2002). Furthermore, good management requires the patients’ active participation in 
decisions regarding therapeutic interventions (Silberstein et ah, 2000). Most 
headaches occur in the absence of health care professionals. Thus, the major 
responsibility for headache management lies with the patient and it is therefore 
important to better understand and to develop the patients’ expertise in headache 
management.
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To date, migraine is under-treated and migraine and CDH patients continue to suffer 
considerable headache-related disability. Effective treatments are available, but the 
high levels of suffering suggest that patients do not benefit from these treatments. 
Patients with chronic diseases may fail to optimally self-manage their disease and 
help in integrating the required self-management behaviours into their lives may be 
needed (Schreurs et al., 2003). Improving patient self-management may be a useful 
tool to improve headache care and enlianced headache self-management may be 
achieved thr ough gaining better understanding of the patients’ perspective, improved 
collaboration between health care professionals and headache patients and patient 
education.
Studies to improve patient self-management through education or psychological 
programmes have been shown to be beneficial in various chronic diseases. A recent 
review on the use of self-management in astlima concluded that self-management of 
asthma can be beneficial from both the family physicians’ and the patients’ 
perspective (Thoonen and van Weel, 2002). In back pain, a randomized control trial 
of a cognitive-behavioural programme showed significantly greater reductions in 
back-related worry and fear-avoidance beliefs for the intervention versus the control 
group (Moore et al., 2000). Pain intensity was also significantly lower at 6 months 
and significantly less interference with activities at 12 months was foimd in the 
intervention group when compared with the controls (Moore et al., 2000). In 
diabetes, a psychological intervention to improve lifestyle led to positive experiences 
for patients. Patients rated the intervention as highly satisfactory and acceptable in 
comparison to more traditional approaches to managing eating and exercise 
behaviours (Clark and Hampson, 2001). One study assessed disease management, 
including headache education, for headache patients attending a Headache Clinic in
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the US (Maizels et a l, 2003). Although the cost of triptans increased by 19%, 
headache-related consultations reduced by 32% and emergency department 
consultations reduced by 49%. Headache frequency was reduced in 86% of patients 
who had severe headaches more than 2 days per week at their initial clinic visit.
1.4. Aim of the study and research questions
To date, studies on the patients’ perspective of headache management often remain 
focused on consultations with doctors and medication use. Little remains laiow of the 
patients’ perspective of the complete picture of migraine and CDH management. 
Therefore, the aim of this study was to gain insight into the patients’ perspective of 
migraine and CDH management. The following research questions were formulated:
1. How do migraine and CDH patients perceive and experience headaches and 
headache care?
2. What is the patients’ involvement in their migraine and CDH care?
3. Which management strategies do migraine and CDH patients use?
4. What are the differences in the use of management strategies between different 
types of headache patients (migraine, migraine with aur a and CDH)?
1.5. implications of the study
Investigating the patients’ perspective of migraine and CDH management will 
contribute to knowledge in several ways. It will help to understand migraine and 
CDH management outside clinical practice, by gaining insight into the holistic 
picture of management of migraine and CDH. It will help to identify the patients’
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current involvement in their own cai'e and to identify areas for potential patient 
education and patient self-management.
1.6. Rationale for qualitative methods
If it is the aim of health care to increase user participation in car e and try and work to 
some extent to a user-led agenda, then it is important to use methodologies that give 
voice to the users and allow patients some scope to lead agendas for change, rather 
than being restricted to providing data for researcher and health care provider-led 
agendas (Edwards and Staniszewska, 2000). From the surveys on the patients’ 
management of migraine and CDH, there is little, if any, evidence of patient 
involvement in the design of the instruments of data collection (usually interviews 
and questiomiaires). Therefore, it can be assumed that studies investigating the 
patients’ perspective of migraine and CDH management have generally been 
designed by headache clinicians and researchers without the patients’ input. Thus, 
little opportimity has been given to the patients to spealc openly and unrestrictedly 
about their migraine and CDH management. Qualitative research has been advocated 
as a suitable method to gain access to the users’ perspective (Edwards and 
Staniszewska, 2000). The contribution of qualitative methods to headache resear ch is 
further outlined in Chapter 3. Qualitative inquiry requires the investigator to listen 
and try and understand, rather than to control and shape the inquiry (Edwards and 
Staniszewska, 2000). However, only 2 studies using qualitative methods have been 
published in headache research. One of these studies used interviews to explore the 
patients’ decision-making for using sumatriptan, one of the acute migraine-specific 
medications (Ivers et al., 2000). The second study, based on focus groups, 
investigated the patients’ perceptions of migraine (Cotterell et al., 2001).
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Thus, studies on migraine and CDH management have predominantly used 
quantitative methods and have focused on issues that are quantifiable. If research 
only focused on what can be quantified reliably, many researchers may never 
discover the strengths of qualitative reseai’ch (Soafer, 1999) and may never access 
areas of research that are only amenable by qualitative methods (Pope and Mays, 
1995). The use of qualitative methods is advocated to explore research topics that are 
not amenable by quantitative research. Qualitative reseaich aims to gain insight into 
the world of those who are being reseaiched (Soafer, 1999) by studying the 
pai'ticipants unique experiences of natuially occurring events (Miles and Huberman, 
1994) and/or social/human problems (Creswell, 1998) and their inteipretations of 
these experiences (Jones, 1995; Saiantakos, 1998). Qualitative reseaich is a holistic 
process of enquiry and seeks to understand the phenomenon under study as a 
complex system that is more than the sum of its parts (Patton, 1990). The strengths of 
qualitative methods are its validity and its potential to discover new aieas, identify 
patterns, reveal and explain complexity and develop, construct and test concepts or 
theories (Soafer, 1999; Creswell, 1998; Pope and Mays, 1995). Suitable topics for 
qualitative studies in health care, including research into migraine and CDH, 
comprise decision-malcing processes; doctor-patient relationship; interactions among 
patients and clinicians; self-management; care-seeking, illness and compliance 
behavioui"; patients’ perceptions and experiences, and health caie delivery (Britten et 
al., 1995).
Given the limitations of studies to date, the strengths of qualitative reseaich and the 
research aim, qualitative methods were chosen to answer research questions 1-3 
formulated for this study. Grounded theory was chosen, because it is a specific, 
highly developed and rigorous set of procedures for generating theory (Glaser and
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Strauss, 1967). Both patients suffering from migraine and CDH were interviewed in 
the qualitative phase. The findings of the qualitative study aie described in Chapters 
4-6.
1.7. Rationale for combining quaiitative and quantitative methods
Combining qualitative and quantitative methods has been advocated to enhance the 
study of chronic diseases (Casebeer and Verhoef, 1997). Previous studies have 
shown that the integration of qualitative and quantitative methods emphasises the 
findings (Chan, 2001; Clarke, 2003) or the inteipretation of findings was facilitated 
by the simultaneous use of qualitative and quantitative methods (Etter and Perneger, 
1997). Abu et al (2001) found that qualitative findings confirmed the quantitative 
results and suggest that a combined approach should be used in future studies of the 
patients’ views of health care.
Using both qualitative and quantitative methods sei-ved several purposes. If used as a 
prerequisite to quantitative research, qualitative research facilitates the development 
of the quantitative research by identifying the ‘coiTect’ terminology for inclusion in a 
sui'vey questionnaire or generating hypotheses (Greene et al., 1989). The qualitative 
data infonned design the reseaich questions and a valid questiomiaire that was 
relevant to migraine and CDH patients. The second piupose of a combined 
methodology was methods triangulation. This involves comparing data collection 
thi'ough qualitative methods with data collected through quantitative methods 
(Patton, 1999).
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1.8. Rationale for the survey
Given the limitations of qualitative research in terms of generalisability, the study 
was to comprise a second phase using quantitative methods to malce the findings 
applicable to a larger population. Thus, to increase knowledge about the patients’ use 
of migraine and CDH management and to make the qualitative findings more 
objective and more useful for explanation and prediction, a postal survey was carried 
out. No previous questionnaire had investigated the holistic management of migraine 
or CDH from the patients’ perspective. The quantitative phase was based on a postal 
questiomiaire that investigated the holistic management of migraine, including health 
caie consultations, medication use, general acute and prophylactic management and 
social support, as well as tlie patients’ opinions. The smvey was aimed at patients 
with migraine without aum, migraine with aura or CDH. The aim was to investigate 
(research question 3) and compare the patients’ use of management strategies 
(research question 4) in the 12 months preceding the study. The smvey compaied 
tliree groups, rather than the 2 groups (migraine and CDH) used for the qualitative 
phase, because the qualitative data indicated that patients with different headache 
diagnoses and increasing headache severity managed their headaches differently. 
Also, migraine diagnosis has been shown to be more likely when certain symptoms 
aie present, including aura and increasing disability (Lipton et al., 2001). The design 
of the sui'vey is described in Chapter 7. The results of the quantitative phase are 
described in Chapter 8. The complete study, reporting and integrating the results of 
the qualitative and quantitative phases, as well as the added value of combining the 
two methods aie presented in Chapter 9. In Chapter 10, an overview is presented of 
this study’s contribution to the body of loiowledge of migraine and CDH, to the 
methodology and theoretical understanding.
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1.9. The presentation of the thesis
As described in this introduction, this thesis is presented in 10 chapters. Rather than 
being presented as chapters in the usual UK style, Chapters 3 to 9 aie presented as 
articles, one of which has been published, one of which is in press, and the remaining 
chapters of which are submitted or in the process of being submitted for publication. 
Presenting the thesis in that manner means that repetitions occur within the thesis. 
These repetitions are most notable within the methodology sections, as the 
qualitative phase is presented as 3 articles (chapters) and the sui'vey design is 
described in detail in Chapter 7 and as pai't of an article in Chapter 8. Presenting the 
thesis as such also means that the references are presented at the end of every 
chapter, rather than the usual reference list at the end of the thesis.
1.10. The researchers ' invoivement
The research was caii'ied out as a team effort between the researcher and her 
supervisors. The main part of the research was carried out by the reseai'cher, but the 
input of her supervisors will be described as appropriate within the chapters. As an 
overview. Prof. H.Huijer Abu-Saad (HAS) was involved in designing the qualitative 
interview guide, qualitative analysis and questiomiaire design. Dr Margaret Murphy 
(MM) was involved in the recruitment for the qualitative interviews and 
questionnaire design. Dr Andrew Dowson (AD) was the clinical supervisor on 
headaches and was involved in diagnosing the interview participants and 
questionnaire respondents, questionnaire pilot study and validation of the diagnostic 
tool of the questiormaire. Dr Vasso Vydelingum (VV) was involved in the qualitative 
analysis and questionnaire design. Prof. Ian Robbins (IR) was involved in the design, 
pilot testing and statistical analysis of the questionnaire.
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2.1. Abstract
Migraine and chronic daily headache (CDH) are common, primary headaches that 
can have a gr eat impact on the lives of the sufferers. Migr aine causes at least some 
disability in the majority of patients and quality of life is significantly reduced when 
compared to the general population and, in severe cases, to patients suffering fi'om 
other chr onic diseases. CDH leads to an even greater reduction of quality of life than 
episodic migraine. This review sets out to give the diagnostic criteria for migraine 
and CDH and to describe their treatments, including pharmacological and non- 
phannacological treatments. Then it will outline the management of migraine and 
CDH in clinical practice, as well as the management strategies employed by patients 
suffering fiom migraine or CDH and initiatives taken to improve management.
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2.2. Headaches
In 1988, the International Headache Society (IHS) introduced diagnostic criteria for 
all types of headache (Headache Classification Committee o f the International 
Headache Society, 1988). Translated fully or in abbreviated form into many 
languages, the primary use of the IHS criteria was for research. Indeed, these criteria 
are now recognised as the ‘gold standard’ in clinical trials and epidemiological 
research. The criteria are often used in simplified form in specialist clinical practice, 
but the adoption of the criteria in primary care has been limited (Lipton et al., 
2000a).
There aie many different types of headache. Broadly they aie divided into primaiy 
and secondary headaches. Primary headaches do not have an underlying disease. 
Secondary headaches have an underlying disease (such as in influenza or brain 
tumours), of which the headaches are a symptom. Primary headaches comprise 
migraine, tension-type headaches (TTH), cluster headaches and chronic paroxysmal 
hemicrania and miscellaneous headaches unassociated with structural lesions such as 
ice-cream headache (Headache Classification Committee of the International 
Headache Society, 1988). Chronic daily headache (CDH) is also a type of primary 
headache, but CDH is not described within the cun ent IHS criteria.
2.2.1. Migraine
Migraine is a disease with many sub-types (Table 2-1), all o f which have been 
described by the IHS (Headache Classification Committee of the International 
Headache Society, 1988). The two main types of migraine are migraine with aura 
and migiaine without auia, previously called common migraine (Table 2-2).
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Migraine with aura, previously called classical migraine, comprises complex focal 
neurological symptoms, which initiate or accompany attacks (aura). Aura usually 
develops over 5 to 20 minutes and lasts less than 60 minutes. The headache, with 
nausea and/or photophobia, develops after an interval of less than an hour and lasts 
for 4 to 72 hours. Migiaine auia can also occur without the headache phase. Auras 
aie mostly visual, such as flashing lights. Other aura symptoms include speech 
disturbances, pins and needles or vertigo.
Other migiaine symptoms, such as premonitory (warning) symptoms or osmophobia, 
can be present, but these are not necessary for tlie diagnosis of migraine. Premonitoiy 
symptoms, or prodromes, are symptoms that occur before the attack. These can be 
considered warning signs of migraine attacks. Examples of prodiomes are fatigue, 
thirst and imtability.
The patient needs to have suffered five migraine attacks to fulfil IHS criteria. 
Secondary headache such as brain tumours, influenza must be eliminated prior to the 
diagnosis of migraine. Difficulties with the diagnosis of migraine arise from the co­
existence of different types of headache within the same patient and the changes in 
headache diagnosis over time (Oleson and Lipton, 1994).
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Table 2-1: Migraine sub-types (Headache Classification Committee of the 
International Headache Society 1988)
1. Migraine
1.1. Migraine without aura
1.2. Migraine with auia
1.2.1. Migraine with typical aura
1.2.2. Migraine with prolonged aura
1.2.3. Familial hemiplegic migraine
1.2.4. Basilar migiaine
1.2.5. Migiaine with acute onset aura
1.3. Ophtamoloplegic migraine
1.4. Retinal migraine
1.5. Childhood periodic syndi'omes that may be precursors to or associated 
with migraine
1.5.1. Benign paroxysmal vertigo of childhood
1.5.2. Alternating hemiplegia of childhood
1.6. Complications of migraine
1.7. Migrainous disorder not fulfilling above criteria
Table 2-2: Migraine without aura (Headache Classification Committee of the 
International Headache Society 1988)
A) At least 5 attacks fulfilling B-D
B) Headache lasting 4-72 hours (untieated or ti*eated unsuccessfully)
C) Headache has at least two of the following characteristics
1. Unilateral location
2. Pulsating quality
3. Moderate or severe intensity (inhibits or prohibits daily activities)
4. Aggravation by walking stairs or similar routine physical activity
D) During headache at least one of the following
1. Nausea and/ or vomiting
2. Photophobia and phonophobia
E) No evidence of organic disease
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2.2.2. Chronic dally headache (CDH)
A considerable number of patients who attend speciality headache centres suffers 
from daily or near daily headaches (Nappi et al., 1999). However, the criteria of the 
IHS for classification of headaches do not adequately address the classification of 
daily or neai-daily headaches, which are known as chronic daily headache (CDH). 
Chronic tension-type headache (CTTH) is the only available classification for high 
frequency headaches within the IHS system. In 1987, to address these problems, 
Mathew et al (1987) gave a description of transformed migraine (TM), which is a 
daily or near daily headache syndrome that evolves from migraine.
As described by Silberstein et al (1994), several studies have shown that the IHS 
system does not adequately classify daily or near-daily headaches. Thus, the authors 
proposed a new classification system comprising four daily or near daily headache 
disorders: 1) chronic tension-type headache (CTTH), 2) tiansfbimed migraine (TM) 
(Table 2-3), 3) new daily persistent headache (NDPH) and 4) hemicrania continua 
(HC). These chronic headaches have one common feature; they occur at a frequency 
of 15 or more headache days per month. Silberstein and his colleagues propose 
specific criteria for the thr ee latter o f these types of headaches, as well as providing 
modified criteria for CTTH and giving criteria on medication overuse in CDH. These 
criteria for the classification of daily and near-daily headaches were tested and 
compared to the IHS criteria (Silberstein et al., 1996). This study showed that when 
using the IHS criteria, 43% of patients could not be classified, whereas when using 
the Silberstein et al. criteria, 100% of patients could be classified.
Furthermore, when the Silberstein et al. (1994) criteria are applied, patients are given 
one diagnosis, as opposed to the majority of patients receiving multiple diagnoses
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when applying the IHS criteria. According to the IHS only 1.6% of patients have one 
diagnosis, 27.1% have two, 61.9% have three, 8.3% have four and 1.1% are 
unclassifiable (Bigal et al., 2002a).
Table 2-3: Classification for transformed migraine and transformed migraine 
with medication over-use (Silberstein et al., 1994)
Diagnosis Criteria
Transformed
migraine
History of episodic migr aine meeting IHS criteria
Daily or almost daily (>15 days/ month) head pain >1 month
Average headache duration >4 hours (if untreated)
History of increasing headache frequency with decreasing severity 
of migrainous features over at least 3 months
No disorder listed in IHS groups 5-11
Transformed
migraine
with
medication
over-use
As above and
At least one of the following for at least 1 month:
Simple analgesic use (>1000mg ASA/ acetaminophen) >5 days/ 
week
Combination analgesics (caffeine, barbiturate-containing 
medication) (>3 tablets/ day)>3 days/ week
Narcotics (> 1 tablet/ day) >2 days/ week
Ergotamine use (Img PO or 0.5mg PR) >2 days/ week
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2.3. Epidemiology of migraine
2.3.1. Migraine prevalence
Migraine can affect any person of any gender, age and ethnicity. However, certain 
population groups are more likely to be affected as shown by epidemiological 
studies. Wlien (Stewart et al., 1994a) reviewed 24 studies, they found wide variations 
in migraine prevalence (3.2-57.1% in women and 1.7-33.1% in men). These 
variations are largely based on the different definitions used to describe migraine 
prior to the introduction of the IHS criteria. A more coherent picture of migraine 
prevalence has emerged from studies using the IHS diagnostic criteria. World-wide 
(England, USA, Japan and Norway) the estimates for IHS migraine prevalence range 
from 12.9-18.2% in women and 3.4-7.0% in men (Winnem, 1992; Stewart and 
Lipton, 1993; Sakai and Igarashi, 1997; Lipton et al., 2001a). An estimated 6 million 
people suffer from migraine in the UK (Rush, 1996). Most prevalence studies do not 
differentiate between migraine sub-types. The Genetic Epidemiology of Migraine 
(GEM) study in the Netherlands foimd that 64.1% of their sample suffered from 
migraine without aura, 17.9% had migraine with aura, 12.9% had both types and 
5.2% could not be classified (Terwindt et al., 1998).
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2.3.2. Factors influencing migraine prevalence
Migraine can affect anybody, but certain groups are more likely to be affected. 
Factors influencing migraine prevalence include gender, age, race and socio- 
demographic backgromid. The prevalence figures show that migraine is about three 
times more common in women than in men, possible as a result o f the hormonal 
differences between women and men (Breslau and Rasmussen, 2001). Migraine 
prevalence increases from the ages 12 to 38 and decreasing thereafter (Stewart and 
Lipton, 1993). The median age of migraine onset is 20 years (Steiner et al., 1999). 
Migraine prevalence was highest between the ages of 26 to 55 years (Goadsby and 
Oleson, 1997; Steiner et al., 1999). hr England, non-whites were significantly less 
affected by migraine than whites (Steiner et al., 1999). In the US, migraine 
prevalence was lower in blacks than in whites (Lipton et al., 2001a). It has been 
speculated that the lower prevalence of migraine in blacks may be partly attributed to 
genetic differences, rather than cultural or environmental differences (Stewart et al., 
1996). A higher proportion of migraine sufferers are in the lower income group 
(Kryst and Scherl, 1994), with prevalence in the lowest income group being 60% 
higher than in the highest income group (Lipton et al., 2001a).
2.3.3. Characteristics of migraine
It is generally accepted that migr aine attacks have a median duration of 24 hours, and 
that the median frequency of migraine is once or twice per month (Launer et al., 
1999; Steiner et al., 1999). However, migraine is a heterogeneous disorder and 
migraine duration can vary from less than 4 hours to several days (Henry et al.,
1992). As far as migraine fi*equency is concerned, 25% of migraine sufferers had five
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or fewer attacks per year and another 25% had two or more attacks per month 
(Launer et al., 1999). At least 10% of the migraine sufferers experience four or more 
attacks per month (Stewart et al., 1994b), in which case it seems likely that they 
suffer from CDH rather than episodic migraine. Not only is migraine more prevalent 
in women, female migraine patients reported more frequent attacks than male 
migraine sufferers (Stewait et al., 1992).
Over 50% of patients report severe or very severe pain (Henry et al., 1992). The most 
frequently reported migraine symptoms were pulsatile pain (85%), photophobia 
(80%), phonophobia (76%), nausea (73%), unilateral pain (59%), blurred vision 
(44%), aura (36%) and vomiting (29%) (Lipton et al., 2001a). Compared with male 
patients, female migraine patients were more likely to report photo- and phonophobia 
and nausea (Lipton et al., 2001a).
2.4. Epidemiology of CDH
2.4.1. CDH prevalence
Since there are no IHS criteria for CDH, studies to establish the prevalence of CDH 
have used different diagnostic criteria, including the Silberstein et al. (1994) criteria. 
The studies by Scher et al., (1998); Granella et al. (2000); Wang et al. (2000); and 
Lanteri-Minet et al. (2003) did not use the Silberstein et al. criteria. In a population 
based study in the US, 4.1% of subjects were found to suffer from frequent 
headaches (Scher et al., 1998). One year prevalence rates of CDH were 2.98% in 
France (Lanteri-Minet et al., 2003), 3.2% in Taiwan (Lu et al., 2001) and 4.7% in 
Spain (Castillo et al., 1999). In a Chinese elderly community-based sample, 3.9% of 
respondents were found to have CDH (Wang et al., 2000).
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Women aie more affected by CDH than men. In the US, 5.0% of women and 2.8% 
of men suffered from frequent headache (Scher et ah, 1998). In Spain, 9% of women 
suffered from CDH (Castillo et al., 1999). In France, 4.18% women versus 1.62% of 
men (Lanteri-Minet et al., 2003) and in Taiwan, 4.3% of women versus 1.9% of men 
were affected by CDH (Lu et al., 2001). Of the CDH patients, 72% were women and 
significantly younger than the male CDH patients (Lu et al., 2001).
The prevalence of the different types of CDH is not clear. Although studies have 
investigated the different types, different labels and even different diagnostic criteria 
are used to sub-group CDH. A study in 9 Italian headache centies has acknowledged 
that only CTTH is included in the IHS criteria, and used CTTH, chronic migraine 
(CM) and chronic coexisting migraine and TTH (CCMTTH) to describe their sample 
(Granella et al., 2000). Of the CDH patients, 46.5% were given a diagnosis of 
chronic co-existing migraine and tension-type headache, 30.2% were classed as CM 
and 23.3% as CTTH. However, the authors do not define how they classified CDH, 
CM or CCMTTH.
The most common type of CDH is thought to be TM, also called chronic migraine 
(CM). Based on the Silberstein et al. (1994) criteria, CM affected 87.4%, new daily 
persistent headache affected 10.8% of a tertiary care population in the US (Bigal et 
al., 2002a). Using their own criteria, Silberstein et al. found that in the US 78% of 
CDH patients suffer from TM, 1.53% from CTTH and 6.7% from other headache 
disorders (Silberstein et al., 1996). hi Spain, 47.2% of CDH patients had CTTH 
(2.2% of general population) and 50.6% had TM (2.4% of general population) 
(Castillo et al., 1999). hi the Chinese elderly population, 70% suffered from CTTH, 
25% from TM and 5% from other CDH (Wang et al., 2000). Reflecting the higher
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prevalence of CDH in women, most CTTH (90.5%) and TM (88.9%) were women 
(Castillo et al., 1999). In France, 29.1% of CDH patients fulfilled the IHS criteria for 
migraine without aura or migraine with aura, 43.2% fulfilled all these criteria but 
one, and 27.7% of patients did not have a diagnosis consistent with the diagnosis of 
migraine (Lanteri-Minet et al., 2003).
Medication ovemse is often thought as a causing or contiibutory factor to the 
development o f CDH and CDH with medication overuse aie given within the 
Silberstein et al. (1994) criteria for the classification of daily and near-daily 
headaches. The prevalence of CDH with medication over-use is about 2% (Castillo et 
al., 1999). In Taiwan, 34% of CDH patients over-used medication (Lu et al., 2001), 
whereas in Spain, medication overuse was found in 19% of CTTH patients and in 
31.1% of TM patients (Castillo et al., 1999). These levels of medication overuse are 
low in comparison with those found in an American tertiary care population, in 
which 81.7% of CDH patients were ovemsing medication (Bigal et al., 2002a).
2.4.2. Characteristics of CDH
Unlike the characteristics of migraine, which have been well studied and are 
accepted as described above, knowledge about the features o f CDH is mainly based 
on clinical experience. Only recently studies have investigated the features of CDH. 
The first important feature to diagnose CDH is headaches occurring at a firequency of 
15 or more days per month. This means that the actual number of days with 
headaches in CDH can vary by 15 days per month (i.e. a headache frequency 
between 15 and 30 days per month). Some studies have investigated the number of 
headache days in CDH. In Taiwan, 0.5% of participants and 15% of the CDH 
patients (n=16) had daily headaches i.e. headaches 30 days per month (Lu et al.,
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2001). In Brazil, 80% of TM patients, reported daily headaches and 20% had almost 
daily headaches (>15 days per month) (Galego et al., 2002). In Canada, TM patients 
had a mean headache frequency of 26.92 days per month (out of a 28-day month) 
(Magnusson and Becker, 2002).
The clinical presentation of CDH has been described in 4 studies. Table 2-4 
summarises the findings of these studies. Drawing conclusions on the features of 
CDH is difficult, due to the differences in study designs. The items or headache 
features included within the different studies were not consistent. Furthermore, the 
type of headache studied and the diagnostic criteria used differed between the 
studies. The French study based their headache classification on the IHS criteria 
(Lanteri-Minet et al., 2003). The study by Galego et al (2002) compared episodic and 
ti'ansfonned migraine and only included 40 patients of each diagnosis. 
Krymchantowski and Moreira (2001) compared male and female CDH patients, 
including 3 of the 4 different types of CDH (as defined by Silberstein et al, 1994). 
They analysed the data according to gender, and not according to the type of CDH, 
despite headache features differing between the various types of CDH. Also, the 2 
studies in Brazil (Krymchantowski and Moreira, 2001; Galego et al., 2002) have 
been carried out in headache specialist centres. The headache population within 
specialist centres may differ from headache sufferers in the general population, who 
do not consult headache specialists or specialist headache centres, and therefore the 
findings o f these studies may not be generalisable to the general population.
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2.4.3. Factors influencing CDH
The most commonly reported factor to cause or contribute to the development of 
CDH is medication overuse, although more recently questions as to whether 
medication overuse is a consequence rather than a cause of CDH have been raised. In 
most instances, CDH is a progressive form of a primary disorder (usually migraine), 
that is likely to be influenced, if  not determined, genetically (Srikiatkhachom, 2002). 
A recently published debate presents both data supporting and rejecting medication 
overuse as a cause of CDH (Tepper and Dodick, 2002). More than half of CDH 
patients who are detoxified improve (usually by their headache pattern returning to 
episodic migraines), particular ly if prophylaxis follows detoxification. However, not 
all episodic migraine patients who overuse medication develop CDH, and not all is 
caused by medication overuse. Furthermore, as outlined in the debate, population- 
based studies have shown that the majority of patients do not overuse medication. 
Therefore, the debate concludes that it appears that causality is bi-directional and that 
daily headache and medication overuse may coexist.
Some associations between CDH and other medical conditions have been 
investigated and specific types of CDH have been shown to be strongly corr elated to 
certain somatic conditions or behaviours. CM is associated with allergies, asthma, 
hypothyroidism, hypertension and daily consumptiorr of caffeine and CM with 
analgesic ovemse was associated with hypertension and daily consumption of 
caffeine (Bigal et al., 2002b).
Little is known about the long-term prognosis of CDH, but a study in Taiwan 
provides insight into outcome predictors. At the 2-year follow-up for the study 
population in Taiwan, 35% of the CDH patients still had CDH (Lu et al., 2001).
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Significant predictors for chronic CDH were age > 40, CDH onset after 32 years of 
age, CDH duration over 6 years, medication overuse and ‘daily’ headaches.
2.5. The impact of migraine and CDH
Not all symptoms outlined by the IHS criteria for migraine need to be present to 
diagnose a patient with migraine. This flexibility of the criteria and the presence or 
absence of the aura, prodromes and postdromes already indicate the heterogeneous 
nature of the disorder, hideed, migraine is highly individual and different people are 
affected at different levels of severity. Migraine changes over time, thus affecting 
sufferers differently at different points o f their lives. The impact of migraine can be 
reduced through the use of management strategies, as was shown by a study of 
members of the Dutch Society of Headache Patients (Vos and Passchier, 2003). 
Seventy percent of the sample (n=448) reported reduced headache impact. Those 
patients who reported reduced impact had less migraine attacks and a higher quality 
of life. The most frequently reported reasons for reduced impact was a change in 
medication (77%). Other reasons included a change in life-style (56%), more relaxed 
coping (42%), reduction o f sti'ess in general (28%), reduction of work-related sti'ess 
(24%), more regular life-style (21%) and social support strategies such as the support 
by the Dutch Society o f Headache Patients (58%) and family (46%).
Headache severity and fr equency in migraine and CDH give some indication of the 
impact of these headaches and of the disruption they can cause to the sufferers’ lives. 
Since the heterogeneous nature of migraine makes it difficult to capture its severity, 
other measures, along with the frequency, pain severity and dur ation of headaches 
have been used to describe the burden of migraine. The impact of migraine has been 
a current topic of interest within headache research and multiple studies have been
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published. The impact of CDH has also been investigated, but fewer studies have 
focused on CDH rather than migiaine impact. This following section will discuss the 
impact of migraine and CDH in the following areas: quality of life, disability, lost 
time and cost.
2.5.1. Quality of life
Health-related quality of life (HRQoL) is one measure to assess the burden of 
migraine. HRQoL instruments measure global aspects o f a person’s health status 
over a period of time, including time with and without illness (Dahlof and Solomon, 
1998). Studies have shown that migiaineurs have a poorer quality o f life (QoL) than 
the normal, healthy population (Table 2-5). QoL is also poorer in severe migraineurs 
than in people suffering from other chronic diseases that are considered a more 
serious health problem, such as diabetes and hypertension (Table 2-5). Reduced QoL 
is also reported between attacks, when migiaine symptoms are absent (Dahlof and 
Dinemas, 1995). Decrements in QoL in migiaine are associated with increased lost 
activity days (Lipton et al., 1999), increased frequency of migraine attacks (episodic 
vs. transformed migraine) (Terwindt et al., 1998; Meletiche et al., 2001) and 
increasing levels of disability (Lipton et al., 1999). Over the last three months, TM 
patients had statistically (p<0.05) and clinically significantly lower QoL scores than 
migraine patients on physical functioning, bodily pain, general health, vitality, social 
functioning, role-emotional and mental health (as assessed by Short-Form 36 scores) 
(Meletiche et a l, 2001). fri France, using the QVM (qualité de vie et migraine) 
questionnaire, CDH patients scored significantly (p<0.01) worse than migraine 
patients (Lanteri-Minet et a l, 2003).
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HRQoL instruments, particularly those that are disease-specific, tend to be sensitive 
to the specific disorder (Lipton et al., 2000a). The disadvantage with QoL 
measurements is, that the instruments are often difficult and lengthy to score, are 
often not intuitively meaningful to the physician and are difficult to translate into 
economic terms. Therefore they are not suitable for routine use in clinical practice, 
where brevity, simplicity and clinical meaning are needed (Lipton et al., 2000a).
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2.5.2. Disability
The World Health Organisation (WHO) defines disability in terms of consequences 
of illness on ability to function in various settings, including paid work, household 
work and non-work activities (National Academy of Sciences/ Institute of Medicine, 
1991). Migraine causes little or no disability during mild attacks and prolonged 
incapacitation in severe attacks (Stewart et al., 1994a). The majority of migraineurs 
report at least some disability (Holmes et al., 2001a). Moderate disability was most 
common (40%), followed by severe impairment (30%) and women were more likely 
to suffer from severe disability than men (Sakai and Igaiashi, 1997). According to 
the Global Burden of Disease study (Murray and Lopez, 1997), severe migraine was 
rated as disability class VII, alongside dementia and quadriplegia. Levels of 
migraine-related disability have been assessed world-wide and are summarised in 
Table 2-6. All the studies used the IHS criteria for the diagnosis of migr aine.
Studies on disability for CDH have focused on TM to draw a comparison with 
episodic migraine. In Canada, no difference was found in the levels of disability 
between TM and EM (To and Wu, 1995). However, although the number of 
headache days between TM and EM were significantly different (p<0.001), the mean 
headache frequency of EM patients (9.22 headache days per 28-day month), was 
above the median migraine frequency.
Several studies have assessed disability using the MIDAS (Migraine Disability 
Assessment) questionnaire, which collects disability information in terms of missed 
days of paid work or school, housework and leisure time in the last 3 months 
(Stewart et al., 1999). In France, 74.2% of CDH patients reported some disability 
from their headaches. MIDAS scores of CDH were significantly worse than the
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scores of migraine patients (p<0.01), with CDH patients with migrainous symptoms 
scoring the worst (Lanteri-Minet et al., 2003). In a headache specialist centre 
population, although both migraine and TM patients were classed as severely 
disabled, according to their MIDAS scores (scores of 21 or more correspond to 
severe disability), TM patients reported significantly higher MIDAS scores (70.7 
versus 27.3, p>0.05) (Meletiche et al., 2001). A further study in a specialist headache 
centre used the MIDAS questionnaire to compare disability between TM and 
migraine patients (Bigal et al., 2003). Patients with TM had a mean of 66.7 days with 
headaches in the last 3 months, whereas migraine patients had 15.5 headache days 
(p<0.001). TM patients missed significantly more work or school days (5.3 vs.2.3; 
p=0.0007), had more days with reduced effectiveness at work or at school (11.9 vs. 
4.6; p=0.0001), missed more days of housework (16.5 vs. 3.3; p=0.0001) and missed 
more days of family, social and leisure activities (7.0 vs. 5.5; p=0.03). Patients with 
TM were more likely to be in the severe disability group (64.3% vs. 43.2%; p=0.01) 
and the mean MIDAS score for TM patients was 34.9 (severe disability) vs. a mean 
score 19.3 (moderate disability) for episodic migraine. However, the studies by 
Meletiche et al (2001) and Bigal et al (2003) have been earned out in a specialist 
sub-group of patients, and the findings may not be representative of the general 
population. Patients who do not consult at specialist centres may experience different 
levels o f disability.
Assessing headache-related disability is important, since disability information has 
been shown to be an important determinant of physicians’ judgements of migraine 
severity and treatment needs (Slater et al., 1999). Furthermore, disability, through 
lost time, particularly from work, captures the economically most significant aspect 
of migr aine (de Lissovoy and Lazarus, 1994).
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2.5.3. Lost time
Lost time arises from absenteeism and from reduced productivity. Time is lost from 
school, work, family and social lives due to migr aine. The inclusion of time lost due 
to reduced productivity is important, since migraine sufferers avoid taking time off 
work for headache (Michel et al., 1999). Migraine sufferers spent 15.5 days at work 
with migraine vs. 2 days of absenteeism due to headache a year (Clarke et al., 1996). 
Time lost is highly individual, thus reflecting the highly individual severity of 
migraine. In the UK, 76% of migraine patients had not taken any time off work in the 
thr-ee months prior to the surwey, 13% had taken 1 day, 6% had taken 2 days, 6% 3-5 
days, and 1% over 6 days (Clarke et al., 1996). Despite avoiding sick leave for 
headache, overall sickness-related absenteeism in migraine patients is higher than in 
controls, due to migraine co-morbidities (Michel et al., 1999). In Canada, mean 
productivity losses due to migraine amounted to 84 horns of paid work, 48 hours of 
unpaid work and 113 hours of leisirre time lost (Caro et al., 2000), for a total of 245 
hours lost per patient per year. Interest on lost time has mainly focused on time lost 
from work, because this captmes the economic burden of migraine.
2.5.4. Cost
The burden of migraine through cost is expressed through direct and indirect cost. 
Direct costs involve the medical costs, such as visits to the GP and specialist, 
medication and in the US, the use of emergency services.
For individual patients, direct cost averaged $280 (£120) per patient per year and 
indirect cost was estimated to be Can$ 1949 (£719) per patient per year in Canada 
(Caro et al., 2000). In France, per capita dmg consumption for CDH was six times
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higher (Euro 73.5 per year, i.e. £52.3 per year) than in the migraine group (Euro 11.5 
per year, i.e. £8.2 per year) (Lanteri-Minet et al., 2003). Overall, direct cost in 
Europe and Australia amounts to tens of millions of pounds per year (FeiTaii, 1998). 
The use of emergency services in the US mean that American direct cost of migraine 
are up to twice the cost o f Europe and Australia (Fen ari, 1997).
Indirect costs arise from time lost from work that can be attributed to migraine. 
Indirect cost in France was 5.22 billion French Francs (£500 million) per year, based 
on a total of approximately 0.7% of the annual number of working days lost on 
average per individual (Michel et al., 1999). In a Tmst hospital in the UK, lost time 
due to migraine was estimated to be over £50,000 of work time each year (Clarke et 
al., 1996). The indirect cost of migraine in the UK has been estimated at £611 
million (Cull et al., 1992). Annual indirect cost in the US was estimated to between 
$1.4 to 17.2 billion (de Lissovoy and Lazains, 1994).
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2.6. Migraine and CDH Management
At present, there is no complete “cure” for migraine (Lance and Goadsby, 1998). 
However, a wide range of management stiategies is available to help deal with the 
attacks, achieve relief of pain and associated symptoms and to improve the quality of 
life of the sufferers. Management stiategies include pharmacological and non- 
pharmacological strategies for either acute or prophylactic treatment of migraine.
2.6.1. Pharmacological management of migraine
The phaimacological treatment of migraine is divided into acute and prophylactic 
treatment. In recent years, guidelines and scientific articles have been published to 
help doctors choose appropriate treatment for their patients. Different sets of 
guidelines have been published in various countries, such as the ‘Migraine in 
Primaiy Care Advisors’ (MIPCA) guidelines in the UK (Dowson et al., 2000), the 
‘US Headache Consortium’ guidelines in the US (Silberstein and the US Headache 
Consortium, 2003), the ‘Deutsche Migrane und Kopfschmerzgesellschaft’ (DMKG) 
in Germany (Diener et al., 2000) and guidelines for diagnosis and clinical 
management (Pryse-Philipps et al., 1997a) and non-pharmacological management in 
Canada (Pryse-Philipps et al., 1997b). No international guidelines have been 
published by the IHS. It may not be feasible to try and implement international 
guidelines given the vaiiations between health caie systems of different countiies.
The following sections describe both acute and prophylactic migraine treatments, and 
give a brief overview on how the treatments ai e selected.
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2.6.1.1. Acute treatment of migraine
Goadsby and Oleson (1996) divided drug-based acute migraine treatments into 2 
categories: non-specific and specific compounds. Non-specific treatments are 
analgesics with anti-pain actions that are not specific to migraine. Specific 
compounds with anti-migiaine action do not have any general anti-pain actions, such 
as non-steroidal anti-inflammatories (NSAIDs) and combination analgesics and anti­
emetics.
Specific compounds, which are prescription medications, include ergotamine 
(ergotamine tartrate or dihydroergotamine) and triptans. Ergotamine has been used in 
the treatment of migraine for over 50 years (Lance and Goadsby, 1998). Triptans 
were only first introduced about ten years ago. Triptans have dramatically changed 
the treatment of migraine and are often the dmg of choice for moderate to severe 
migraine (Goadsby, 1999; Goadsby and Oleson, 1997). The triptans, currently 
available in the UK aie sumatriptan (hnigran), zolmitriptan (Zomig), rizatriptan 
(Maxalt), naiatriptan (Naramig), eletriptan (relpax), almotriptan (almogran) and 
fi*ovatiiptan (migard). The triptans are available in different formulations, including 
tablets, wafers, nasal sprays, injections and suppositories.
All migraine patients need acute medication (Lipscombe et al., 2003) and most 
patients need acute treatment only for episodic migraine (Tfelt-Hansen and Welch,
1993). Mild to moderate attacks may be treated with the non-specific medications, 
whereas moderate to severe attacks should be treated with the specific prescription 
medications (Celentano et al., 1992). Acute treatment should be tailored to the 
individual patients’ clinical and personal needs, which aie determined by assessing 
migiaine severity, migraine impact, headache frequency and duration, and the
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patients’ co-morbidities, individual lifestyle needs and preferences (Lipscombe et al., 
2003).
2.6.1.2. Prophylaxis of migraine
Some patients need prophylactic medication in addition to their acute treatment. Few 
migraine sufferers take prophylactic medication (Clarke et al., 1996; Edraeads et al., 
1993). Prophylaxis may be recoimnended for a frequency of or above 4 attacks per 
month (Dowson et al., 2000); for particularly severe and disabling attacks; when 
acute treatments are contra-indicated, ineffective, over-used or have serious side 
effects; in special circumstances such as hemiplegic migraine or the when the patient 
is psychologically unable to cope with the attacks (Tfelt-Hansen and Welch, 1993; 
Silberstein, 1997; Lance and Goadsby, 1998; Silberstein et ai., 1999). Preventive 
medications are given on a daily basis, whether or not the patient is suffering from a 
headache (Silberstein et al., 1999). Treatment can be episodic, sub-acute or chronic 
(Silberstein, 1997). Even with successful preventive treatment, the medication should 
be giadually withdrawn after 6 to 12 months, to ascertain whether prophylaxis is still 
necessary (Tfelt-Hansen and Welch, 1993). The main drugs that are used for 
migraine prophylaxis include beta-blockers, anti-depressants, calcium channel 
blockers, serotonin agonists, anti-convulsants and non-steroidal anti-inflammatories 
(NSAIDs) (Silberstein, 1997; Lance and Goadsby, 1998; Silberstein et al., 1999). 
The obvious initial choice of prophylaxis in the UK is a beta-blocker, which is the 
only prophylactic drug licensed for migraine in the UK (Lipscombe et al., 2003).
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2.6.2. Non-pharmacological management of migraine
Non-phamiacological treatments are employed both acutely and prophylactically. 
There aie two main types o f non-pharmacological management: self-help measures 
and alternative therapies. Prophylactic non-phaimacological management (self-help) 
aims to help the migiaine sufferer identify situations that make the attacks worse and 
to encourage their modification (Goadsby, 1999), such as trigger identification and 
avoidance and lifestyle changes, such as regular meals and sleep and avoiding stress. 
Non-phaimacological prophylactic methods to treat migiaine also include 
approaches such as psychological management, relaxation, biofeedback, meditation, 
hypnotherapy, acupuncture, exercise, elimination diets, behavioural modification, 
herbal remedies such as Feverfew, osteopathy and chiropractic treatment (Lance and 
Goadsby, 1998) and education, coping skills training (Gauthier et al., 1996).
For alternative therapies, there is some evidence for the effectiveness of acupuncture 
(Allais et al., 2002); homeopathy (Walach et al., 2000) and chiropractic spinal 
manipulation (Tuchin et al., 2000). The herbal remedy Feverfew has also been shown 
to be effective in two studies (Jolinson et al., 1985; Muiphy et al., 1988). However, 
the study by Muiphy et al, although a randomized, double-blind, placebo controlled 
trial, only included 59 patients (18 of which had previously tried Feverfew and 11 
had found it helpful) and migraine was not diagnosed according to IHS. The study by 
Johnson included only 17 patients and tested discontinuation of Feverfew, rather than 
the effect of the herb. The positive findings of these 2 studies have not been 
confirmed in a larger double-blind, multi-centre, randomized placebo-controlled 
dose-response study, comprising 147 IHS migraine patients. This study failed to 
show a significant prophylactic effect of Feverfew (Pfaffenrath et al., 2002).
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A comprehensive review of empirical findings from contiolled studies on non- 
pharmacological treatments for migraine has been presented by Gauthier et al., 
(1996).
2.6.3. Management of CDH
Studies on the management of CDH focus on prophylactic tieatment and in the case 
of TM, breakthrough migraines are treated with the same acute treatments that are 
used in the acute treatment of episodic migiaine. In 1999, Rothrock concluded that 
there were few reports on treatment trials for the management of CDH and that 
clinicians use anecdotal and personal experience to guide CDH management 
(Rothrock, 1999). Based on previous data, Rothrock proposed 4 different pathways 
for pharmacological treatment, sequential administration o f divalproex sodium, 
amitriptyline, amitriptyline plus phenelzine or methadone. Outcome was considered 
successful treatment if  more than 15 headache free days within 30-day period were 
achieved. Sixty-seven percent of patients reported a 50% or greater reduction in 
headache days per month following initiation of treatment. Divalproex sodium was 
attributed the most positive tieatment response, but was the first treatment 
administered. The other treatments were only given if this treatment was 
unsuccessful and few patients proceeded to the next treatment. Furthermore, the 
study only included 33 patients, o f which only 29 completed treatment and there was 
no control gioup.
To help evaluate the pharmacological management of CDH, (Redillas and Solomon,
2000) have summarised the studies on prophylactic agents that have been reported to 
be effective in the treatment of CDH. This study shows the extent of publications on 
the prophylactic management of CDH. However, as the authors concluded many of
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the reports on CDH prophylactics are anecdotal and have often been published as 
abstracts or letters to the editors and most studies are open rather than double-blind 
studies, with the majority not defining criteria for efficacy and using a small number 
of patients. Still, the study revealed that there is a great availability o f prophylactic 
pharmacological agents for CDH, of which only anti-depressants have been studied 
extensively. Prophylactic medications include anti-depressants (tri-cyclic, 
tetracyclics, monoamine oxidase inhibitors, selective serotonin re-uptake inhibitors); 
anti-convulsants, muscle relaxants, 5-HTi agonists, ergots, 5-HT2 agonists, anti­
anxiety agents and miscellaneous drugs.
In other types of headaches, the use of non-pharmacological management is 
recommended in adjunction to drug therapy. Thus non-pharmacological management 
may also be a suitable method in the management of CDH. Two studies have 
investigated the use of non-phaimacological management of CDH, but these 
management techniques have been studied in conjunction with pharmacological 
treatments and both studies have focused on only one type of CDH and one type of 
non-pharmacological management.
A randomized contiol trial in the US (Holroyd et al., 2001) showed that both tricyclic 
anti-depressants and stress management therapy produced greater reductions in 
headache activity, use in analgesics, and headache related-disability than placebo 
after 6 months. Improvement occuired more rapidly with anti-depressants than with 
stress management. Combined therapy of anti-depressants and stress management 
was more likely to produce a clinically significant effect (i.e. 50% or more reduction 
of headaches) than anti-depressants (p=0.006), stress management (p=0.003) or 
placebo (p=0.001). However this study was carried out in CTTH patients only.
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The combined treatment of medication and biofeedback for the treatment of TM has 
been investigated in one study (Grazzi et al., 2002). Patients (n=69) with TM with 
analgesics overuse were recmited through a neurology institute in Italy. The study 
showed that at 36 months follow-up, patients who had received the combined 
tieatment (n=14) had a significantly greater reduction in headache days (18.1 vs. 
11.2) (p<0.01) and used significantly less analgesics (monthly consumption 4.9 vs. 
20.1) (p<0.01) than patients in the pharmacological tieatment group (n=32). Within 1 
yeai', 20% of patients of the pharmacological treatment group and in 10% of the 
patients in the combined treatment group relapsed into CDH. After three years, 
significantly more patients (42.1%) in the pharmacological treatment group had 
relapsed vs. 12.5% of patients in the combination treatment group (p<0.04). 
However, as with other studies on the management of CDH, the sample size was 
small and few patients completed the study. Furthermore, there was no control group, 
although the phannacological treatment group could be considered a control group.
2.7. Summary
Migraine and CDH are primary headaches that affect a large proportion of the 
general population. Migraine and CDH can vary in their symptomatology and some 
patients are more severely affected than others. Generally, patients who suffer from 
migraine or CDH report high levels of headache-related disability and have a 
reduced quality of life. Due to the higher frequency of their headaches, CDH patients 
are more significantly affected by their headaches than patients who suffer fiom 
episodic migraine.
A multitude of stiategies to treat and prevent these headaches is available. Strategies 
include pharmacological and non-pharmacological treatments both for acute
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treatment and the prophylaxis. The specific treatments given to a patient vary 
depending on the patients’ level of headache severity, frequency and duration, as 
well as level of disability and the patients’ individual needs and preferences.
The following section sets out to describe migiaine and CDH management in clinical 
practice, including consultation rates, factors influencing consultations and proposed 
solutions to maximise the outcome of consultations in terms of achieving appropriate 
management for patients. Finally, the patients’ management, including 
pharmacological and non-phaimacological behavioui's will be described.
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2.8. Migraine and CDH in clinical practice
2.8.1. Migraine in clinical practice
When consulting a doctor, General Practitioners (GPs) are the most common primary 
medical contact for migiaine sufferers, as most migraine patients have access to 
primary care, with only a small minority having access to neurologists (Shapero, 
1999). It is thought that GPs aie well suited to manage migraine because of their 
position within the health care system and their long-standing relationship with the 
patient (Shapero, 1999). Indeed, most of the consultations for migraine were with a 
GP (41%); 26% of migraine sufferers had consulted a specialist and 15 % had 
consulted other health care professionals (Lavados and Tenhaimn, 2001). When 
patients consult a doctor, effective migiaine treatment includes making a diagnosis, 
explaining the condition to the patient, developing a tieatment plan and setting 
priorities to deal with the symptoms that the patient finds the most disturbing 
(Silberstein et al., 1999).
2.8.1.1. Consultation rates for migraine
Consultation rates for migraine have increased in the last decade, but still 
consultation rates remain lower than estimates fi*om prevalence studies (Holmes et 
al., 1999). From 1990 to 1998, doctors’ consultations for migraine doubled fiom 9.4 
visits per 1000 persons to 18 consultations per 1000 persons (Gibbs et al., 2003). In 
the UK, general practice consultations for headache significantly increased from 
1993 to 1997 (Laughey et al., 1999).
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Studies concerned with doctors’ consultation rates for migraine mainly examine the 
proportion of migraine patients who consult and who do not consult. The 
consultation rates are usually linked to a time frame and often a one-yeai* period has 
been used as a cut-off point. According to Lipton and Stewart (1999), migraine 
patients who had ever consulted a physician aie divided into two groups: those who 
had consulted within the last year (cunent consulters) and those who had not seen a 
physician within the last year (lapsed consulters). Fewer data are available on follow- 
up consultations or lapsed consulters than ever consulters. Based on their 
consultation definition, Lipton and Stewait (1999) found that 46.7% of migraine 
patients were current consulters, 20.6% were lapsed consulters and 32.3% had never 
consulted for their migraine. Other studies, that have investigated consultation rates 
over 12 months, found 5.6% male and 13.9% female consulters (age group 12-29) in 
the US (Linet et al., 1991); 30.6% in Japan (Sakai and Igarashi, 1997) and 45% in a 
more recent US study (Adelman et al., 2000a). A multi-national study, including the 
US, the UK, France, Germany and Italy showed consultation rates of 48% (range 41- 
63%) within the last 12 months (MacGregor et al., 2003).
Further studies have used other time frames to examine consultation rates for 
migiaine. In France, based on a 6-months time frame, significantly more migraine 
sufferers (76%) had consulted their GPs than contiols (69%) (Michel et al., 1996). 
However, these consultations were not necessarily for headache. Forty-seven percent 
of men and 60% of women reported having discussed headaches with a doctor 
(Michel et al., 1996). Another UK study revealed that only 32% of migraineurs had 
consulted a GP thiee months prior to the study (Clarke et al., 1996). Ever 
consultations (i.e. consultation for headache at some point in their lives) were 
reported by 13.6% of men and 26.7% of women (Linet et al., 1991), 64% in Canada
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(Ednieads et al., 1993); 68% of women and 57% of men in the USA (Lipton et al., 
1998), 63% of in Chile (Lavados and Tenhamm, 2001) and 75% in the UK (Dowson 
and dagger, 1999). The different time frames make it difficult to compare the 
findings of these studies, but it is generally accepted that the majority of migiaine 
patients do not cuirently consult their doctor about migraines. Furthermore, studies 
on consultation rates have mainly been canied out in the US. The differences in 
health care systems make it difficult to draw inferences from the findings on 
consultations, since the health caie systems may influence consultations and findings 
from one country may not be applicable to other countries. Differences in health care 
systems include the use of emergency rooms for migraine treatment and managed 
care in the US and the National Health Seiwice (NHS) and the GP gate-keeping 
system in the UK.
Follow-up consultations are less widely studied. The available data shows that 
follow-up consultations are rare and rates decrease rapidly. In Canada, only 32% of 
migiaineurs returned for follow-up care (Edmeads et al., 1993) and in the US 32% 
had lapsed from care within 1 year (Adelman et al., 2000a). Less than half of the 
Chilean migraine consulters (36% of men and 47% of women) underwent treatment 
within the practice for more than one year (Lavados and Tenhamm, 2001). Forty-six 
percent of British patients only consulted once and the mean number of headache 
consultations was 3.09 per consulting patient (Laughey et al., 1999), which is low 
considering that many patients suffer from migraine for most of their life.
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2.8.1.2. Type of health professional consulted and frequency 
of consultations
Studies on the type of health professional consulted generally focus on consultations 
with the doctor for migraine and there is little evidence on consultations with other 
health professionals. Consultations with doctors predominantly occur within the 
primary care setting, both in terms of initial consultations and frequency of 
consultations (Lipton et al., 1998). Initial consultations in the US were with the 
general/family practitioner (46.4% of women and 48.1% of men), neurologist (13.6% 
of women and 10.4% of men), internist/ paediatiician (11.5% of women and 14.1% 
of men), obstetrician/ gynaecologist (4.2% of women), ophthalmologist (3.6% of 
women and 1.9% of men), emergency physician (3.4% of women and 1.9% of men), 
pain/headache specialist (1.6% of women and 4.7% of men) and other (15.7% of 
women and 18.0% of men). Most frequent consultations were with the 
general/family practitioner (43.8% of women and 38.5% of men), neurologist (12.3% 
of women and 10.3% of men), internist/ paediatiician (14.9% of women and 15.4% 
of men), obstetrician/ gynaecologist (2.6% of women), ophthalmologist (0.4% of 
women), emergency physician (0.9% of women), pain/headache specialist (1.3% of 
women and other (23.8% of women and 23.8% of men) (Lipton et al., 1998).
Based on medical records in the US, primary care physicians (family medicine, 
internal medicine, paediatiics and obstetiics/ gynaecology) were the most frequently 
consulted doctors for migraine consulted (72.2%) (Gibbs et al., 2003). Neurologists 
only accounted for 17.3% of consultations, but they had the highest fr equency of 
consultations per physician (87.4 visits per physician per year) (Gibbs et al., 2003).
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As far as consultations with health professionals other than physicians aie concerned, 
few data are available. Edmeads and colleagues (1993) reported that many headache 
patients consulted chiropractors, acupuncturists, masseuses, homeopaths and 
nutritionists, but they did not give any details on consultation rates and/or frequency. 
A further Canadian study revealed that 15.1% of migraine patients reported 
consulting a nuise, 71.4% had consulted a dental practitioner, 42.5% an optician, 
23.9% a phaimacist, 6.9% a physiotherapist, 14.8% a chiropractor and 11.7% a 
psychologist, social worker or other counsellor (To and Wu, 1995). However, due to 
its design, this study did not allow to conclude whether these visits were for 
migiaine.
The data on the type of health professional consulted and frequency of consultation 
remain limited to the US (Lipton et al., 1998; Gibbs et al., 2003) and Canada 
(Edmeads et al., 1993; To and Wu, 1995). Thus again it may not be appropriate to 
draw conclusions on the type of health care professional consulted in other countries. 
Furthermore, the studies have focused on a variety of health care professionals, but 
the type(s) of health care professionals differed within each study. Apart from the 
study by Gibbs et al (2003), which examined medical records, the studies relied on 
the patients’ reports to investigate which types of health care professionals were 
consulted by migraine patients.
2.8.1.3. Consulters characteristics
Consultation behaviour differs not only between countiies, but also according to 
gender, marital status, level of education, headache characteristics, impact 
(disability) and medication use. Female migraine sufferers are more likely to ever 
consult than male migraine patients (Linet et al., 1991; Lipton et al., 1998; Lavados
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and Tenhamm, 2001; Gibbs et al., 2003). In female sufferers, consultation was also 
more likely with increasing age and being mairied (Linet et al., 1991; Lipton et al.,
1998). The highest frequency of consultations for migraine occurred in patients aged 
40 to 49 (25.8 visits per 1000 persons) (Gibbs et al., 2003). However, in Chile 
migiaine patients were more likely to consult if  they were younger (Lavados and 
Tenhamm, 2001). Migraine sufferers in the US and in Chile with a higher level of 
education were less likely to have obtained medical advice for headache (Linet et al., 
1991; Lavados and Tenhamm, 2001).
Men and women who had consulted a physician within the last year, reported their 
headaches to be more severe, of longer duration (women only), o f higher disability 
and were more likely to have migraine characteristics than headaches of persons who 
had not consulted within the last year (Linet et al., 1991; Lipton et al., 1998; Lavados 
and Tenhamm, 2001). However, in the USA, 61% of the sufferers who had never 
consulted reported severe or very severe pain and 67% reported severe disability 
(Lipton et al., 1998). In the UK, despite 94% of sufferers reporting suffering from 
moderate to severe headaches, only 32% had consulted their GP and 60% had never 
consulted a health professional (Clarke et al., 1996).
2.8.1.4. Patients’ beliefs and attitudes
Few studies have been published on the patients’ perspective o f migraine, and again 
they have predominantly been carried out in the US. Gaining better understanding of 
the patients’ beliefs and attitudes is important as beliefs and attitudes may have an 
influence on the patients’ consultation behaviour. Nearly 70% of the headache 
patients thought to cope as well as possible and as well as other headache sufferers 
(Bamat and Lake, 1983). Despite this, nearly half of the patients reported that their
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headaches caused frequent dismptions in functioning. In the UK, of migraine patients 
who had never consulted, 17% believed that their doctor would not treat their 
migraine seriously enough, 76% said that they did not need a doctor’s opinion to 
tieat their migraines, 52% reported that their headaches were not that bad and 50% 
said that they had a treatment option that worked (Dowson and Jagger, 1999). 
However, 42% of those with headaches in the US said that there was nothing the 
doctor could do, 41% said that seeing a doctor was too inconvenient and 32% said 
that seeing a doctor was too expensive (Lipton and Stewart, 1999). The lapsed 
consulters (65%) said they had not seen a doctor within the last year, because the 
prescribed treatment was working and 59% said that their headaches had improved. 
Conversely, 26% had lapsed because they thought there was nothing the doctor could 
do for their migraines, 20% said that their doctor did not help them and 15% believed 
that their doctor was not interested in headache (Lipton and Stewart, 1999). Another 
study showed that reasons not to seek medical advice included statements like the 
following: “it’s only a headache” (28%), “OTC treatments work for me” (32%), “the 
doctor would not be able to do any more for me” (10%) or “previous visit to a doctor 
was unsatisfactory/ treatment did not work” (6%) (MacGregor et al., 2003). At the 
same time, 65% of migraine patients from the US, the UK, Germany, France and 
Italy believe that not enough is being done to help them (Brandes, 2002).
To achieve better understanding of the patient and in response to the development of 
patient preference trials, research efforts have been focused on studying the 
migraineurs’ preferences and satisfaction. Studies included comparisons of 
medication formulation (tablet vs. wafer) (Adelman et al., 2000b), dosing (Dowson 
et al., 1999; Salonen et al., 1999) and different drugs (Pascual et al., 2001). Although
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these studies are important to understand the phannacological preferences of the 
patients, they do not provide the whole pictui e of patient preference.
These studies have been based on quantitative designs, and little opportunity has 
been given to the patients to fteely speak about their perceptions. If headache 
researchers want to truly understand the patients’ perspective, they will need to let 
patients speak freely and listen to the patients’ point of view, rather than obtain 
answers to questions determined by the researchers. Qualitative methods allow 
participants to speak freely and pemiit access to areas not amenable by quantitative 
methods. Qualitative methods have been advocated for use in headache research to 
gain access to areas such as the patients’ perceptions (Peters et al., 2002). One 
qualitative study, using focus groups, aimed to identify the areas that migraine 
patients consider the most problematic as living with their headache and the type of 
physician assistance the patients believe would be most helpful (Cottrell et al., 2002). 
Six main categories were identified, including: 1) effect on social functioning, 2) 
effect of family functioning, 3) effect on work, 4) effect on relationships, 5) issues 
related to physician care and 6) problems with insurance and drug companies. The 
authors concluded from their findings that migraine patients are interested in 
understanding their condition and in securing relevant information about migraines, 
as well as obtaining pain relief. Furthennore, the patients desired collaborative 
relationships and wanted a team approach to treatment that involved both patient and 
doctor.
2.8.1.5. Diagnosis
In the US, the proportion of patients reporting a physician’s diagnosis of migraine 
has increased from 38% in 1989 to 48% in 1999 (Lipton et al., 2001b). Still, a large
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proportion of migiaine sufferers world-wide report never having received a 
physician’s diagnosis for their condition, despite some of them having consulted. The 
proportion of migiaine sufferers reporting a physician’s diagnosis range from 33% in 
Japan (Sakai and Igarashi, 1997), to 44-48% in the US (Lipton et al., 1998; Lipton et 
al., 2001b), 46% in the Netherlands (Laimer et al., 1998), to 62% in the UK (Clarke 
et al., 1996). However, in the UK study, of the 1903 responders to the questionnaire, 
158 suffered from IHS migraine, but 293 had been diagnosed as suffering from 
migiaine by their GP (Clarke et al., 1996). One of the problems with diagnosis at the 
primary care level is a lack of familiarity with the IHS criteria and a lack of 
appreciation of the vaiiability in migraine within and between sufferers (Shapero,
1999).
In the US, the likelihood of receiving a physician’s diagnosis is increased in patients 
with higher income, migraine with aura, vomiting, higher disability, older age and 
being female (Lipton et al., 1992; Lipton et al., 2001b). Physician’s diagnosis is also 
related to the migiaine symptoms. Patients who reported having received a 
physicians diagnosis were more likely to report nausea, vomiting, unilateral pain, 
binned vision, aura, neurological signs, extremely severe head pain and the need for 
bed rest (Lipton et al., 2001b). In the Netherlands, migiaine patients from the lowest 
socio-economic group, who were either over 40 years of age or who suffered from 
photophobia, nausea and aura or who used analgesics more than 4 times per week, 
were more likely to receive a physician’s diagnosis (Launer et al., 1998).
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2.8.1.6. Problems with consultations for migraine and 
proposed solutions
2.8.I.6.I. Step-care versus stratified care
As outlined above, problems with consultations include low consultation rates, and 
under-diagnosis and under-treatment. One reason for the delay o f appropriate 
treatment may be the step-care approach (Lipton et al., 2000b), which prevails in 
migraine management. Step-caie involves first line tieatment with simple analgesics. 
Combination treatments and migraine specific drugs are only given as second or 
third line treatments. Duiing this period, sufferers often lapse from care æid never 
receive the benefits they need (Micieli, 1993).
Since under-treatment may be related to the step-care approach, Lipton et al (2000b) 
propose stratified cai*e as an alternative model for selecting therapy. Stiatified care 
involves treating patients based on their individual needs rather than escalating 
treatment when one tieatment has failed (step-caie). hiitial treatment in stratified care 
is based on headache-related impact. Stratified care may facilitate treatment choice 
by improving understanding of the patient’s needs. Stiatified care was investigated in 
the Disability In Strategies for Care (DISC) trial (Lipton et al., 2000b) to compare 
the clinical benefit of stratified vs. step-caie. Headache response was measured on a 
4-point scale (0-4, no to severe pain) at baseline, 1, 2 and 4 hours. Disability was 
recorded on a 0-100-point scale (0 represented inability to do any activities and 100 
was normal functioning). It was shown that stratified care provided significantly 
better clinical outcomes (headache response and disability time) than step care. Since 
the DISC trial has only been canied out recently, there is no evidence yet on its uses 
in clinical practice.
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2.8.1.6.2. The doctors’ perspective
Even headache interested doctors (neurologists, general practitioners, internists and 
others) do not fully understand the migraine patients’ perspective (Lipton and 
Stewait, 1999). The doctors correctly predicted the most important attributes of acute 
migiaine therapy (rapid pain relief, complete pain relief) and the patients preferred 
route of administration for acute drugs. But they failed to recognise the importance 
of lack of recurrence of the headache, to correctly predict the most frequent reasons 
for patients’ dissatisfaction with their acute medications and to identify the attributes 
that were important in consultations.
Since doctors often do not diagnose or ti*eat migraine effectively (Holmes et al., 
2001a), it may be assumed that physicians’ knowledge about migiaine management 
needs to be improved. Guidelines to help doctors deal with migraine have been 
published by several headache gi'oups and countiies. These guidelines ai*e based on 
clinical experience and evidence. In the UK, the ‘Migraine in Primary Care 
Advisors’ (MIPCA) (Dowson et al., 2000) have their set of guidelines. Other 
guidelines have been published in the US (Silberstein 2000), in Canada (Pryse- 
Philipps et al., 1997a) and in Germany (Diener et al., 2000). No international 
guidelines have been published by the IHS.
2.8.1.6.3. Communication and disability assessment
Clinical intuition suggests that doctors and patients do not always communicate 
effectively about headache, particulai'ly headache disability (Lipton et al., 1994). 
According to doctors only about one third of migraine sufferers report headache- 
related disability, when it is known that the majority of sufferers are affected. This 
information, in most cases had to be solicited by the doctor, but doctors ask for
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disability infoiTnation less often than other symptoms (Holmes et al., 2001b). This 
study was carried out with North American and Eui'opean neurologists and primary 
cai'e physicians with an interest in headache and it is likely that disability infoimation 
is sought even less often by physicians who do not have this special interest in 
headache. However, disability infoimation does affect treatment. The study ftuther 
showed that physicians were 27% more likely to rate migiaine severity as “severe” or 
“very severe”, if disability information was available. Also they were 37% more 
likely to recommend immediate acute plus prophylactic treatment, 41% more likely 
to choose triptans as a treatment, and 18% more likely to make a future appointment 
(Holmes et al., 2001b).
To help physicians assess migraine disability and to close the communication gap, 
two tools to assess migraine disability have been developed: the Migraine Disability 
Assessment (MIDAS) Questionnaire and the Headache Impact Test (HIT). MIDAS 
is a 7 question paper questionnaire. HIT is an internet questionnaire and is available 
as a printed version as HIT-6, a short form of HIT.
MIDAS shows the key attributes of a disability instrument, which can be used in 
clinical practice and epidemiological research, i.e. it is simple to administer, easy to 
score, reliable, valid and intuitive (Stewart et al., 1999; Stewart et al., 2001a). 
MIDAS involves grading migraine severity in terms of disability to allow appropriate 
treatment selection (Lipton et al., 2000b). The use of MIDAS has been shown in 
several studies, including the DISC study and studies to assess treatment needs and 
satisfaction. MIDAS grade 1 (no or little disability) patients predominantly (90%) 
use OTCs, and 92% were either satisfied or very satisfied with this treatment, with 
80% always achieving relief from their medications (Lipton et al., 2001c). MIDAS
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grade IV (severe disability) patients tend to use prescription medications and do not 
achieve high levels of satisfaction with their treatment(Stewart et al., 2001b).
HIT-6 has been shown to be a reliable and valid measure for the impact of headache 
(Garber et a l, 2001;Ware et a l, 2001). Scores for HIT and HIT-6 are easy to 
interpret and to compare (Dahlof et a l, 2001). Both tools aie suitable for use in 
clinical practice, since they are precise, brief and inform the physician about the 
degree of headache-related impact on of individual migiaine patients (Dahlof et a l,
2001). HIT scores were related to consultation rates, with the proportion of 
migraineurs increasing with increasing HIT scores (Dowson et a l, 2001).
2.8.2. CDH in clinical practice
2.8.2.1. Consultation rates for CDH
Consultation rates, as well as the type of physician consulted, consultation frequency, 
and factors influencing consultations, for CDH are less well studied than consultation 
rates for migraine. However, it is known that CDH is the most common reason for 
consultation in specialist clinical practice. In the UK, 60% of patients who had 
attended a specialist headache clinic suffered from CDH, and only 33% of patients 
suffered from migraine (Dowson, 2003). This study also showed that women were 
more likely to consult (65.2% of women vs. 34.8%) of men. In a community-based 
survey of Chinese elderly, it was found that only 23% of CDH patients had consulted 
a doctor for their headaches in the year* prior to the study (Wang et al., 2000).
In France, CDH patients consulted on average 5.36 times for headaches over 6 
months (Lanteri-Minet et al., 2003). Of these visits per subject per six months, 1.89 
were with GPs, 2.60 visits were with specialists, and 0.87 were with alternative
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medical practitioners. A total o f 46% of patients had consulted their GP. The number 
of GP visits was significantly higher for CDH than for other headaches. Psychiatrists 
were the most frequently consulted specialist, but ophthalmologists were the 
specialist consulted by the highest proportion of patients. In Taiwan, 57% of CDH 
patients had consulted physicians for their headaches during the last 12 months. 
Nineteen percent of patients had consulted physicians more than 10 times. Family 
doctors were consulted the most frequently (41%), followed by neurologists (28%) 
(Lu et al., 2001).
2.9. The patients’ management of migraine and CDH
As described in section 2.4, multiple strategies are available to treat and prevent 
migraine and CDH. However, the high levels of disability and severely impaired 
QoL of the patients suggest that patients do not adequately manage their condition. 
This may be due to a discrepancy between treatment availability and treatment use. 
To date, little is known about the use of non-pharmacological management, as 
research mainly focuses on the phannacological and medical therapies. However, 
studies on the use of pharmacological and medical management strategies, indicate 
that these strategies are under-used by patients. Therefore, the patients may need help 
to integrate these strategies within their self-management regimens.
Migraine, as described above, is under-diagnosed and consequently under-treated. 
Even sufferers who receive an accurate diagnosis may not receive suitable therapy 
(Lipton et al., 1994). The spectium of severity memis that diagnosis alone does not 
provide sufficient infomiation to allow the selection of optimal therapy (Lipton et al.,
1995). Furthennore, despite 83% of primary care consultations for migiaine being 
concluded with one or more prescriptions (Krobot et al., 1999), the majority of
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migraineurs use OTC medication for the treatment of their migraines. The 
predominant use of OTC medication, taken together with the low consultation rates 
and the under-diagnosis, may contribute to the patients’ low levels of satisfaction 
with their acute treatment (Celentano et al., 1992; Edmeads et al., 1993), the reduced 
quality of life and great burden of migraine. This section sets out to describe the 
patients’ use of management strategies, including phannacological treatment, factors 
influencing treatment, satisfaction with treatment, non-pharmacological management 
and the use of social support.
2.9.1. Pharmacological treatment of migraine
2.9.1.1. Type of treatment used
2.9.I.I.I. Over the Counter vs. prescription medication
Most migiaine sufferers rely on some form of pharmacological tieatment to help 
relieve their symptoms. Ninety-five percent of migraine patients in the US (Stewart 
and Lipton, 1993), 91% in France (Lucas et al., 2000) and 80.8% in Japan (Sakai and 
Igarashi, 1997) rely on some acute medication for their attacks. Five to eleven 
percent of migraine patients use prophylactic medication (Edmeads et al., 1993; 
Lucas et al., 2000).
World-wide the majority of migraine sufferers do not use prescription medications 
but rely predominantly on Over the Counter (OTC) preparations. The use of 
prescription medication ranges from 28% of migiaineurs in the UK (Clarke et al.,
1996) to 41% in the US (Lipton et al., 2001b) and 44% in France (Lucas et al, 2000). 
It could be assumed that patients who do not rely on prescription medication have 
low treatment needs and low levels of disability. However, of the migraine patients
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reporting disability, 46.8% relied only on non-prescription medications (Kryst and 
Scherl, 1994). A high proportion of sufferers (34% of women and 43% of men) who 
have 3 or more migraines a month and 47% of female and 61% of male migiaine 
sufferers with moderate to severe disability do not use prescription medication 
(Stewart and Lipton, 1993).
In the US, 58.5% of women and 66.5% of men took OTC medication and 3.1% of 
women and 4.5% of men did not take any medication (Celentano et al., 1992). In 
France, more than twice as many migraine patients had taken OTCs than prescription 
medication (44 vs. 91%) (Lucas et al., 2000). Japanese migraine patients also 
predominantly relied on OTC medication (56.8%) (Sakai and Igarashi, 1997). In the 
UK, more than half of migraine sufferers were taking simple analgesics to treat their 
attacks (Dowson and Jagger, 1999).
Even when on prescription medication, migraine patients still rely on taking 
analgesics (Dowson and Jagger, 1999). In Japan, only 5.4% of migraine patients 
relied solely on prescription medication, whereas 18.6% used both (Sakai and 
Igarashi, 1997). In a multi-national study, including the UK, 53% of patients 
supplemented their prescription medication with OTCs medication (MacGregor et 
al., 2003). Sufferers try a range of medication and do not necessarily believe that 
their current medication is the best they have ever tried (Dowson and Jagger, 1999). 
Different types of acute migraine medication are not only used to treat separate 
attacks, but in any given migiaine attack, 38.4% of patients used a second type of 
treatment and 10.7% a third (Lucas et al., 2000).
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2.9.I.I.2. Types of medication
The majority of studies have concentrated on the differences in use of OTC and 
prescription medication. One multi-national study also investigated the types of 
medication used. The most common types of treatment prescribed for migraine were 
simple analgesics (38%) and NSAIDs (18%). Triptans were prescribed only to 10.4% 
of patients (range 3% in Italy to 19% in the US) (MacGregor et al., 2003).
2.9.1.2. Factors influencing medication use
The use of prescription medication is higher in women than in men (Stewart and 
Lipton, 1993), which is not smprising since female migraine patients are more likely 
to consult than male migraine sufferers. Other factors influencing the prescription of 
medication are certain migraine symptoms (vomiting and aura), high frequency, high 
disability, and duration of the attacks (Celentano et al., 1992). Patients’ decision­
making on which drug (sumatriptan vs. analgesics) to use to treat an attack is 
influenced by the efficacy of the drug selection, pain severity and other migiaine 
characteristics, contextual and environmental factors and expectations (Ivers et al.,
2000). Interestingly in France, migraine patients with the highest attack frequency 
(>1 migraine per week) were less likely to take medication than migraine patients 
with an attack frequency of 1-2 attacks per fortnight and patients with migraines less 
than once a month (55% vs. 73-78%) (Michel et al., 1996).
2.9.1.3. Satisfaction with pharmacological treatment
The low level of satisfaction with treatment illustrates that migraine treatment is sub- 
optimal. Only 29% of migiaine sufferers in the US (Lipton et al., 1998) were “very 
satisfied” with their acute treatment. In the UK, less than 1 in 4 patients were totally
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satisfied with any of the migraine treatments (Dowson and Jagger, 1999). A more 
recent international study showed that only 27% of migraine patients reported that 
their medication was consistently effective and associated levels of satisfaction were 
low, with only 36% of migraine patients being ‘veiy satisfied’ with their current 
therapy (Brandes, 2002). Only about 19% of Canadian migraine sufferers achieved 
complete relief with their acute treatment, and 62% were partially relieved (Edmeads 
et al., 1993). Sufferers most frequently reported dissatisfaction about overall relief, 
delayed onset of relief and the incidence of side effects (Lipton et al., 1998). The 
determinants of patients’ satisfaction with their acute migiaine treatment included 
being pain fiee at 2 houi's, absence of associated symptoms and lack of headache 
recunence (Davies et al., 2000). These deteiminants of satisfaction are current 
clinical endpoint in trials on migraine tieatment.
2.9.2. Non-pharmacological treatment
The use of non-pharmacological treatment for the management of migraine are 
advocated by headache specialists (Pryse-Philipps et al., 1997b; Dowson et al., 2000; 
US Headache Consortium, 2000), but they have not been as extensively studied as 
physicians’ consultations and medication use. Data include infonnation on the 
patients’ behavioural and coping responses to headache and the use of alternative 
therapies. These studies show that these non-pharmacological management stiategies 
are usually employed in conjunction with the more widely studied physicians’ 
consultations and medication use.
In the US, patients with migraine, TTH or a combination of migraine and TTH 
showed that the patients were all active users of behavioural management during a 
headache (Scharff et al., 1995) (Table 2-7). Behavioural responses differed
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according to the headache diagnosis. TTH patients were significantly less likely to 
engage in the behavioural responses (p<0.01 for all behaviours), including 
avoidance/ reduction of light, reduction of social contacts or sleep and carrying on 
despite the pain. No significant differences were found between the TTH and 
combined headache group, and the only significant difference between migraine and 
the combined group was that migraine patients were significantly more likely to 
reduce social contact (p<0.002).
Table 2-7: Percentage of patients reporting coping behaviours at least 
sometimes (Scharff, Turk, & Marcus 1995)
Take time off 75.0 78.3 73.1 69.3
Avoid physical 
activity
91.2 94.2 88.2 90.0
Avoid/reduce
lights
87.9 94.2 76.9 90.4
Avoid/reduce
noise
92.5 95.7 88.5 92.3
Reduce social 
contacts
86.7 95.7 78.9 82.7
Lie down 90.8 94.2 82.7 94.2
Go on with 
activities
81.7 71.6 71.6 88.2
Take medication 93.0 92.7 92.7 94.2
Sleep 75.6 83.6 83.6 76.9
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In the UK, 13% of migraine patients used alternative therapies such as homeopathy, 
yoga and acupuncture (Clarke et al., 1996). In Japan, 40% of patients used sleep, 
21% used shoulder and neck massage, 12% used compressions of the head and 9% 
used cooling of the head to relieve migraine (Sakai and Igarashi, 1997). Portuguese 
patients spontaneously reported using an average of 2.9 manoeuwes to help relieve 
migraine pain. When prompted by a questionnaire, the patients reported an average 
of 6.4 behaviouis (Pavâo Mailins and Parreira, 2001a). However, this study only 
included 55 migraine patients recruited from a specialist headache outpatient clinic. 
In a ftuther study by the same authors, a comparison was drawn between migraine 
and TTH patients behavioural response to headache (Pavâo Martins and Parreira, 
2001b). This study showed that migraine patients used more strategies to relieve pain 
than TTH patients (average o f 6.2 vs. 3). The percentage of patients using the 
specific strategies, fiom both studies, are summaiised in Table 2-8. The most recent 
study on the patients coping behaviours was an international study in 5 countries (the 
US, the UK, Germany, France and Italy). This study revealed that 62% of patients 
supplemented their prescription medication with bed rest, 33% with avoidance of 
triggers, 20% with stress management, 19% with relaxation therapy, 18% with 
régulai" exercise, 14% with herbal remedies and 7% with homeopathic remedies 
(MacGregor et al., 2003).
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Table 2-8: Behavioural responses to headache by Portuguese migraine patients 
comparison of 2 studies.
Take medication 98.2 100
Changing eating habits --- 85.7
Avoid foods/ not eating 61.8 62.9
Eat special foods 23.6 22.9
Vomit --- 80.5
Spontaneously 67.3 59.7
Induced 16.4 20.8
Sleep 58.2 60
Local cold pads 50.9 50
Local pressure 78.2 74.2
Change position 100 97.1
Lie down --- 88.8
Use more pillows than usual --- 33.8
Do not move/ immobility 88.9 88.1
Isolation 94.4 95.3
Massage --- 3.8
Other 28.5
2.9.3. Pharmacological treatment of CDH
As for migraine, the majority of CDH patients use acute medications to treat their 
headaches. Also, as in migraine, the use of OTC medication was more common than 
the use of prescription medication. In France, 84.4% of CDH patients used acute 
medications, (55.0% used analgesics, 24.5% used NSAIDs and 5.3% used triptans), 
but only 43.0% of patients found this to be effective in relieving their headaches 
(Lanteri-Minet et al., 2003). In Taiwan, most CDH patients used OTC medications 
(73%), followed by 22% of patients using prescription medication and 5% of patients 
using both (Lu et al., 2001). In a UK specialist headache clinic, 66% of CDH patients
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used regular analgesia, and 14% had used triptans prior to their visit to the clinic 
(Dowson, 2003).
Given the concerns of medication overuse in the development of CDH and the actual 
use of acute medications by CDH patients, it is necessary to carefully monitor the use 
of acute medication. Of the 108 CDH patients in the study by Lu et al (2001), 34% 
had overused medication and 65% of the patients overusing medication had done so 
for more than 6 months in the previous year. Medication abuse was significantly 
more likely in older patients (p<0.005). According to tlie Silberstein et al. criteria 
(1994), 83.8% of female and 87% of male TM patients in Brazil overused medication 
(Kiymchantowski and Moreira, 2001). Headache prophylaxis is given to reduce the 
number of headache days and consequently the amount of acute medications taken. 
However, few patients use prophylactic medications, and the levels are as low as 5% 
in Taiwan (Lu et al., 2001) and 6.6% in France (Lanteri-Minet et al., 2003). The 
highest use of prophylaxis was found in an audit in a UK specialist headache clinic, 
where 15% patients used prophylaxis at their initial visit (Dowson, 2003). At the 
clinic visit, 74% of patients were prescribed prophylaxis (Dowson, 2003).
2.9.4. Patient management behaviour- comparison of episodic and 
chronic headache
One study explored and compared the episodic (EH) and chronic (CH) headache 
patients’ behaviour of analgesic dmg taking (Fenari et al., 1997). CH patients had a 
headache frequency of above 15 days per month. The study showed that the majority 
o f patients (54%, 56.1% of EH and 23.8% CH) thought it was better to treat with 
OTC medications, 39.3% EH and 21.7% CH patients preferred prescription analgesic 
and 4.6% EH and 9.5% CH preferred not to take medication. In terms of actual
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behaviours, 49% (52% EH and 44% CH) of patients used OTCs, 43% (40.9% EH 
and 46.5% CH) used prescription medication and 8% (7.1% EH and 9.5% CH) 
reported not to use any medication. The study also examined the patients’ use of 
analgesic on working days and on days off. On working days, 13% of patients 
reported to break off work, whereas 52% continued to work after taking medication 
and 35% continued to work without taking medication. On days off, 44% of patients 
discontinued their activities; 38 % took an analgesic and continued their activity and 
18% carried on regardless. The authors concluded that behaviour was significantly 
different on working days and on days off (p<0.0001), but they did not describe the 
direction of this statement. Furthermore, they compared the behaviours between the 
EH and CH in a table (Table 2-9 as given below), which showed that behaviours 
differed significantly between EH and CH patients on their days off (p<0.05), but 
again the authors did not describe the direction of this difference. Furthermore, the 
percentages given in the table for taking analgesics and carrying on working/ 
activities on days off, do not match with the overall percentage given for the two 
groups.
Table 2-9: Patients’ behaviours when headaches started on working day and on 
a day off (Ferrari et al, 1997)
Behaviour Episodic
Headache
(n=196)
Chronic
Headache
(n=84)
Episodic
Headache
(n=196)
Chronic
Headache
(n=84)
Went on working/ activities 
without taking any drug
38.8 26.2 16.3 22.6
Took analgesic and went on 
working/ activities
47.9 60.7 35.2 4.52
Interrupted work/activities 13.3 13.1 48.5 32.1
NB. Values given in percentages, * p<0.05
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2.9.5. The use of social support for the management of headaches
The patients’ use of social support for the management of their headaches has 
received little attention and no studies have directly investigated the patients’ use of 
social support. Still, the importance of social support has been shown by a study of 
members of the Dutch Society o f Headache Patients. Of the study participants who 
reported reduced impact of their migraines, 58% attributed their reduced impact to 
social support offered by the Society, 46% to family support and 28% to the support 
of their GP (Vos and Passchier, 2003).
An American study investigated the volume and natuie of telephone calls over the 
period of one month in a specialist headache practice in the US (Loder and Geweke,
2002) and give an indication for the use of social support in the management of 
headache. A total of 165 calls were received (mean 3.17 calls per hour of clinic 
scheduled). The majority of calls (65%) were generated by 36% of callers. Of the 
patients who placed more than one call, 50% suffered from CDH, 53% had a 
personality disorder and 38% had both. Furthennore, not all the telephone calls were 
from the patients themselves, but as many as 27% of calls were placed by friends, 
family members, phamiacies, health professionals or insurance companies. The 
reasons for the calls included request for a refill (58%), report o f new symptom or 
side effect (17%), general request for infoimation (13%), request for treatment 
changes (5%) and discussion about the patient (5%).
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2.10. initiatives to improve patients’ self-management in 
headache
Chronic disease has become the principal medical problem and therefore the 
patients’ opinion has become increasingly important. Thus it is believed that the 
patient must become a partner, who contributes at almost every decision and action 
level (Holman and Lorig, 2000). The Depaitment of Health in the UK considers the 
expert patient as a new approach to managing chronic disease in the 21®^ century 
(Department of Health, 2001). A new chronic disease paradigm implies that the 
health professional is the expert about the disease, whereas the patients are the 
experts about their own lives. Patients aie empowered, which means that they accept 
responsibility to manage their own condition and are encouraged to solve their own 
problems with information, but not orders, from health professionals (Bodenheimer 
et al., 2002).
For the patient to be or to become an expert, patient self-management is inevitable. 
Self-management of chronic illness implies patients monitoring and managing 
symptoms, adhering to tieatment regimens, keeping a healthy life-style and 
managing the impact o f illness on daily functioning, emotions and social 
relationships (Schreurs et al., 2003). Good headache management requires the 
patients’ active participation in decisions regarding therapeutic interventions 
(Silberstein et al., 2000). Headaches mostly occur in the absence of health care 
professionals and therefore, the major responsibility for headache management lies 
with the patient.
To date, migiaine is under-treated and migraine and CDH patients continue to suffer 
considerable headache-related disability. Effective tieatments are available, but the
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high levels of suffering suggest that patients do not benefit from these treatments, 
either because they do not receive/ or use the management strategies or they fail to 
use the strategies effectively. Patients with chronic disease may need help in 
integrating the required self-management behaviours into their lives (Schi'eurs et al., 
2003).
The effect of headache education on quality of life and locus of control has been 
assessed on three different groups of migraine patients in the US (Allen et al., 2000). 
Group 1 (n=51) had participated in a 1-hour education session. Group 2 (n=13) were 
patients who had received individual headache education and Group 3 (n=15) were 
patients who reported not to have received any headache education. The findings 
showed that patients who had received headache education (either group or 
individual) had higher quality o f life scores than patients who had not received 
headache education. These findings were clinically significant, but it is not known 
whether the findings were statistically significant. No statistically significant 
differences were foimd between locus of control between the 3 groups. The 
population was selected fiom a neurology department, which may not be a 
representative sample for migiaine patients within the general population. Also the 
sample size was small and disproportionate.
One study assessed disease management (DM) for headache patients (n=264) 
attending a Headache Clinic in the US (Maizels et al., 2003). The patients included in 
the study suffered fi"om migraine (n=76), TM with medication overuse (n=205), TM 
without medication overuse (n=38), CTTH (n=3), CDH (n=14), cluster headache 
(n=5) and miscellaneous, missing or unknown (n=23). The programme started with a 
group education session led by a registered nurse practitioner. Patients were educated
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on migraine diagnosis, pathophysiology, triggers and treatments with emphasis on 
dmg rebound headache. The group session was followed by a consultation with the 
nurse practitioner or a doctor. Where appropriate, patients were prescribed a triptan. 
Although the cost of triptans increased by 19%, headache-related consultations 
reduced by 32% and emergency department consultations reduced by 49%. The total 
cost saving from the programme (taking into account the increase in triptan cost) was 
$18,757 (£11,254). The main outcome measure of the study was cost and the number 
of visits to the headache clinic and emergency department. The only patient outcome 
measured was headache frequency and the only result given was for patients who 
initially had suffered more than 2 severe headaches per week (n=75). Headache 
frequency was reduced in 86% of those patients. The reduced cost and lower use of 
headache clinics and emergency department may be inteipreted as showing that 
disease management programmes can be effective in headache management. 
However, the study did not have a control group and it is not possible to conclude 
whether any change in the direct cost of migraine was due to the programme. Also, 
with the study including headache patients with different diagnoses, it is not possible 
to conclude whether the outcomes differed between the headache types. Furthennore, 
there was no restiiction on how many tiiptans were prescribed and it cannot be 
concluded whether the change in direct costs was due to increased use of triptans, the 
patient education or a combination of the two.
Another DM programme was designed in the US to improve patient self­
management in migraine (Solomon et al., 2002). This programme aimed to
• increase the proportion of migraine patients who achieve symptom relief and 
return to normal activities within two houi'S after taking medication;
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• increase proportion of patients taking prophylactic medications (patients with 
more than 3 attacks per month)
• increase the proportion of patients reporting knowledge on potential triggers 
® decrease utilisation of emergency departments
• increase satisfaction with migraine treatment
® increase satisfaction with health plan and/or provider.
The results of this study are not yet available, although early feedback from patients 
and health care providers have been positive.
2.11. Summary
To summarise, migraine and CDH are prevalent, chronic conditions that can severely 
impair the patients’ quality of life. This review has described the diagnostic criteria 
for migraine and CDH and has outlined the wide range of management strategies, 
including pharmacological and non-pharmacological management strategies for the 
acute treatment and prophylaxis of migraine and CDH. Although effective 
management strategies are available, migraine and CDH patients continue to suffer. 
Thus, the review has examined the management of migraine and CDH in clinical 
practice, as well as the patients’ management, including medication use and the use 
of non-pharmacological management. Overall, the review has revealed that more 
studies have focused on the management of migraine than CDH. In line with this, 
initiatives to improve headache care have focused on migraine. Initiatives include 
tools to assess headache-related disability to improve communication between
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doctors and patients, the use o f stratified caie (vs. step-care) and the implementation 
of education or disease management programmes.
The review has also shown that the majority of studies examining the patients’ use of 
headache management strategies have adopted quantitative designs and there is 
scope to investigate migraine and CDH management using qualitative research 
methods. Furthermore, no study has been identified that investigated the complete 
picture of migiaine and CDH management. Qualitative methods are suitable to reveal 
the complex picture of the patients’ management behaviours. These qualitative 
findings can be used to undeipin and validate a quantitative study to make the 
qualitative findings applicable to a larger population and relevant to headache 
patients.
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Chapter 3: Research into headache: The contribution o f qualitative methods
3.1. Abstract
Concerned with understanding the world and perspective of those who are being 
researched, qualitative research aims to gain insight into new phenomena and to 
describe and explain complex realities and processes. Qualitative research is also 
useful to explain, interpret and validate quantitative findings and tianslate 
quantitative findings into clinical practice. Headache research has given little 
attention to qualitative methods and few qualitative studies have been published. 
This chapter aims to define qualitative methods, to compare it to quantitative 
research, and describe their contribution to health and particularly headache research.
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3.2. Introduction
Historically qualitative research has been used in anthropology and later in the social 
sciences. Initially, qualitative research struggled to find its place in health research. 
However, an increasing number o f resear chers want to better rmderstand qualitative 
research and the claims made by qualitative researchers about their findings (Mays 
and Pope, 2000a). Researchers attempt to maximise knowledge by using both 
qualitative and quantitative approaches and to answer new research questions that 
cannot be answered by quantitative methods alone. Such a strategy is important for 
progress in health research and practice. Consequently, the divide between both 
approaches and the respective researchers is diminishing. Qualitative research is 
increasingly applied in various areas of health research (Pope and Mays, 2000) and 
published in medical and related journals (Mays and Pope, 2000a).
The wider use of qualitative methods in health research (Pope and Mays, 2000) has 
not yet been adopted in headache research. Experimental or quantitative designs 
prevail in headache research and few qualitative studies have been published. This 
chapter sets out to define qualitative research methods and to explore their 
contribution separately and in conjimctron with quantitative methods in headache 
research.
3.3. Qualitative research
3.3.1. Compared to quantitative research
Belonging to a distinctively different paiadigm, qualitative reseai'ch is considered the 
antithesis of quantitative research. Quantitative research, based on a positivist
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paradigm, is experimental, deductive, numeric, and realist. Qualitative research, on 
the other hand based on an interpretive paradigm, is natuialistic, inductive, 
contextual, non-numerical, and constructionist (Richardson, 1994). The main 
strengths of quantitative reseaich are its reliability and generalisability, whereas the 
strengths o f qualitative methods are its validity and its potential to discover new 
areas, to identify patterns, to reveal and explain complexity and to develop, construct 
and test concepts/theories (Creswell, 1998; Pope and Mays, 1995). In qualitative 
research, the generation of hypothesis replaces the testing of hypothesis, explanation 
replaces measurement and understanding replaces generalisability (Jones, 1995). To 
outline their differences, the main features of qualitative and quantitative reseaich are 
outlined in Table 3.1.
3.3.2. Definition of qualitative research
The main aim of the interpretive paradigm, which underlies qualitative research, is to 
understand the world of those who are being researched (paiticipants), thus giving 
voice to those who are rarely heard (Soafer, 1999). To gain insight into the 
participants’ world, qualitative reseaich deals with the participants unique 
experiences o f naturally occurring events (Miles and Hubeiman, 1994) and/or 
social/human problems (Creswell, 1998) and their interpretations of these 
experiences (Jones, 1995; Sarantakos, 1998). As a holistic process of enquiry, 
qualitative research seeks to understand the phenomenon under study as a complex 
system that is more than the sum of its parts (Patton, 1990).
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Table 3.1: Comparision of qualitative and quantitative research
Aim Understanding Quantification
Exploration Measurement
Concept development Hypotheses
Verification
Analysis Taxonomy or classification 
Interpretive
Statistical
Approach/ reasoning Inductive Deductive
Conditions/ setting Natural Rational
Artificial
Experimental
Data Rich, deep, real Hard
Non-replicable Replicable
Non-numerical Numeric
Design Flexible Precise and thoroughly planned 
Structural 
Functionalist
Generalizability Tentative explanation o f  one time Generalizable to other places and
and one place other times
M ethodologies Interviews Experimental
Focus groups 
Participant observation
Survey
Perspective Insider Outsider
Point o f view o f  those who are 
being researched
Point o f  view o f researcher
Philosophical basis Naturalistic, interpretive paradigm Positivism
Research questions What is X? How big is X?
How does X vary in different How many Xs are there?
circumstances and why? How often does X occur?
What is the purpose o f X? How does X vary in certain 
circumstances?
Researcher Active Passive
Involved Distant
Sampling method Purposive Random
Theoretical Statistical
Study population Few Many
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Methods and methodologies
Qualitative research comprises different methodologies that shaie featmes such as 
open research question(s); a flexible, yet rigorous design; a small number of 
participants; purposive or theoretical sampling; no statistical analysis and the 
researcher as instrument of data collection, analysis and inteipretation. Qualitative 
research often adopts a ‘multi-method’ approach that reflects an attempt to secure an 
in-depth understanding of the phenomenon under study (Denzin and Lincoln, 
2001b). It involves the studied use and collection of a variety of empirical materials 
such as case study, personal experience (Denzin and Lincoln, 1994), participant 
observation (Atkinson and Hammersley, 1994), individual (Kvale, 1996; Britten,
1995) or group interviews (Kitzinger, 1995; Morgan, 1997; Kitzinger, 2000). 
Methodologies include grounded theory, phenomenology, ethnography and 
heimeneutics. These methodologies are not the subject of this review and have been 
described by Denzin and Lincoln (2001a).
3.3.3. The strengths and weaknesses of qualitative research
The strengths and weaknesses of qualitative research both relate to the study the 
participants as individuals and the paiticipants’ experiences and inteipretations 
(Sarantakos, 1998). The strengths include researching people in their natural settings 
and achieving deeper understanding of the participants’ world. The research process 
is humanised by raising the role of the participants and by considering their 
perspectives. It allows greater flexibility, presents a more realistic view of the world 
and accesses, reveals information, views, perceptions and attitudes that cannot be 
obtained by quantitative methods.
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Qualitative research has been criticised for many reasons and suffers foremost from 
the ‘stigma of the small n ’. However, this feature is irrelevant to the strength of the 
approach in expert hands (Mays and Pope, 2000b). As the researcher is the main 
instrument of data collection, analysis and interpretation, the outcome and quality of 
the research depend greatly on the skills o f the researcher. The qualitative researcher 
needs knowledge about the relevant literature of the area of inquiry and the 
methodology; a self-disciplined and informed approach to data collection and 
analysis and considerable degree of judgement, interactive and interpretive skills 
(Pope et al., 2000; Britten et al., 1995) for the cumbersome and difficult data 
analysis. To strengthen the interpretations of the data and to reduce bias from 
preconcepétions, multiple researchers, including independent researchers, are 
involved in the analysis to verify or triangulate the findings.
Qualitative research also remains criticised for its subjectivity and lack of reliability, 
randomisation and generalisability (Pope and Mays, 2000). However, qualitative 
research does not seek to be or to make claims to being objective, reliable, 
randomised and generalisable (Schwandt, 1997; Mays and Pope, 2000b) If  research 
only focused on what can be quantified reliably, many researchers may never 
discover the strengths of qualitative research (Soafer, 1999). All research is 
interpretive and is guided by a set of beliefs and feelings about the world and how it 
should be understood and studied (Denzin and Lincoln, 2001b). Each interpretive 
paradigm makes paiticular demands on the research, including, the questions asked 
and the interpretations the reseai'cher brings to them. Quantitative research may 
ignore factors that are significant in explaining important realities, complexities and 
phenomena in natuial settings. Benefits gained by the rich and valid infoimation of
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qualitative research, which are not open or amenable by quantitative reseaich (Pope 
and Mays, 2000) may be lost.
3.3.4. Quality in qualitative research
As in quantitative research, the basic stiategy to ensuie rigour in qualitative research 
is a systematic and self-conscious research design, data collection, interpretation and 
communication (Mays and Pope, 1995). Furthermore, the aim is to create an account 
o f method and data, which can stand independently (i.e. another reseaicher could 
analyse the same data in the same way and come to essentially the same conclusions) 
and to produce a plausible and coherent explanation of the phenomenon under 
scrutiny (Mays and Pope, 1995). The criteria to assess quantitative research are 
reliability, validity, objectivity and generalisability. Some researchers believe that the 
same criteria should be used in qualitative methods, but with modified means of 
assessment to suit the distinctive aims of qualitative methods (Mays and Pope, 
2000a). Other researchers take the view that, due to its different purpose, qualitative 
research needs a distinct set of criteria. First described by Guba and Lincoln (1989), 
these criteria, refer to, but are not the same as, the quantitative criteria (Figure 3.1). 
The criteria are dependability, confirmability, transferability and credibility.
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Dependability refers to consistency (reliability). It focuses on the process of inquiry 
and the researchers’ responsibility for ensuring that the research process was 
consistent, logical, traceable and documented (Miles and Huberman, 1994; 
Schwandt, 1997), while adapting to the changes o f the studied environment and to 
new inputs during the study (Hamberg et al., 1994). Dependability is enhanced 
through the clarity of questions, the researchers role and status, involvement of 
multiple researchers, collection of data across the full range of appropriate settings, 
sampling, use of appropriate recording equipment and keeping notes and memos.
Confirmability refers to neutiality (objectivity). Confirmability is concerned with 
establishing the fact that the data and interpretations of the data do not distort the 
reality they set out to describe and were not merely figments of the researchers’ 
imagination (Schwandt, 1997). It also ensures that the findings and concepts were 
founded in the data and not the result of poorly performed analysis and preconceived 
assumptions (Hamberg et al., 1994). Techniques to enhance credibility include the 
involvement of multiple researchers in the study, questioning findings and rethinking 
and critically reviewing the data.
Transferability refers to applicability (generalisability). Findings must be 
understandable to others and be regarded as reasonable (Hamberg et al., 1994). To 
achieve transferability, researchers must provide the readers with sufficient 
information on the study to make it possible for the readers to decide whether the 
findings are relevant to the situation and applicable to other situations and contexts 
(Hamberg et al., 1994; Miles and Huberman, 1994).
Credibility relates to truth value (validity) to establish whether truthful and credible 
findings and interpretations were produced. The researchers need to provide
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assurances of the fit between the participants’ experiences and the researchers’ 
reconstmction and representation of these experiences (Schwandt, 1997). Credibility 
is highly dependent on the researchers’ skills during data collection and analysis 
(Hamberg et al., 1994). Considered a stiength of qualitative research, credibility is 
ensured by triangulation and the inclusion of ‘deviant’ or ‘negative’ cases, in which 
the researchers’ interpretations and explanations seem weak or contradicted by the 
evidence (Mays and Pope, 1995). Triangulation is a means of checking the integrity 
o f the inferences the researchers draw. The reseaicher looks for patterns of 
convergence to develop an overall interpretation (Mays and Pope, 2000b). 
Triangulation can involve the use of multiple data sources, multiple investigators, 
multiple theoretical perspectives, multiple methods or all o f these (Schwandt, 1997).
3.4. Qualitative and quantitative methods in the research setting
Due to their particular attributes, some researchers consider the two methods as 
contradictory and fundamentally different, and rigid demarcations do not encourage 
movement between the two traditions (Pope and Mays, 1995). Qualitative and 
quantitative researchers operate within different sets of assumptions about the world 
and ways of leaiiiing bout the world (Casebeer and Verhoef, 1997). Qualitative and 
quantitative researchers are often ignorant of each other’s work and argue that their 
particular approach is best (Sarantakos, 1998).
Other researchers see qualitative and quantitative methods as the extremes of the 
same continuum. They believe that every research project, although predominantly 
quantitative or qualitative, contains aspects of the other methods (Hammersley, 1992; 
Sarantakos, 1998). They believe that qualitative and quantitative methods are not 
mutually exclusive, but complementary (Richardson, 1994) and that the two methods
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can and should co-exist as potential tools of the research trade (Casebeer and 
Verhoef, 1997). Qualitative and quantitative methods can investigate a similar topic 
by addressing a different research question (Jones, 1995), collecting different types 
of data and producing different sorts of answers (Barbour, 1999). This view is 
increasingly accepted in health research (Barbour, 1999).
3.4.1. Choosing between qualitative and quantitative methods
Both qualitative and quantitative methodologies are good and right, depending on the 
circumstances and the research question under study (Sarantakos, 1998). The 
stiengths and weaknesses of either method determine their suitability for a given 
research project. First, the choice o f method depends on the research question(s). To 
answer questions such as ‘how many’, ‘how much’, ‘what size’ or numerically 
measurable associations between factors, a suivey is appropriate (Miller and 
Crabtree, 1994). To answer questions such as ‘if  _, then _ ’ or ‘is _  more effective 
than _ ’, an experimental style is appropriate (Miller and Crabtiee, 1994). Questions 
that concern meanings, experience, patterns, relationships and values are best 
addressed by qualitative methods (Miller and Crabtiee, 1994). For reseaich questions 
that can be addiessed by either design, the choice is based on the aims and objectives 
of the study, or a combined/ mixed qualitative and quantitative study can be used.
3.4.2. The contribution of qualitative research
Qualitative research can be used as “stand alone” approach or in combination with 
quantitative research. Mixed or combined designs help to maximise knowledge by 
providing different perspectives of the same problem and adding scope to a study
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(Greene et al., 1989), and to compensate for short comings of individual methods 
(Barbour, 1999).
Qualitative research, if  used as a prerequisite to quantitative research, facilitates the 
development of the quantitative research (Greene et al., 1989) by identifying the 
‘correct’ terminology for inclusion in a survey questionnaire or generating 
hypotheses. This is useful to explore areas that have received little previous attention 
(Pope and Mays, 1995) and may help to ensure the validity of the quantitative data 
(Pope and Mays, 2000). When quantitative work precedes qualitative research, 
quantitative findings can be validated, explained and reinterpreted with help of 
qualitative reseaich (Miles and Hubeiman, 1994).
When used together, qualitative research helps to inteipret quantitative findings with 
more insight and quantitative reseaich allows testing of hypotheses raised by 
qualitative research, thus leading to conclusions and outcomes that would have been 
different without the qualitative input (Wenger, 1999). Furthermore, combining 
randomised controlled trials (RCTs) with qualitative and quantitative studies of 
process are believed to be the best means of assessing whether inteiwentions work 
and why, thus increasing the generalisability of findings from RCTs (Weaver et al.,
1996). Approaches to combine RCTs with quantitative and qualitative observational 
studies will generate information to help to successfully implement effective 
interventions in natural settings and to further refine the interventions (Weaver et al.,
1996).
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3.5. Qualitative methods in health research
Qualitative research enriches health research (Huston and Rowan, 1998) by enabling 
access to areas not amenable by quantitative research. In health research, the gap 
between qualitative and quantitative approaches has been closing and it is 
increasingly believed that a creative dialogue between the two methods is of 
considerable mutual benefit (Jones, 1995). There is a slow but important movement 
towai'ds a more collaborative use of qualitative and quantitative methods in health 
research, particularly for the study of chionic disease (Casebeer and Verhoef, 1997).
Original qualitative research is more widely used and published in the medical and 
health related fields both in specialised qualitative journals (e.g. Qualitative Health 
Research) and medical or health-related journals such as the British Medical Journal 
(BMJ), and Social Science and Medicine. Some journals now have reviewers trained 
in qualitative research (Miller and Crabtree, 1994). Qualitative reseaich, alongside 
quantitative methods, for health care and health services research, is introduced, 
reviewed and advocated by publications in leading medical journals such as the BMJ 
and the Lancet and by fimding agencies (such as the Medical Research Coimcil in the 
UK (MRC Topic Review, 1997).
On the whole, people are more complex than the subjects in the natural sciences and 
health care deals with people as either patients or health professionals. Numerous 
research areas dealing with the patients’ or the health professionals’ perspectives are 
suitable for qualitative investigation. They include: lay and professional health 
beliefs; lay diagnosis; consultation and decision making processes; doctor-patient 
relationship; interactions among patients, families and clinicians; coping with illness; 
self-management; care-seeking, illness and compliance behaviour; patients’
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perceptions, experiences, expectations, preferences, satisfaction and beliefs; the 
personal meaning of events and health care delivery (Britten et al., 1995; Pope and 
Mays, 1995; Faltermaier, 1997; Soafer, 1999).
Qualitative reseaich methods have been used successfully and have added to the 
body of knowledge in many areas o f health care research. Studies have been carried 
out in pain (Borkan et al., 1995; Johanssen et al., 1999), epilepsy (Ridsdale et al.,
1999), asthma (Clai*k and Nothwehr, 1997) and cancer (Sheik and Ogden, 1998); in 
health care settings such as general practice (Chew-Graham and May, 1999; Britten 
et al., 2000) or in management approaches (Armstrong et al., 1996; Britten et al.,
2000) from both the patients’ (Peters et al., 1998) and the health professionals’ 
perspectives (Armstrong et al., 1996). Canied out in different settings and 
investigating different population groups, these studies shared one common feature. 
Their reseaich aims and objectives were to describe, explore and assess the 
relationships of the findings of the studied topic.
3.6. Qualitative methods in headache research
Headache is one of many specialised areas of health research. Current headache 
research interests include topics that are suitable for and would benefit from 
qualitative methods. Headache research has yet to discover the benefits of qualitative 
research. To date, quantitative and experimental methods prevail and few qualitative 
studies have been published. However, headache research would benefit from 
qualitative input by improving understanding of clinical practice and the physicians’ 
and the patients’ perspectives.
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3.6.1. Headache in clinical practice and qualitative research
In clinical practice, there is a discrepancy between treatment availability and delivery 
for migraine (Lipton et al., 1994). Consisting of a body of Tules’ represented by the 
‘evidence-based approaches’, clinical practice is founded on the randomised 
controlled trials (RCTs) and a set o f improvisational skills to adapt the RCTs 
findings to individual cases (Dingwall et al., 1998). Physicians may encounter 
difficulties when applying information fiom RCTs to individuals (Miller and 
Crabtree, 1994), since traditional scientific knowledge frequently does not fit the 
patients’ uniqueness (Meyer, 2000). The heterogenous nature o f migraine means that 
translating research findings into clinical practice is a challenging task, particularly 
for clinicians with limited headache experience. The discrepancy between treatment 
availability and delivery in migiaine suggests that quantitative methods do not 
provide the whole picture of the complex behaviours, attitudes, preferences and 
interactions that are part of the consultation process and clinical decision-making. 
Migraine management is highly individual and the role o f qualitative research 
becomes more important, the more individualized an intervention becomes 
(Dingwall et al., 1998). Therefore, qualitative methods could help to provide a more 
holistic picture and findings that are more meaningful to practitioners. This may 
facilitate translating findings fi-om clinical trials into clinical practice, in all areas of 
health care including primary and specialised headache care.
Fmthermore, qualitative research may be particularly important for the health 
professionals who do not specialise in headache. The majority of headache sufferers 
who seek help from a physician consult their General Practitioner (GP) about their 
headache (Laughey et al., 1999). However, GPs only see an average of 27 migraine
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patients a year (MacGregor, 1999) for consultations lasting an average of eight 
minutes. Unlike headache specialists GPs have little opportunity to develop an 
intuitive understanding of headache disorders through clinical experience. Hence, 
there is a need to provide health care professionals with infomiation about a disorder 
that, although it can cause severe disability (Clarke et al., 1996; Stewart and Lipton, 
1993; Lipton et al., 2001) is still receiving little attention in health research and 
clinical practice. Qualitative research, particularly studies focusing on the patients’ 
perspective, may help to increase GPs understanding about headache disorders, the 
meaning, experience and impact of headache.
3.6.2. The headache patient and qualitative research
Few studies have been conducted on the patients’ perspective on headache. Patients’ 
characteristics (Lipton et al., 1998) influencing consultation behaviour, patients’ 
preferences (Lipton and Stewait, 1999; Salonen et al., 1999; Pascual et al., 2001) 
have been studied. Previous research has mainly focused on clinical practice, 
consultation behaviours and pharmacological treatment. Furthermore, the studies 
examined issues predeteimined by the researchers and listed, rather than explained, 
behaviours and predictive factors. Qualitative research, by exploring behaviours, can 
help explain complex issues such as factors influencing behaviours and decisions.
Furthermore, qualitative research may help to reveal the benefits o f a ‘hidden health 
care system’, based on self-management strategies. Migraineurs often have a 
fatalistic attitude and learn to cope with their condition without seeking medical care 
(Michel et al., 1996). They rely on self-management strategies, such as avoiding 
triggers (Scharff et al., 1995) and self-medication with Over The Counter drugs 
rather than using prescription medication (Celentano et al., 1992; Edmeads et al..
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1993; Forward et al., 1998). Of headache patients who are prescribed medication, 
52% have been shown not be compliant with their medication (Packard and 
O'Connell, 1986). A qualitative study revealed factors involved in patients’ decision­
making and compliance with their treatment (Ivers et al., 2000). Qualitative research 
is useful to understand and explain health seeking behaviours (Sheik and Ogden, 
1998) and variations in adherence to tieatment (Britten et al., 1995). Improved 
insight into the migraineurs’ behaviours and perceptions may help identify patients 
as competent persons to cope with their illness, at least partly independent from 
physicians. This may lead to more patient-centred health practice (Faltermaier,
1997), which is the prefeiTed approach of primary care patients (Little et al., 2001). 
This may be of particulai* importance in view of improving the educational and 
behavioural interventions that headache management guidelines (Diener et al., 2000) 
advocate in addition to pharmacological therapy.
With the recent development of patient preference studies (Torgerson et al., 1996), 
patient preference in headache therapy needs greater understanding. Migraine is 
more than a headache and the current endpoints of clinical trials need further 
development, as for example measuring headache relief as an endpoint alone does 
not capture the complete pictine about the new treatments (Goadsby, 2000). By 
letting the headache patients speak openly and freely about their preferences in 
qualitative studies, greater understanding of the patients’ opinions about the benefits 
and disadvantages of headache therapy, their expectations, their treatment 
preferences and their prefeiTcd outcome can be achieved. Thus giving voice to the 
patients, in a flexible, yet rigorous research process, would provide a more realistic 
assessment of headache treatments and may help to make soft and subjective 
endpoints, such as impact, more acceptable outcome measures.
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Conclusion
Qualitative research is concerned with the understanding of social or human 
problems in their natural settings. It has a strong potential for discovery of new ai*eas, 
to reveal complexity, to identify patterns and processes, to develop theories and to 
move towards explanation. Qualitative reseaich can complement and validate 
quantitative research. Health researchers increasingly recognise the strengths of 
qualitative research. Consequently, qualitative studies ai*e increasingly being carried 
out in health research to answer research questions that cannot be answered by 
traditional quantitative methods. The knowledge gained by qualitative methods in 
health research justifies the integration of qualitative research into specialised areas 
of health research including headache. In headache resear ch, areas such as improving 
the physicians understanding, translating quantitative findings into everyday clinical 
practice, gaining insight into the patients’ perspectives and behaviours may 
particularly benefit fiom a qualitative input.
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4.1. Abstract
Objective: To gain insight into the patients’ decision-making for migraine and 
chronic daily headache management.
Methods: Patients were recruited by theoretical sampling in Surrey (UK). Semi­
structured and tape-recorded interviews (n=13) were conducted, transcribed 
verbatim, coded and analysed according to the grounded theory methodology.
Results: Thirteen patients (8 migraine and 5 chronic daily headache) described their 
management. All patients employed multiple behavioms to manage their headaches. 
From the patients’ descriptions emerged their decision-making. Based on experience, 
perceptions and new information, the decision-making process involved four stages: 
headache seventy, evaluation, decisions and behaviours. Although the participants 
were passive with regards to certain management strategies, overall they were 
actively involved in treating and preventing their headaches. Furthermore, they were 
active decision-makers in choosing appropriate management.
Conclusions: Migraine and chronic daily headache patients are actively involved in 
managing their headaches. They are key decision-makers and should not be 
overlooked as a resource for effective management.
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4.2. introduction
Affecting about 12% of the population (Breslau and Rasmussen, 2001), migi aine is a 
chronic disease with acute episodes and needs to be managed over a prolonged 
period of time. To date, migraine is under-diagnosed and under-treated (Lipton et al., 
1992; Lipton et al., 2000a). Initiatives taken to improve management in clinical 
practice have mainly focused on facilitating the physicians’ role in the management 
of migraine by providing guidelines (Dowson et al., 2000; US Headache Consortium, 
2000), disability assessment tools (Lipton and Silberstein, 2001) and stratified care 
(Lipton et al., 2000b). The low consultation rates and the under-use of prescription 
medication, suggest that migr aineurs learn to cope and live with their disease, rather 
than actively seek effective treatment (Michel et al., 1996). Consequently the burden 
of migraine remains great, and most migraineurs suffer at least some disability and 
have a reduced quality of life. However, with the wide range of management 
strategies available, it is possible to improve headache management and ease the 
suffering of many migraineurs.
Since “headache control is best when patients play an active role in their treatment” 
(p S46) (Silberstein et al., 2000), the patients’ involvement in the treatment of their 
disease is essential. Selecting a suitable and effective therapy can be a complex task 
for both the physician and the patient. Recent publications (Silberstein et al., 2000)) 
and headache management guidelines (Pryse-Philipps et al., 1997a; Pryse-Philipps 
et al., 1997b; Dowson et al., 2000; US Headache Consortium, 2000) predominantly 
educate the physician on selecting appropriate drug therapy for individual 
migraineurs. The “Migraine in Primary Care Advisors” (MIPCA) guidelines 
(Dowson et al., 2000) additionally educate practice nurses and pharmacists about
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migiaine management, to move towaids patient centred care. However, since the 
majority of migiaineurs do not consult their physician about their condition 
(Edmeads et al., 1993; Lipton et al., 1999), they do not benefit from the physician’s 
expertise mid fi*om prescription medication. Furthermore, as attacks occur generally 
in the absence of the physician, patients, even those who do consult, need, and 
maybe even prefer, to make their own choices for managing their migraines.
Few studies have addressed the patients’ perspective in the management of headache.
Studies to date focus on what migraine patients want from medical consultations 
(Packard, 1979) and their satisfaction (Pascual et al., 2001) and preferences for acute 
drug therapy to compare medication (Salonen et al., 1999) or different doses of the 
same medication (Salonen et al., 1999). These studies shed some light on the patient 
perspective, but by remaining focused on physicians’ consultations and acute 
medications, they fail to recognise other management strategies that the patients may 
choose to adopt, as well as the factors that influence the patients’ decision-making.
Fui'theimore, the issues investigated in these studies were determined by the ;
I
researchers. Little opportunity has been given to the patients to speak openly and I
unrestrictedly about the factors that influence their decisions for migraine and j
chronic daily headache (CDH) management. Qualitative research provides the 
opportunity to address these limitations. Qualitative research has been applied in 
non-headache research to explore similar research questions, for example in asthma 
management (Clark and Nothwehr, 1997). Concerned with understanding the 
perspectives, interpretations and meanings of the world of those who are being 
researched (Jones, 1995; Sarantakos, 1998), qualitative research reveals new 
phenomena and complexity by giving voice to those whose views are rarely heard 
(Soafer, 1999). The data presented in this ar ticle are part of a study, which aimed at
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gaining insight into the patients’ perspective and into the factors influencing 
migraine and CDH management. This chapter sets out to describe the factors 
involved in the patients’ decision-making.
4.3. Methods
4.3.1. Grounded theory
First described by Glaser and Strauss (1967), grounded theory is a specific, highly 
developed and rigorous set of procedures for generating theory through comparative 
analysis. The theory emerges out of and is created through and grounded on 
empirical data (Sarantakos, 1998). Groimded theory is mostly concerned with 
sampling and data analysis. There is no specified method of data collection, although 
interviews are commonly used. The steps involved in grounded theory include 
theoretical sampling, data collection and analysis through coding, writing notes and 
memos about key concepts and their relationships until theoretical saturation. The 
steps are closely interrelated and may be employed simultaneously.
Theoretical sampling is non-probability sampling based on seeking participants who 
have the most experience of the topic of interest (Cutliffe, 2000). Recriritment of 
participants is driven by the emerging theory. Analysis reveals gaps in the data and 
theories, and the researchers need to collect more data to fill these conceptual gaps 
(Charmaz, 2000). This is achieved by recruiting participants who add to the fullness 
of the concepts. Therefore, a grounded theory study is best conducted if each 
participant is only selected after the data from the previous participant has been 
analysed. Sampling continues until each concept is saturated.
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Analysis begins early and data is analysed as it is collected. Analysis involves 
generating conceptual categories by comparing similar and different facts from the 
raw data (for example interview transcripts). Coding starts the chain of theory 
development. Data are studied to create codes or categories of data, which are 
grouped to gain a new perspective on the data and to collect fruther data (Charmaz,
2000). Once initial categories have been established, additional data are collected to 
further compare concepts with more empirical indicators and with each other to 
sharpen the definition of the concepts and to define their properties (Schwandt,
1997). Theories are foimed from proposing plausible relationships among sets of 
concepts (Schwandt, 1999). The evidence from which the categories and concepts 
emerge is used to illustrate the concepts (Glaser and Strauss, 1967). Comparisons 
continue until theoretical saturation, i.e. additional data do not contribute anything 
new to the concepts (Schwandt, 1999).
4.3.2. Recruitment, Data Collection and Analysis
Ethical approval was obtained from the University of Surrey Ethics Committee 
(Appendix 2). Recmitment, data collection and analysis were carried out 
simultaneously by the researcher (unless stated otherwise), in accordance with the 
grounded theory methodology. This allowed for theoretical sampling, revision of the 
interview guide, to help with data interpretation and to identify emerging themes and 
data and theoretical saturation.
4.3.2.1. Recruitment
Based on theoretical sampling, a convenience sample, consisting o f 15 adults, was 
recruited in Suirey (UK). The participants, aged 18-65 years, were suffering from 
migiaine according to the International Headache Society (IHS) criteria (Headache
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Classification Committee of the International Headache Society, 1988). Patients with 
co-existing headaches or patients who had developed CDH were not excluded. For 
the purpose of this study, CDH was defined as headaches occurring at a frequency 
above 15 days per month. Initially participants were recmited thiough personal 
contacts (the reseaicher and MM). Since this mainly led to recmitment of 
migraineurs within the University, posters (Appendix 3) were put up in 2 local 
supeimai'kets to broaden the background of the participants. Finally, letters were sent 
to 20 members of the Migraine Action Association to complete the sample. A total of 
39 patients had been contacted and 15 were recmited consecutively. The selection of 
participants was based on the findings from previous interviews. Potential 
paiticipants were given a letter to introduce the study (Appendix 4) and an 
information sheet to explain the procedure of the study (Appendix 5). The patients, 
who were not recmited, did not suffer fi*om IHS migraine, could not be interviewed 
during the time of the study or could not contiibute to the emerging theory.
The participants were recruited to reflect a range of characteristics (dissimilar cases). 
The aim was to include 1 male to every 3 female sufferers (to reflect migiaine 
prevalence), a variety of socio-demographics and one participant per age group, per 
disability group and per consultation group. Socio-demographic factors were 
determined by the participants’ marital and employment status, type o f employment 
and/ or level of education. There were 4 age groups: 18-29, 30-39, 40-49 and 50-65. 
Consultation status was deteimined according to Lipton and Stewart’s criteria 
(Lipton and Stewart, 1999). Patients who had never consulted a physician about 
migraine were classed as ‘never consulter’. Patients who had consulted within the 
last year were classed as ‘current consulter’ and those who had not consulted for 
more than one year were classed as ‘lapsed consulter’. Disability assessment (by
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MIDAS questionnaire) was used to include patients with varying levels of headache 
severity, which was reflected in their current headache status of migraine or CDH.
4.3 2.2. Data Collection
Interviews were semi-structured, individual and tape-recorded. A flexible interview 
guide (Appendix 6) was devised based on recent migraine literature to comprise 
opening and more specific follow-on or clarifying questions and prompts. Opening 
question were aimed to be non-leading (Table 4.1), whereas follow-on questions 
tended to be more leading. Initially the interviews focused on migraine experience, 
physician consultations and treatments for migraine. However, with the emerging 
theory, and as part of the verification procedure, the interview guide was further 
developed to include previously raised issues and emerging concepts (Appendix 7). 
Additional questions focused on patients’ preferences, choices and decisions and a 
more holistic approach to management (i.e. beyond physicians’ consultations and 
pharmacological treatments).
Table 4.1: Opening interview questions
1. How would you describe your migraines/ headaches?
2. How do your migraine/ headaches affect your eveiyday life?
3. How do you treat your migraines/ headaches?
4. What are the reasons for using this treatment?
5. How satisfied are you with your treatment?
6. What do you expect from migraine/headache treatment?
7. Who gives you advice about your migraines/ headaches (who do you consult)?
8. Tell me more about talking to your GP about your migraine / headaches.
9. What are the reasons for consulting/ not consulting your GP?
10. How satisfied are you with your migraine/ headache consultations?
11. Who/ what else do you think may be able to help with your migraine/ 
headaches?
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Interviews were arranged to the participants’ convenience, at their home, work place 
or at the University of Sun*ey. One participant withdrew before the inteiwiew and 14 
migraineurs, who all signed the consent form (Appendix 8), were interviewed once. 
Interviews lasted up to 2 hours with recording time averaging 1 hour (range 50-90 
minutes). The first interview served as a pilot interview and was not included in the 
analysis. HAS and VV read inteiviews to assess inteiview technique and content. 
Interviewing finished with data saturation. Interviews were transcribed verbatim. An 
example of a transcript is included in Appendix 9. Participants were offered a copy 
of their interview transcript.
4.3.2.3. Analysis
Inteiwiews were prepared for analysis and coded using QSR NUD*IST5 (N5), a 
qualitative software package. The interview transcripts were imported as text files 
into N5 to be coded. In N5, data are coded by units of text (either paragraphs, lines or 
sentences). In this study, the raw data were coded sentence by sentence. The aim of 
N5 is to code and re-arrange data according to the emerging codes and to build a 
hierarchical taxonomy within the software, while keeping memos with the raw data 
and the emerging codes.
To reduce bias of the coding scheme and emerging taxonomy and concepts, all 
authors, as well as an independent researcher, were involved in different stages of the 
analysis. A guide (Appendix 10) was devised (by the researcher and HAS) to 
standardise the coding procedure for triangulation. One by one, the first 5 interviews 
were summarised (by the researcher, HAS, VV and an independent researcher). Then 
the inteiwiews were coded sentence by sentence to give an initial coding scheme (the 
researcher, VV and independent researcher). No notable differences were found
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between the coding of different researchers. Codes were grouped into a hierarchical 
taxonomy to foim concepts and theories. These concepts and theories were based on 
theoretical memos and discussions between the researcher and her supervisors. The 
last 8 interviews, coded according to the same technique, were used to verify the 
coding scheme and refine the emerging taxonomy and concepts. First, a summary of 
the concepts and later detailed definitions, descriptions and interpretations of the 
main concepts were discussed by all authors.
4.3.3. Ensuring scientific rigour
Qualitative research stresses the paiticipants’ personal interpretation of meaning and 
how such experiences constmct their social reality (Vydelingum, 1998). The basic 
strategy to ensure rigour in qualitative research is a systematic and self-conscious 
research design, data collection, interpretation and communication (Mays and Pope, 
1995). The aim of scientific rigour in qualitative reseaich is to create an account of 
method and data, which can stand independently (i.e. another researcher could 
analyse the same data in the same way and come to essentially the same conclusions) 
and to produce a plausible and coherent explanation of the phenomenon under 
scrutiny (Mays and Pope, 1995). First described by (Guba and Lincoln, 1989), the 
criteria used to ensure scientific rigour in qualitative research are dependability, 
confirmability, transferability and credibility.
4.3.3.1. Dependability
Dependability refers to consistency (reliability). It focuses on the process of inquiry 
and the researchers’ responsibility for ensuring that the research process was 
consistent, logical, traceable and documented (Miles and Huberman, 1994) 
(Schwandt, 1997), while adapting to the changes of the studied environment and to
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new inputs duiing the study (Hamberg et al., 1994). In this study, dependability was 
enhanced in several ways. First, the interview guide was developed through the 
collaboration of the researcher and her supervisors. One pilot interview was carried 
out to ensure the clarity, suitability and content of the inteiwiew guide. Based on the 
taxonomy and theory emerging from the analysis of the initial interviews, the 
interview guide was further developed in a dynamic fashion to include issues raised 
by the participants, as suggested by Glaser and Strauss (Glaser and Strauss, 1967) 
when following the grounded theory approach.
Secondly, dependability is ensured through the use o f appropriate recording 
equipment and keeping notes and memos. In this study, all the interviews were tape 
recorded and transcribed verbatim to give a true account of the participants’ reports. 
Fui'thennore, the emerging themes, taxonomy and theory were cleM y defined and 
documented in memos within QSR N5, the qualitative software package for data 
analysis and management, used in this study.
Thirdly, dependability was further achieved by using multiple researchers. In this 
study, the analysis o f the data and the hierarchical grouping of the emerging themes 
were carried out by the researcher, HAS, VV and an independent researcher to verify 
the emerging themes and taxonomy.
Finally, dependability was also enhanced by a decision trail (Silverman, 1993) in the 
clear explanation of the processes involved in eliciting the categories and themes. 
This involved the development (by the researcher and HAS) of a coding guide 
(Appendix 10) that was used to standardise the coding procedure.
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4.3.S.2. Confirmability
Confirmability refers to neutrality and is concerned with establishing the fact that the 
data and interpretations of the data do not distort the reality they set out to describe 
and were not merely figments of the researchers’ imagination (Schwandt, 1997). It 
also ensures that the findings and concepts were founded in the data and not the 
result o f poorly performed analysis and preconceived assumptions (Hamberg et al., 
1994). In this study, techniques to enhance credibility included the triangulation of 
data interpretation, by involving multiple researchers in the data analysis and 
interpretation. As described above, several researchers, fi-om different areas of 
expertise (including expertise about qualitative methods, pain, health care and 
headache research) contributed to the data analysis and interpretation.
Confirmability was also enhanced by a process, which involved the questioning of 
findings and the rethinking and critical reviewing o f the data. The data were 
collected and analysed simultaneously, to allow comparing the findings from initial 
interviews with the findings fi-om later interviews. Also, group meetings between the 
researcher and her supervisors were used to discuss, rethink and critically review the 
findings and interpretations.
4.3.33. Transferability
Transferability refers to applicability. Findings must be understandable to others and 
be regarded as reasonable (Hamberg et al., 1994) and is referred to as ‘fittingness’ by 
Guba and Lincoln (1989). To achieve transferability, researchers must provide the 
readers with sufficient information on the study to make it possible for the readers to 
decide whether the findings are relevant to the situation and applicable to other
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situations and/or contexts (Hamberg et al., 1994; Miles and Huberman, 1994) or ‘fit 
into’ situations and experiences outside the study situation. In study, transferability 
was enhanced by tape-recording and transcribing the interviews. This allowed the 
use of verbatim quotes when reporting the data, to illustrate the themes and emerging 
taxonomy and theory. A test of this ‘fittingness’ was whether the audiences 
(migraine and CDH patients) view the findings as meaningful and relevant in terms 
of their own experiences. Moreover, most of the findings have been validated by 
other studies from the current literature. Transferability was fuither enhanced by the 
confirmation of the qualitative data through the suiwey.
4.3.3A  Credibility
Credibility relates to tmth value to establish whether ti-uthful and credible findings 
and interpretations were produced. The researchers need to provide assurances of the 
fit between the participants’ experiences and the researchers’ reconstruction and 
representation of these experiences (Schwandt, 1997). To achieve credibility, 
verbatim quotes from the interviews portrayed the vivid and faithful interpretations 
of human experience of migraine and CDH sufferers in a way that could be 
recognised by other sufferers.
Furthermore, credibility is highly dependent on the researchers’ skills during data 
collection and analysis (Hamberg et al., 1994). The interview skills of the researcher 
were assessed by the more experienced researchers and a migraine patient in a pilot 
interview. The involvement of multiple researchers, with varying experience of using 
qualitative methods, helped to ensure credibility within this study. Furthermore, 
quotes from the interviews, wliich had been tape-recorded, were used when reporting 
the findings of tliis study to illustrate the decision trail of the researchers.
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Credibility is ensured by triangulation (through multiple paiticipants) and the 
inclusion of ‘deviant’ or ‘negative’ cases, in which the researchers’ interpretations 
and explanations seem weak or contradicted by the evidence (Mays and Pope, 1995). 
Thus, the study recruited multiple and dissimilar cases, in terms of the participants’ 
personal characteristics and their headache severity. The recmitment of participants 
was an ongoing process to allow triangulating findings from previous interviews, by 
raising previously discussed issues within the later interviews. Data collection 
continued until data saturation was reached, i.e. until no new issues were raised 
within the interviews.
4.4. Results
The descriptive codes that emerged fiom the inteiwiews related to the interview 
questions. These codes were grouped into three main themes: headaches, 
consultations and management. These themes gave the base data o f the participants 
to describe the patients’ chaiacteristics and the patients’ subjective reality of 
headache management (consultations and stiategies).
Furthermore, the patients explained their reasons for using or not using management 
strategies, by relying on and generalising from their subjective experiences, which 
they perceived as significant in their management decisions. The interpretative codes 
(Table 4.2) of the descriptive themes, revealed the patients’ involvement in their 
headache management and the 4 stages of decision-making. Drawing on their 
experiences, the patients were the key decision-makers for the management of their 
headaches.
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Table 4.2: Interpretative codes and themes
H eadache
severity
Evaluation
Decision
B ehaviour
Diagnosis (headache types)
Impact
Headache changes over time
Awareness
Assessment
Balancing options with 
perceptions
Specific
Non-specific
Explicit
Implicit
Active
Passive
Management strategies
Symptoms
Pain
severity
Frequency
Duration
Headache severity
Experiences o f management
Outcome and limitations o f  
management
Management available 
(knowledge)
Information gathering
Perceptions
Consultations
Pharmacological
Non-pharmacological
Health professionals
Family and fnends
Media
Headache Societies
Attitudes
Beliefs
Expectations
Satisfaction
Preferences
Doctor
Other health 
professionals
Acute
Prophylactic
Self-help
Social support
Alternative therapies
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4.4.1. Patients’ characteristics
All thirteen participants (9 women and 4 men, aged from 24 to 60) suffered from IHS 
migraine. Three patients also suffered from tension-type headache (TTH). Based on 
their headache frequency above 15 days per months, 6 patients were classed as CDH 
patients. These patients experienced higher frequency and lower severity headaches, 
as well as full migraine attacks. Of these 6 patients, one had been effectively treated 
and did not suffer from CDH at the time of the study. One participant was a ‘never 
consulter’ for migraine, 6 participants were ‘lapsed consulters’ and 6 participants 
were ‘current consulters’. Current consultations were associated with the diagnosis of 
CDH. Four participants (1 lapsed and 3 current consulters) had consulted either a 
headache specialist or a neurologist. MIDAS scores ranged from 0 to 47. The 
individual patients’ characteristics are described in Table 4.3.
Table 4.3: The participants' characteristics
1 38 Female Migraine,
TTH
4 3 17 Never consulter
2 24 Male CDH 24 9 47 Current consulter
3 58 Female CDH Most 5 21 Current consulter
4 52 Female Migraine 3 — 5 Lapsed consulter
5 55 Male Migraine <1 5 3 Lapsed consulter
6 38 Female Migraine,
TTH
3 6 5 Lapsed consulter
7 28 Female CDH 15 10 15 Current consulter
8 34 Male Migraine 10 5 18 Current consulter
9 60 Female Migraine 5 9 14 Current consulter
10 56 Female Migraine,
TTH
12 5 20 Lapsed consulter
11 48 Female Migraine, 
history o f  
CDH
2 10 6 Lapsed consulter
12 41 Male CDH 45 2 0 Lapsed consulter
13 24 Female CDH 16 3 17 Current consulter
NB. Frequency- days per month. Severity- 0 (no pain) -  10 (pain as bad as it can be)
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4.4.2. Management strategies
All participants described a range of management strategies and self-help measures 
that they had used in the past or were still using at the time of the interview. All 
participants used several strategies at any one time. The combination of strategies 
used was individual to every patient. Management stiategies included such as 
medication, consultations with health care professionals, trigger detection and 
avoidance and gathering infoimation from family and friends, the media and 
specialised organisations. The participants described their adoption, maintenance and 
cessation of their personal management sti ategies over time.
4.4.3. The 4 stages of decision-making
Through the patients’ descriptions o f their management strategies emerged their 
decision-making to adopt, maintain or discontinue management behaviours. Four 
stages o f decision-making, that were linked in a cyclical process (Figure 4.1), were 
identified. The 4 stages were: headache severity^ evaluation^ decision and behaviour. 
Decision-making was a complex, dynamic and continuous process that developed 
over time and operated on a justification and consequence system. Every decision, 
behaviour and change in migraine severity added to the experience and perceptions 
of the patients, hi the figure (Figure 4.1), the shadows represent the experience, 
illustrating the influences of previous decision-making. These experiences, 
perceptions and newly gathered information influenced the outcome of their next 
decision, behaviour and headache severity.
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4.4.3.1. Headache Severity
Headache severity, an objective and factual stage, comprised the diagnosis 
(symptoms, pain severity, frequency and duration) of migiaine, CDH and TTH, the 
progiessive nature of migraine during attacks and over the years and impact of the 
headaches. Pt8 described the progressive nature of migraine:
“ ... I would say that the migraines got noticeably worse in the last five or 
six years.,.”.
Pt7 outlined the impact o f migraines on work:
“.. .I’ll have the days off for the migraines and then I tend to be not at full 
capacity the day after...”
The onset of the headaches and their severity were the starting point of decision­
making, Pt 6 explains how the pain severity induces her to rely on medication:
“ ...the thing that really affects my working efficiency and just generally 
affects me, is the pain. Obviously I want to relieve the pain, so therefore 
I’m taking painkillers...”
However, headache severity was also an end-point as it served as an outcome 
measure to assess the efficacy of the management strategies. Ptl3 explains how 
headache severity served as outcome measure:
“ ...try avoiding food, I gave up chocolate, cheese and red wine for three 
months... they made no difference, I still got headaches, even when I 
wasn’t taking it and then when I re-intioduced it...”
4.4.3.2. Evaluation
Evaluation was the most active, involved and complex stage o f decision-making. It 
comprised 3 steps including awaieness, assessment and balancing options with 
perceptions. Awareness was when the patients’ stopped believing that their migraines
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or headaches will not come back and they started thinking about how to deal with the 
problem.
The patients progressed to assess their headache seventy, their experiences of 
headache management and the outcome and limitations of the previously employed 
strategies. Pt2 recognised the limitations of his own ideas for headache management 
and resorted to a GP consultation :
“ .. .the initial ideas came from me, but there were some things, obviously 
without medical knowledge; I don’t have medical knowledge, so I 
thought the GP could certainly say “this is possibly a cause, you haven’t 
thought of this”. .
The participants described options for pharmacological and non-pharmacological 
treatment. Knowledge about management strategies was acquired through the 
participants’ own and other people’s experiences and through information gathering. 
New management strategies were learnt by actively seeking and/or spontaneously 
receiving information and advice from other people (healtli professionals, family and 
friends), the media and specialised migraine organisations. The patients balanced 
treatment options with their individual perceptions to underpin their decisions. For 
example for Pt6, the severity of migraines did not justify prophylaxis:
“ ...although migraines are bad, I don’t know if  I’d want to take 
medication every day...”.
Ptl3 opted against acupuncture due to personal preference:
“...the GP did mention acupuncture, but I don’t believe in acupuncture, 
so I didn’t choose that...”.
Perceptions, included preferences, satisfaction, expectations, beliefs, and attitudes. 
They were influenced by the participants’ personality and their and other people’s
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experiences of health care, particularly migiaine management, and the health care 
system. Based on her satisfaction with her GP generally, Pt6 chooses to consult:
“ ... the doctor I’ve got is very good and he’s very understanding and he 
does listen and discuss things with you. So I thought it would be 
interesting to have his opinion on them [migraines], to see if  there is 
anything that he could suggest...”
Difficulties with evaluation, and the patients’ subsequent decisions, arose with 
misconceptions, when the management outcome was not clear or when there was 
conflict between the patients’ preferences and the management approach. Ptl 
outlines how her beliefs about treatments influenced her consultation behaviour:
“ ... I didn’t really think that there were particularly effective treatments.
And if I don’t expect there to be anything for me... [consulting the GP] is 
a waste of tim e...”.
Other people influenced the participants’ evaluations and sometimes convinced or 
hindered the participants to take action. P tl2 was encouraged by his wife to try 
various ticatments:
“ ...A  [wife] is now pushing me to have reflexology, which apparently 
some people say is good for migraine... so I’m now considering that...”
As the central figure, the migiaineurs felt that they knew best and the final decision 
was theirs, as P tl3 explained:
“ .. .[the GP] couldn’t argue with me, because that was my opinion...”.
4.4.S.3. Decision
Evaluation served as justification for the decisions these patients made for their 
headache management. Pt7 assessed the type of headache and accordingly selected 
treatment to achieve the best outcome:
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“...you work out what you think it’s going to turn into and therefore 
taking the drugs that you will think will best suit it...”.
Decision was an active stage that described the patients’ choices for management. 
Decision, the outcome of evaluation, was often a compromise between their options 
and perceptions. Decisions were specific and non-specific. Specific decisions were 
those related to a specified management strategy, whereas non-specific decisions 
were general decisions to headache management. Non-specific decision were 
described as follows by Pt 2 :
“...I want to move fbrwaid and ti*y and deal with the problems..
A specific decision was outlined by Ptl 3:
“.. .I  told him [GP] that I was going to the chiropractor and that I didn’t 
want to take the drngs [beta-blockers]...”.
4.4.3.4. Behaviour
Following their decisions, the participants adopted, maintained or discontinued 
behaviours to manage their headaches acutely or prophylactically. Behaviour, which 
could be active or passive, outlined the paiticipants’ past and current management 
strategies (trials and eiTors), as well as their individual management combinations. 
Pt2 relied on the combination medication and lying down for acute tieatment:
“ .. .the only way I can deal with the pain is to obviously take medication, 
but really to commit myself to bed ...”
Pt7 talked about her past experience with alternative therapies:
“ ...I ’ve tried Feverfew as well, I didn’t like the smell o f those...and I 
have tried massaging smelly oils in my forehead, which didn’t really 
help...”.
138
Chapter 4: Patients’ decision-making for migraine and chronic daily headache
management
Depending on the failure or success of a behaviour, a change occurred in the 
headache severity \  thus making the theme of headache severity an outcome 
measure and also adding further to experience on which to base their subsequent 
decisions. Ptl 3 described how unsatisfactory headache relief motivated her to trying 
a variety of medications:
“...I went to the nurse and she gave me, I was taking Ibuprofen, but she 
gave me Co-codamol. And I was on maximum dose of that and it didn’t 
touch it. And then I went on maximum dose of Ibuprofen and Co- 
codamol together. That didn’t touch it. And then I was prescribed 
Diclofenac and that didn’t have any effect either. So after that I pretty 
much decided that if  that couldn’t kick it, then I couldn’t do anything..
4.5. Discussion
The main finding was that these patients were actively involved in managing their 
migraines or CDH, tluough both their decision-making or their behaviours. The 
patients were the central or key figure of migraine and CDH management and 
decision-making. Four stages of decision-making were identified: headache severity, 
evaluation, decision and behaviour. As illustrated by Figure 1, these 4 stages were 
linked in a cyclical process that developed over time through experience gained from 
previous decisions, behaviours and new information. Similar illustrations have been 
proposed for general decision-making (MacPhail-Wilcox and Bryant, 1988), the self­
management of asthma (Clark and Nothwehr, 1997), and decision-making for taking 
sumatriptan (Ivers et al., 2000).
' Patient defined headache severity including changes in headache frequency, duration, symptoms, 
and pain severity.
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Ivers et al (2000) described the decision-making process for taking sumatriptan based 
on symptom monitoring, evaluation outcome, tieatment decision-making, health 
behaviour and final outcome. However, the sumatriptan decision-making model was 
limited to decisions about one ding for acute treatment for migraine. The results of 
tins study add fiuther to decision-making in headache management by bringing acute 
and preventive decision-making about different types of headache.
The findings of this study reveal the complexity and provide a more holistic picture 
of migiaine management, which brings a new perspective on quantitative findings. 
Migraine patients have been described as being passive and as having a fatalistic 
attitude (Michel et al., 1996). This may be tine if  migraine management or health 
care behaviouis are studied in isolation. However, in this study, all the participants 
were active in managing their migraines and CDH, despite not relying on all the 
available options as for example physicians’ consultations. The role o f these 
participants went beyond playing an active role in their management. As the key 
decision-makers for headache management, the patients integrated their knowledge 
with their experiences and perceptions to make decisions and adopt behaviours that 
suited their individual expectations and preferences. Furthermore, self-management 
strategies, based on the patients’ experiences and preferences and input from other 
people, were found to play an important role in the patients’ perceptions of the 
management of high impact headaches.
Chi'onic disease has become the principal medical problem and it is thought that the 
patient must become a partner, who contributes at almost every decision and action 
level (Holman and Lorig, 2000). The doctor provides the general information and the 
patients provide individual information to achieve effective management (Holman
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and Lorig, 2000). Initiatives that have been taken to improve migraine care, such as 
disability assessment tools (Edmeads et al., 2001; Garber et al., 2001), stratified care 
(using information available at tbe initial consultation to choose treatment) (Lipton et 
al., 2000b) and headache management guidelines (Dowson et al., 2000) are aimed at 
physicians. Although an important step in improving migraine care, these initiatives 
may overlook the migraineur as an essential resource of migraine management. 
Patients want to be informed of their treatment options and they want to be involved 
in decisions when more than one alternative treatment exists (Michel et al., 1996). 
The active role the participants adopted in decision-making and behaviours in this 
study illustr ates the extent to which migraine and CDH patients want to be involved 
in the management of their condition. The chronic features o f migraine and 
particularly CDH, the patients’ desire of involvement and the fact that headache 
control is best when patients play an active role in their treatment (Silberstein et al.,
2000) demand the patients’ input into headache management.
4.6. Conclusion
The study aimed to gain insight into the patients’ perspective o f migraine and CDH 
management. The descriptive results showed the holistic picture of management. 
Due the qualitative methodology these findings caimot be generalised. However, 
they can be used to inform headache researchers and clinicians about the patients’ 
perspective of migraine and CDH management. Fiuthermore, these results can be 
used to generate future quantitative work, fi’om which broader conclusions can be 
drawn.
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In addition to describing the holistic picture of the topic under study, qualitative 
research aims to understand, explain and reveal processes. This study showed how 
headache patients use their and other people’s experiences to justify, explain and 
generalise their decisions and behaviours. Health care problems can only be 
addressed if the user’s perspective is understood and if health care professionals and 
patients co-operate (Edwards and Staniszewska, 2000). By raising headache 
researchers’ and clinicians’ awareness of the patients’ involvement in their own 
migraine and headache care, the results of this study can be used to educate and 
empower the patient and to make headache reseai'ch and clinical practice more 
patient-centred and relevant to the headache patient.
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Chapter 5: The patients’ perceptions of migraine and CDH
5.1. Abstract
Purpose: The puipose of this study was to gain insight into the management of 
migraine and chronic daily headache from the patients’ perspective. This chapter 
outlines the patients’ experiences, perceptions and their management of migraine and 
chronic daily headache.
Methods: Thii*teen semi-structuied interviews were carried out with patients 
suffering from IHS migraine. Five patients, due to their headache fr equency of more 
than 15 headache days per month, were classed as CDH patients. The data were 
transcribed verbatim and analysed in accordance with the grounded theory 
methodology.
Main findings: Three main themes were identified: 1) headaches, 2) impact and 3) 
headaches in relation to health issues. The participants described their headaches, 
including their pain and symptoms, how they differentiated between their headaches 
and how their perceptions of their headaches influenced their management. They also 
described the impact of headaches on their lives, in terms of headache-related 
disability and put headaches into the wider picture of health in general.
Conclusion: The patients’ perceptions of migraine and chronic daily headache were 
sometimes conflicting and influenced the patients’ management behaviours. The 
qualitative methodology used in this study may help to inform doctors, other 
healthcare professionals and headache researchers about the patients’ perspective and 
possibly develop future headache research, care and education.
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5.2. introduction
High-impact headaches such as migraine and Chronic Daily Headache (CDH) affect 
12% (Breslau and Rasmussen, 2001) and 3.2- 5% (Castillo et al., 1999; Lu et al.,
2001) respectively of the general population. These headaches can cause disability 
and impair quality of life (QoL). Over 70% of migraine patients reported at least 
some disability, with about 30% of the migraineuis reporting severe disability 
(Stewai't et al., 1994). QoL is significantly reduced in migraineuis when compared to 
healthy controls (Lipton et al., 1995). CDH has an even greater impact than migraine 
(Monzon and Lainez, 1998). QoL is more severely reduced in patients with CDH 
than in patients with episodic migraine (Meletiche et al., 2001).
Few studies have been published on the patients’ perceptions of migraine and even 
fewer data are available on the patients’ perceptions of CDH. Gaining better 
understanding of the patients’ beliefs and attitudes is important as beliefs and 
attitudes may have an influence on the patients’ consultation behaviour*. Similarly to 
the study of patients’ management behaviours, the study of patients’ beliefs and 
attitudes has focused on clinical practice and medication and predominantly used 
survey designs. Of migraine patients who had never consulted, 17% believed that 
their* doctor would not treat their* migraine seriously enough, 76% said that they did 
not need a doctor’s opinion to treat their* migraines, 52% reported that their 
headaches were not that bad and 50% said that they had a treatment option that 
worked (Dowson and Jagger, 1999). However, 42% of those with headaches in the 
US said that there was nothing the doctor* could do, 41% said that seeing a doctor 
was too inconvenient and 32% said that seeing a doctor was too expensive (Lipton 
and Stewart, 1999). The lapsed consulters (65%) said they had not seen a doctor
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within the last year*, because the prescribed treatment was working and 59% said that 
their headaches had improved. Conversely, 26% had lapsed because they thought 
there was nothing the doctor could do for their migraines, 20% said that their doctor 
did not help them and 15% said that their doctor was not interested in headache 
(Lipton and Stewart, 1999). Another study showed that reasons not to seek medical 
advice included statements like the following: “it’s only a headache” (28%), “OTC 
treatments work for me” (32%), “the doctor would not be able to do any more for 
me” (10%) or “previous visit to a doctor was unsatisfactory/ treatment did not work” 
(6%) (MacGregor et al., 2003). Sixty-five percent of migraine sufferers from the US, 
the UK, Germany, France and Italy believe that not enough is being done to help 
them (Brandes, 2002). A focus group study in the US found tliat migraine patients 
are interested in understanding their condition and in securing relevant information 
about migraines, as well as obtaining pain relief. Furthermore, the patients desired 
collaborative relationships and wanted a team approach to treatment that involved 
both patient and doctor (Cottrell et al., 2002).
These studies have predominantly been based on a survey (quantitative) design and 
little opportunity has been given to migraineurs or CDH patients to freely express 
their points of view. Qualitative research addresses these limitations by increasing 
understanding of the headache patients’ world. The data presented in this chapter are 
pai*t of a study, which aimed at gaining insight into the patients’ perspective of 
migraine and CDH and their management. The aim of this chapter is to shed more 
light on patient’s perceptions and their experiences.
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5.3. Methods
Recruitment, data collection and analysis were carried out simultaneously by the 
researcher (MP), unless stated otherwise, in accordance with the groimded theory 
methodology (Glaser and Strauss, 1967). Ethical approval was obtained from the 
University of Surr ey Ethics Committee.
5.3.1. Sampling
A purposive sample of adult patients, who had suffered fr om migraine according to 
International Headache Society (IHS) criteria (Headache Classification Committee of 
the International Headache Society, 1988), were recruited in Surrey (UK) by 
theoretical sampling (Coyne, 1997). Participants were recruited through personal 
contacts (the researcher, MM), posters in 2 local supermarkets, and letters to 20 
members of the Migraine Action Association. Thirty-nine patients had been in 
contact with the researcher to obtain a final sample of 15 patients, who all suffered 
from IHS migraine. Due to the high frequency of their headaches (frequency >15 
days per month), 5 patients were classed as suffering from CDH. Dissimilar* cases 
were recruited to reflect a range of patients’ characteristics based on the patients’ 
gender, socio-demographics, age, headache-related disability and consultation status. 
The patients’ characteristics are described in Table 4.3 (Chapter 4, page 131).
5.3.2. Data collection and analysis
Data were collected by semi-structured, individual and tape-recorded interviews 
(n=14). Based on recent migraine literature, a flexible interview guide was devised 
(initial interview questions are described in Table 4.1, Chapter 4, p. 123). As part of
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the verification procedure, the interview guide was further developed to include 
previously raised issues and emerging concepts (Glaser and Strauss, 1967).
Interviews were arranged to the participants’ convenience, at their home, work place 
or the University of Suri'ey. Interviews lasted up to 2 hours with recording time 
averaging 1 hour (range 50-90 minutes). The first interview served as a pilot 
interview and was not included in the analysis. HAS and VV read interviews to 
assess interview teclinique and content. Interviewing finished with data saturation.
Interviews were transcribed verbatim and prepared for analysis in QSR NUD*IST5, 
a qualitative software package. All authors and an independent researcher were 
involved in the analysis to reduce bias of the coding and the emerging taxonomy, A 
coding guide devised by the researcher and HAS, was used to standardise coding for 
triangulation. To begin analysis, the first 5 interviews were summarised (by the 
researcher, HAS VV and an independent researcher). Secondly, the interviews were 
coded sentence by sentence to give an initial coding scheme (the researcher, VV and 
an independent researcher). No notable differences were found between the coding 
of the different researchers. The third stage of analysis involved comparing similar 
and different codes to group the codes into a hierarchical taxonomy to form concepts 
and theories. These concepts and theories were based on theoretical memos and 
discussions between the authors. The remaining 8 interviews were used to verify the 
coding scheme and refine the emerging taxonomy and concepts. First, a summary of 
the concepts and later detailed definitions, descriptions and interpretations of the 
main concepts were discussed by the researcher and her supervisors.
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5.4. Results
Tlnee main themes were identified from the interviews: 1) headaches, 2) headache 
impact and 3) headache as a health issue. The theme entitled ‘headaches’ was fuifher 
divided into ‘pain and other symptoms’, ‘differentiating between different types of 
headaches’ and ‘perceptions of headaches as baii'iers and facilitators to care’. The 
patients’ perceptions of headache are described in relation to these four themes. 
These perceptions were not static, but evolved over time, depending on the 
participants’ experiences of headache and treatment.
5.4.1. Headaches
This theme focused on the patients’ perceptions of their pain and other symptoms, 
their differentiation between different types of headaches and the influence of their 
perceptions on management. This theme illustrated the severity of the participants’ 
headaches and particularly migraines.
5.4.1.1. Pain and other symptoms
For most participants, pain was the dominant feature of their headaches. To help 
assess the severity of pain the participants explained their pain severity, their 
experience of the pain and how the pain developed over time (within an attack) and 
changed over the years (between attacks). Pain and migraines could be present upon 
waking up in the morning or could gradually build up during the day. Pt 10 
frequently woke up with a migraine:
“ ...the first thing that I am aware of, it’s like somebody’s put an laiife 
through my head. The pain is so intense that for several seconds I don’t 
ever open my eyes, in the hope that I’m just dreaming about it...”.
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Symptoms, other than pain, were also perceived as distressing and sometimes as 
more upsetting than the headache pain. Pt 12 described:
“ ...the thing that upsets me the most in a really bad one [migraine], I lose 
all coherency. I actually don’t know who I am or what anything is and 
just sounds and colours and brightness then really upset you...”
5.4.1.2. Differentiating between different types of headaches
The participants all suffered from IHS migraine, and 9 participants also had other 
headaches, such as daily or near-daily headaches (n=5) or tension-type headaches 
(n=3). The participants outlined the differences between those headaches. Knowing 
the difference between headache types was an important factor in the decision­
making for treatment. Migraines were mostly associated with severe, throbbing pain, 
nausea and aura symptoms. Other headaches were described as not interfering with 
daily activities and as being treatable with simple painldllers, which migraines 
frequently were not. Pt 2 said that with a headache:
“ ...there is not a wide variety of symptoms as with the migraine. There 
seems to be less symptoms with the headache. It affects [me] less, so 
obviously the severity is less. And the way that the headache develops, I 
would say is different to the way the migraine develops...The migraine 
almost always begins at the back of my skull and works up and forwar d 
into my eyes. The headache... just materialises on the top of my head and 
stays there, it doesn’t really affect anything else. It can usually be dealt 
with in half an hour* to three-quai*ters of an hour with painkillers...”
Most, but not all of the participants felt confident about differentiating between their 
headaches. Pt 13 was not sure about her* diagnosis:
“ ...I’m not very good at necessarily differentiating between the migraine 
and the bad tension headaches... I always think ‘oh, no I don’t suffer 
from migraine’, but the doctor* seemed to thinlc that the way I was 
describing them that it was more migrainous. I guess I have never* been a 
hundred percent certain of the differentiation between the tw o...”
154
Chapter 5: The patients’ perceptions of migraine and CDH
5.4.1.3. Perceptions of headache as barriers and facilitators 
to management
The type of headache and pai'ticulai'ly pain severity were often perceived as a cue for 
using pharmacological treatment, thus constituting a facilitator to care. When the 
pain and its severity were the type of pain and severity experienced during previous 
migraines, the participants took medication to stop the migraine from developing to 
its maximum severity. Pt 3 explained how she had learned to adapt her management 
behaviour based on her past experience of pain:
“ ...I can keep it quite moderate, if I get the tablets quick enough.... I’ve 
learned to cany the tablets with me. If I know it’s going to be a migraine 
and I’ll take the tablets quickly. But I do get them really very bad...”
However, the participants’ perceptions of their pain and other symptoms also 
sometimes constituted a barrier to management. The participants sometimes did not 
accept or doubted some of the characteristics of headaches, such as headaches 
recurring monthly or even near-daily, or headache severity. These participants 
expressed hope or optimism tliat the headaches would not return or resolve without 
active treatment (for example without relying on medication). P tl, who has never- 
consulted for her migraines, believed that her that migraine may not recur*:
“ ...I think ‘oh, I haven’t had a migraine for* two weeks, maybe they 
won’t come back’, optimism...”.
P tl3 described how her doubts about her* headache severity influenced her
consultation behaviour*:
“ ...when I don’t have any pain, I then star*t disbelieving whether* it was 
really as bad as I thought it was... because I could just get on with life 
and have a couple of weeks and I think ‘yeah, fine no problem’. And then 
it would hit me again, and I would thinlc ‘oh yeah, it really is that bad’... 
it was almost like I was disbelieving myself that I was ill or that it was a 
serious enough problem to look into it...”
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In contrast to the participants who were in denial about their headaches, some 
participants experienced woiTy and even fear. Wony occurred at the onset of the 
headaches and was related to a sudden onset, the lack of understanding of symptoms 
or the worry of a more sinister condition. Participants who were familiar with 
migraine symptoms, either through a family member or friend, rarely expressed 
wony. Pt7 outlined her fear*;
“ ...my vision’s going, it’s scary and I don’t luiderstand...”.
Similar to denial, worry influenced the participants’ management behaviour. Worried 
patients searched for reassurance by consulting other people, most often their general 
practitioner, for a diagnosis and explanation of the problem and treatment. Thus, 
whereas denial frequently induced passive behaviour, worry on the other hand 
induced active behaviour. Pt7 explained that she consulted the doctor because:
“ ...it was just reassuring, to find out if he could explain what I had, why 
it was doing it, sort of reassure me that other people had [it]. There are 
sort of ways in managing it, controlling it, and there [are] either 
preventatives or over the counters that you can take. Yeah, and mostly 
sort of reassurance I think, ‘cause it’s just so unknown, at the time it was 
unknown...”
5.4.2. Headache impact
The participants’ perceptions of impact illustrated suffering and put the magnitude of 
suffering into the context of the participants’ lives. Headache impact was mainly 
described in terms of disability, i.e. the participants’ inability to carry out their 
everyday tasks. All aspects of the participants’ lives had been affected by their 
headaches, including their work, family and social lives (leisure activities, holidays). 
Disability was personal to the patients, and refened to limitations to the participants’ 
everyday activities, such as work and family life, because of headaches. Pt 10 
described:
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“ ...last year I was to go to an open-air concert, it’s was Mozart, who is 
my favourite composer. I woke up that morning with migraine and I just 
couldn’t believe it. And I thought I’m going... if I have to crawl there on 
all fours. I did go and I sat listening to this music with my head 
pounding. I’d been terribly sick in the morning. But I just could not miss 
it, but in the interval, I admitted defeat and my sister drove me home...”
Headache-related disability went beyond tire impact on the headache sufferers. The 
participants explained that their headaches also had an impact on other people, 
including their families, friends and work colleagues. These people have to help out
when the patients were unable to carry out their tasks. Ptl described the impact of
her migraines on work and family:
“ ...there is this fear that if I get [a migraine] I’m gonna have to dive off 
[work] and I won’t be able to fulfil duties. It’s a disaster at home, 
because I just can’t do anything... I just have to lie down and the 
children just have to play and crawl around me... Mummy just can’t deal
with them or do any housework or do anything... My husband just
pitches in when I get one...”
Impact was a relative concept that was influenced by pain severity and headache
frequency. More painful headaches usually led to greater physical disability, and less
painfril, but more frequent headaches usually were more distressing as described by
Ptl4:
“...I get really long drawn out ones as well. But they are the ones that 
bother you the most because you feel like that all the time and you just 
get sick of it ... I have the constant thing all the time. But at such a level 
that it doesn’t affect me working.
The relativity of impact was further demonstrated when patients with similar pain 
severity and headache frequency did not describe the same impact. The participants’ 
perceptions of impact varied depending on the participants’ commitments (work and 
family), their belief in their ability to cope and their ability to fit their lives aroimd 
their headaches. Participants, who believed that they were able to cope and who were 
able to fit their lives around their headaches, perceived less disruption to their
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everyday lives and activities and tended to be more accepting toward their 
headaches. P tl4  describes how he adapted his life to his headaches:
“ ...I’ve made my own little world and I’m so busy and it’s all in one 
place. I haven’t had to face it [getting treatment]... I put up with the 
stress it [headaches] caused m e...”
5.4.3. Headache as a health issue
The theme of headache as a health issue related to what headaches meant in terms of 
health. The participants assessed what headaches meant as a health problem, as well 
as the meaning of headache within a wider health context. Headache was perceived 
to be a health issue, although not necessarily an illness. The refusal of some 
participants to acknowledge headaches as a problem or an illness meant that the 
participants perceived headaches as a low priority health issue. This denial often 
occurTed before or soon after onset of the headaches or when headaches were 
believed to have little impact.
By comparing headaches to other illnesses, the participants put headaches into a 
wider health context. The participants related their experience of headaches to their 
own experiences of illnesses other than headaches, other people’s experiences of 
illness or illness in general. Mostly, participants related headaches to illnesses that 
they perceived as more serious, and consequently they played down headaches and 
headache impact. This made it easier for the participants to accept their headaches. Pt 
9 felt lucky for ‘only’ suffering from headache:
“ ...a  friend of ours had a stroke. I’m amazed really, I got to sixty and
I’ve not had anything like that... So I’m really lucky in lots of ways. I
just have a few headaches, that’s nothing...”
Not acknowledging headaches as a problem already indicated that the participants 
gave low priority to headaches as a health issue. This finding was reinforced by the
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participants’ beliefs that headaches were less serious or important than other health 
problems. Perceiving headaches as low priority influenced the participants’ 
management behaviours, as outlined by Pt 1 :
“ ...If  I had a breast lump or something like that, something like that. I’d 
go straight there [GP], because I know what it is and it needs sorting out.
But migraine doesn’t fit into that category of absolutely needing sorting 
out desperately...”
Still, some participants had other views and they considered their suffering related to 
headaches worse than their suffering related to other illnesses, even life-tlireatening 
illnesses such as cancer, as described by Pt 10:
“ ...when people say to me ‘oh my goodness me, you’ve had breast 
cancer, how awful’. I said ‘it was nothing, it was nothing in comparison 
to my migraines’...”
5.5. Discussion
Three main themes had emerged from the interview data: 1) headaches, 2) headache 
impact and 3) headache as a health issue. The theme entitled ‘headaches’ was furlher 
divided into ‘pain and other symptoms’, ‘differentiating between different types of 
headaches’ and ‘perceptions of headaches as barriers and facilitators to care’. This 
study adds to the current literature by giving insight into the patients’ perspective of 
headache and by highlighting the influence of the patients’ perceptions on their 
management behaviour*.
Within the theme of headache, the participants revealed their perceptions of their 
headaches and how these perceptions influenced their management. Participants, 
who suffered from more than one type of headache, described how they 
differentiated between various types of headaches. The assessment of whether a 
headache was a migraine or not was important in the patients’ decision-making for
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treatment. Other factors involved in the patients’ decision-making for management 
were the headache pain (type and severity) and other symptoms. These findings were 
in line with the findings of another qualitative study. Aiming to investigate the 
decision-making of migraine patients taking sumatriptan, it was found that at the 
onset of head pain, participants actively compared their symptoms with a ‘migraine 
template’ that they had developed from past experiences (Ivers et al., 2000). Factors 
included in this personalised and complex ‘template’ that aided the participants in 
judging whether a headache was indeed a migraine were the nature, intensity, 
location and course of pain, the exposure to migraine triggers, presence of associated 
symptoms and presence of associated cognitive factors.
The patients’ descriptions of their headaches, and particularly headache severity, and 
headache impact indicate that patients perceive their migraine and CDH as a serious 
problem. However, the patients’ perceptions of headaches within wider context of 
health conflicted with the patients’ perceptions of headaches. The participants 
perceived headaches as less serious than other illnesses and gave low priority to 
headaches as a health problem. These perceptions may help to explain the low levels 
of consultations for migraine (Lipton et al., 1998), despite the high levels of 
disability (Holmes et al., 2001). Patients may thinlc that their headaches are severe 
and disruptive to their lives, but at the same time not a serious enough problem to 
bother the doctor with.
The results of this study show the high impact of migraine and CDH on the patients’ 
lives, through the participants’ descriptions of their disability. Impact emerged as a 
relative concept in relation to other diseases, pain severity and headache frequency, 
as well as social and work commitments. In terms of areas of life affected, a focus
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group study in the US revealed the areas of life that migraine patients perceive as 
most problematic in living with their headaches (Cottrell et al., 2002). The 
participants described effects on social functioning, family functioning, work and 
relationships. Similarly in this study, the participants described disability in relation 
to work, family and social lives. Quantitative findings confirm that migraine and 
CDH have a great impact on the sufferer due to disability (Lipton et al., 1995; Clarice 
et al., 1996; Holmes et al., 2001). The majority of migraine patients suffer at least 
some disability (Holmes et al., 2001) and patients with transformed migraine suffer 
even higher levels of disability than patients with episodic migraine (Meletiche et al.,
2001).
The findings of this study indicated that the patients’ perceptions of headache 
influence headache management. Another study revealed that the patients’ 
perceptions of their abilities to control headaches (self-efficacy) and the patients’ 
belief that factors that influence headaches are within their control (locus of control) 
independently explained the variance in headache-related disability in a sample of 
headache patients (French et al., 2000). Patients who believed they could prevent and 
manage their headache (higher self-efficacy) believed that the factors influencing 
their headaches were potentially within their control (higher locus of control). Also, 
self-efficacy scores were positively associated with the use of positive psychological 
coping strategies to prevent and manage headaches and negatively associated with 
anxiety. Positive coping strategies were for example attempts to reduce muscle 
tension, cognitive restructuring or coping self-statements. Thus, self-efficacy was 
appeared to be a determinant of the patients’ efforts to cope with headaches and 
headache-related disability. However, the patients within this study were all tension-
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type headache sufferers (90% of which suffered more than 15 headache days per 
month), and 29% of patients had an additional diagnosis of migraine.
Headaches remain under-diagnosed and under-treated (Lipton et al., 2001). 
Strategies have been proposed to improve headache management. Disability tools, 
such as MIDAS (Migraine Disability Assessment) (Stewait et al., 2001) and HIT 
(Headache Impact Test) (Gai'ber et al., 2001) have been developed and a care 
approach based on disability assessment (stratified care) (Lipton et al., 2000) has 
been tested. Although shown to be useful, these strategies act at the clinical level, 
and the majority of patients do no consult their doctor about headaches (Lipton et al., 
1998). Thus, it is necessaiy to gain insight into the patients’ actions outside physician 
consultations. The findings of this study increase understanding of the patients’ 
perceptions of migraine and CDH and it shows how the patients’ perceptions 
influence their management behaviours. Management of migraine and CDH can only 
be improved in collaboration with the patients. Patient involvement in the care in 
their chronic illnesses, and patient-doctor collaboration are viewed as a strategy for 
managing clnonic diseases in the 2L ‘ century (Department of Health, 2001). 
Education of headache patients has been shown to positively improve quality of life 
(Allen et al., 2000). Thus education programmes to influence the patients’ 
perceptions of headache (by minimising the barriers and maximising the facilitators) 
may be a suitable approach to improve migraine and CDH management.
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5.5.1. Strengths and weaknesses of methods
The strengths of qualitative methods include researching people in their natural 
settings and achieving deeper understanding of the participants’ world. Allowing 
greater flexibility, qualitative studies give a more realistic view of the world by 
allowing patients to speak freely (Soafer, 1999) rather than addressing issues pre­
determined by the researcher. Few qualitative studies have been conducted in 
headache research and the use of qualitative research to address this gap has been 
advocated to better understand the headache patients’ perspectives (Peters et al.,
2002).
The findings of this qualitative study cannot be generalised. Qualitative research 
does not seek to be generalisable (Mays and Pope, 2000), but opens a window to 
insider perspectives that is not always achievable by quantitative methods. If 
research only focused on what can be quantified reliably, then factors that are 
significant in explaining important realities and complexities may be ignored.
Health care problems can only be meaningfully addressed tln*ough imderstanding the 
patients’ perspective and the co-operation of health caie professionals and patients 
(Edwai'ds and Staniszewska, 2000). The findings of this study can be applied to 
generate quantitative research that is based on the patients’ perspective rather than 
the researchers’ point of view. Furthermore, the results of this study can be used to 
inform doctors and headache researchers and to increase understanding about the 
patients’ perspective of migraine and CDH. This may help to identify headache 
patients as competent persons who cope with their illness, at least paitly independent 
from doctors. Such an understanding may help to develop a more patient-centred 
health practice (Faltermaier, 1997), which is the preferred approach of primaiy care
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patients (Little et al., 2001) and to empower and educate patients to have the 
necessary knowledge and skills to seek help and to manage their headaches 
effectively (Diener et al., 2000).
5.6. Conclusion
This study reveals the patients’ perceptions of their migraine and CDH. The 
participants gave descriptions of their headaches that indicated the seriousness of 
their condition, as well as the impact these headaches have to their lives. However, in 
the wider context of health, the participants mostly found their headaches a less 
serious problem than other health issues. The study also showed how the patients’ 
perceptions influence their management behaviours. Patients may need to be 
educated and empowered to maximise the patients as a resource to management and 
to bring about the maximum benefit from the patients’ efforts.
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Chapter 6: The patients’ perceptions of migraine and CDH management
6.1. Abstract
Objectives: To gain insight into the patients’ perceptions o f migraine and chronic 
daily headache (CDH) management.
Methods: Thirteen, semi-structuied interviews with 7 migraine and 5 CDH patients 
were carried out and analysed in QSR NUD*IST5, using a grounded theory 
methodology.
Results: The participants described using five areas of management: 1) health care 
use; 2) medication use; 3) alternative therapies; 4) social support; and 5) life-style 
and self-help. The participants described their expectations, preferences, worries and 
(dis)satisfaction in relation to these 5 areas of management. The par ticipants adapted 
headache management to suit their needs and preferences, making migraine and 
CDH management highly individual and giving the headache patient a central role 
within their own care.
Conclusion: Health care is changing towards a greater involvement of the patients in 
their own care. Therefore it is important to increase understanding of the patients’ 
perspective of chronic diseases, including migraine and CDH. The results fiom this 
study inform health care professionals of the range of their patients needs and 
preferences. This knowledge can be used to shape clinical practice, to develop 
patient education programmes and to further research efforts into issues that are 
important to the headache patient.
169
Chapter 6: The patients’ perceptions of migraine and CDH management
6.2. Introduction
Migraine and chronic daily headache (CDH) affect 12% (Breslau and Rasmussen, 
2001) and 3.2% (Lu et al., 2001) of the general population respectively. Migraine 
and CDH are chronic conditions that significantly reduce the sufferers’ quality o f life 
(QoL), with QoL being more severely reduced in CDH patients than in migraine 
sufferers (Lanteri-Minet et al., 2003; Meletiche et al., 2001). Differences in QoL 
have also been observed within different CDH diagnoses, with tiansfbrmed 
migi'aine(TM) patients having a lower quality of life than chronic tension-type 
headache (CTTH) patients (Wang et al., 2001a).
In chronic illness, patient self-management is inevitable and patients make decisions 
about their condition everyday, which introduces a new chronic disease paradigm: 
the patient and health care professional relationship involving collaborative caie and 
self-management education (Bodenheimer et al., 2002). This paradigm implies that 
the health professional is the expert about the disease, whereas the patients are the 
experts about their own lives. Patients are empowered, i.e. they accept responsibility 
to manage their own condition and are encouraged to solve their own problems with 
information, but not orders, from health professionals.
Patients indirectly express their choices by behaving in a certain way, for example by 
choosing to take or not to take their medication (Kravitz and Melnikov, 2001). 
Investigating the patients’ perspective of the migraine and CDH management is the 
first step to understanding the patients’ current involvement in their own care, to 
identify areas for patient education and to involve the patients as a resource in 
managing their headaches. Multiple management strategies, such as health care 
consultations, medication and alternative therapies, are available to tieat and prevent
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migi*aine and CDH. Data are available on the patients’ use of the management 
strategies for the management of headache including migraine and CDH. The main 
focus of these studies are the use of health care (general practice, specialist care and 
emergency services) and/or medication for migraine (Linet et al., 1991; Edmeads et 
al., 1993; To and Wu, 1995; Michel et al., 1996; Dowson and Jagger, 1999; Adelman 
et al., 2000); Wang et al., 2001b; Lavados and Tenhamm, 2001; Lipton et al., 2001) 
and for CDH (Lu et al., 2001). Two Canadian studies have investigated consultations 
rates with other health professionals (Edmeads et al., 1993; To and Wu, 1995). Some 
studies have investigated strategies other than health care and medication use, such 
as tiiggers (Dowson and Jagger, 1999), social support (Michel et al., 1996) and the 
use of behavioural responses for headache (migi aine and TTH) relief (Pavâo Martins 
and Paneira, 2001). One recent international study has focused on the broader 
picture o f migraine management by investigating the patients’ use of self-help 
strategies (such as bed rest, trigger avoidance and stress management) and alternative 
therapies (MacGregor et al., 2003).
Most of the studies to date have been canied out in migraine sufferers, and little 
attention has been given to the patients’ management of CDH. Furthermore, studies 
have been based on survey designs, wherein the patients answered standardised and 
pre-determined questions (usually about health care and medication use). To 
understand the patients’ involvement in their own care, it is important for health 
service providers to receive feedback from the patients about the care that is offered 
(Edwards and Staniszewska, 2000). Qualitative research allows the patients to speak, 
not merely to respond (Edwards and Staniszewska, 2000) and deals with the 
participants’ unique experiences and their interpretation of these experiences to gain 
access to the respondent’s perspective (Soafer, 1999).
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Thus, a qualitative methodology would permit headache patients’ to speak 
unrestrictedly about their experience and perceptions of headache management. Only 
one study has used a qualitative methodology, using focus groups, to investigate the 
perceptions and needs of migraine patients (Cottrell et al., 2002). This US study 
focused on migraine impact and the patients’ preferred type of physician’s assistance 
and gave some insights into the patients’ perceptions of management. However, this 
study did not address patients’ perceptions of the holistic picture of migraine 
management, nor did it investigate CDH management.
The study described in this chapter was part o f a larger, qualitative study, which 
focused on the patients’ perspective o f migraine and CDH, and the management of 
these headaches. This chapter presents the patients’ perceptions of migraine and 
CDH management.
6.3. Methods
Ethical approval was obtained from the University of Surrey Ethics Committee. 
Recruitment, data collection and analysis were carried out simultaneously by the 
researcher (unless stated otherwise), in accordance with the grounded theory 
methodology.
6.3.2. Recruitment
Based on theoretical sampling, a convenience sample was recruited in the Guildford 
(Surrey, UK) area. To be included in the study, the par ticipants, had to be aged 18-65 
years and had to suffer from migraine according to the International Headache 
Society (IHS) criteria (Headache Classification Committee of the International 
Headache Society, 1988). Patients with co-existing headaches or patients who had
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developed CDH were not excluded. For the purpose of this study, CDH was defined 
as headaches occurring at a frequency above 15 days per month. Participants were 
recruited through a combination of personal contacts of the researcher and her 
supervisors, posters in 2 local supermai'kets and letters to 20 members of the 
Migraine Action Association. A total of 39 patients had been contacted and 15 
dissimilar' cases were recruited. O f the 15 participants, one woman withdrew before 
the interview and the first inter-view, with a female migraine sufferer, served as a 
pilot interview. Thus the interviews of 13 participants (9 women and 4 men) were 
included in the analysis.
All 13 participants suffered fiom IHS migiaine. Three patients also suffered fi'om 
tension-type headache (TTH) and based on their headache frequency, 5 patients were 
classed as suffering or having fiom CDH. CDH patients experienced higher 
fr equency and lower severity headaches, as well as full migr aine attacks. One patient 
had suffered from CDH in the past, but had been effectively treated and did not 
suffer fr om CDH at the time of the study. One participant (Pt 1) had never consulted 
for migraine, 6 participants had not consulted within the last 12 months and 6 
participants were had consulted within the last year'. Four participants (1 lapsed and 3 
current consulters) had consulted either a headache specialist or a neurologist. Levels 
of headache-related disability ranged from no disability to severe disability (as 
assessed by the Migraine Disability Assessment (MIDAS) questionnaire). The 
patients’ charactei'istics are described in Table 4.3 (Chapter 4, p. 132).
6.3.3. Data Collection
Interviews were semi-structured, individual and tape-recorded, A flexible interview 
guide was devised by the researcher and her supervisors based on recent migraine
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literature to comprise opening and more specific follow-on or clarifying questions 
and prompts. Initially the interviews focused on migiaine experience, physician 
consultations and treatments for migraine and CDH (Table 4.1, Chapter 4, p. 123). 
As interviewing and the analysis progressed, the interview guide was further 
developed to include previously raised issues and emerging concepts. Additional 
questions concentrated on patients’ preferences, choices and decisions and a more 
holistic approach to management.
Interviews were arranged to the participants’ convenience, at their home, work place 
or at the University of Surrey. The participants, who all signed the consent foim, 
were interviewed once. Interviews lasted up to 2 hours with recording time averaging 
1 hour (range 50-90 minutes). Inteiviewing finished with data saturation. Interviews 
were transcribed verbatim.
6.3.4. Analysis
Interviews were prepared for analysis and coded using QSR NUD*IST5 (N5), a 
qualitative software package. To reduce bias of the coding scheme and emerging 
taxonomy and concepts, the researcher and her supervisors, as well as an 
independent researcher, were involved in different stages of the analysis. A guide 
was devised (by the researcher and HAS) to standardise the coding procedure for 
triangulation. One by one, the first 5 interviews were summarised (by the researcher, 
HAS, VV and an independent researcher). Then the interviews were coded sentence 
by sentence to give an initial coding scheme (the researcher, VV and independent 
researcher). No notable differences were found between the coding of the different 
researchers. Codes were grouped into a hierarchical taxonomy to form concepts and 
theories. These concepts and theories were based on theoretical memos and
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discussions between the authors. The last 8 interviews, coded according to the same 
technique, were used to verify the coding scheme and refine the emerging taxonomy 
and concepts. First, a summary of the concepts and later detailed definitions, 
descriptions and interpretations of the main concepts were discussed by the 
researcher and all her supervisors.
6.4. Results
6.4.2. The patients’ use of management strategies
The participants described the management strategies they had used to tieat and 
prevent their headaches. The management strategies employed fitted into five areas 
of management: 1) health care use; 2) medication use; 3) alternative therapies; 4) 
social support; and 5) life-style and self-help (Figure 6.1). Health care use involved 
consultations with doctors, predominantly the GP, neur ologists and other health care 
professionals. Medication use related to the pharmacological agents used for the 
acute and prophylactic treatment of headaches. Alternative therapies comprised 
consultations with alternative therapists (such as osteopaths, chiropractors or 
acupuncturists) and the use of herbal and homeopathic remedies. Social support 
involved seeking and receiving advice for headache management from family, 
friends, work colleagues and other headache patients; the media and headache 
support groups such as the Migraine Action Association. Life-style and self-help 
dealt with non-pharmacological management such as trigger detection and 
avoidance, bed rest, relaxation and stress management and healthy life-style such as 
healthy eating and exercise
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6.4.3. The patients’ perceptions of management strategies for 
headaches
6.4.3.1. Health care use
The participants’ descriptions of health care use mainly focused on consultations 
with doctors and mainly the GP, although consultations with other health care 
professionals, such as nurses and phaimacists were also described. As far as general 
practice consultations were concerned, some participants had low expectations and 
questioned the GPs ability and interest to treat headaches, to the extent that they did 
not consult for headaches. Pt 5, who was not consulting for his migraines, thought 
the following:
“...nothing has ever indicated to me that anybody is interested and that 
there is any medical help...”
Participants, who had consulted a neurologist for their headaches, described higher 
expectations and often a preference for specialist consultations. They were, however, 
not necessarily more satisfied. Pt 7 described her reasons for prefemng a 
consultation with a specialist clinic:
“ ...GPs are very good at general practice. That’s what they are qualified 
to do. They know a limited amount about a lot of different illnesses, 
symptoms, problems. Going to a specialised clinic, they are specialist, 
they spend their working day dealing purely with headaches, they can 
also [do] diagnostic tests, whatever. It’s that additional sort of support.
The GP can only do one to one discussion of what your symptoms are. 
Whereas if you go to a specialist clinic you can go along for scans or x- 
rays and see if there is anything in your head that is causing the 
headaches or the migraines. That was the theory...”
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Independent of their consultation status, the participants thought that general practice 
consultations, and consequently the role of the GP, mainly revolved around 
pharmacological tieatments. The GP’s role was to advise on Over the Counter (OTC) 
medications or to give out prescriptions to treat symptoms. Little attention was given 
to issues, such as uncovering the causes of the headaches, finding a cure and 
discussing the impact of headaches or non-phaimacological and alternative therapies. 
However, these were issues that the participants would have liked to discuss with 
their GPs. For example, Pt 13 was interested in the causes o f her headaches, rather 
than the use of medication:
“ ...I thought I don’t want to be on these [dings] long-term. I want to 
find... if  there is a cause to these headaches. I’d rather get to the bottom 
of it, rather than just taking drugs to deal with the symptoms...”
Pt 12 would have liked to talk about the impact of headaches, rather than only 
receive medication:
“ ...it’s [GP consultations] orientated by drugs, it seems to me. It wasn’t 
about ‘how do you feel’, ‘how does this affect you’, ‘what are you 
experiences with diet, whatever’. It was ’’yeah ok, we’ve got Inderal, that 
will slow you heart down, we’ve got [diazepam], will make you calmer, 
we’ve got Imigran, will squash it when it happens, we’ve got Paiamax to 
stop you vomiting”. It’s almost sort of like, they’re not looking at the 
cause and possibly just trying to treat the symptom...”
When issues other than medication were discussed during consultation and the 
participants were encouraged to return for fiirther consultations, the GP was 
perceived as helpful and interested in the participants’ headaches. Consequently, the 
participants were more likely to be satisfied with the consultations and to return for 
follow-up consultations. Pt 9 had different experiences with doctors and described 
how the doctor’s attitude influenced her consultation behaviour:
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“ ...I think they [GPs] are concerned and they do, they are very 
sympathetic. And they all want to do the best, you know, for you. I think 
if they were the other way you wouldn’t go, would you? I don’t think if 
you got the ‘oh don’t bother me with this’. I did have a lady doctor years 
ago and I have been to her with the headaches... She used to turn around 
to me and say ‘well, you’re like my father, my father used to get them at 
weekends, because he was relaxing’”. And that’s the only sympathy I 
got, so I thought ‘alright, if  that’s all I am going get’, she never gave me 
anything.. .so I didn’t go and see her...”
G.4.3.2. Medication
The participants’ perceptions of the medications ranged as widely as the number and 
types of medications they had used. Despite expressing preferences for not taking 
any medication, all 13 participants had relied on medication for their headaches in 
the past. Some participants had only used OTC drugs, whereas other participants had 
also used prescription medication, including prophylaxis. Generally, the participants 
found using acute medications more acceptable than using prophylactic drugs, as 
outlined by Pt 6:
“ ...although migraines are bad, again I don’t know if  I’d want to take 
medication every day and there might be side effects...”
Despite all having used acute medication for headaches, some participants had low 
expectations of and low satisfaction with medication. Frequently these patients had 
only tried OTC medications and had experienced unsuccessful pharmacological 
treatment. Pt 6 found painkillers and Migraleve, which was recommended by her GP, 
ineffective and concluded that there was no effective treatment:
“ ...although it is very disabling really to have a migraine [pause] 
somehow, you know you just think, you should; it’s just a headache and 
nothing is going to help it really. If  painkillers don’t work, then there is 
probably nothing else that is going to work. Once I’ve tried Migialeve, I 
thought that was it, obviously the treatment he [GP] suggested to me and 
then it didn’t work...”
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Based on these low expectations and the worry of side effects, some patients 
prefeiTed to cope without medication (Pt 10) or restricted their medication use. Pt 5 
frequently opted against taking acute medication, because he was convinced he 
would suffer from side effects:
. .1 know it’s impossible to take any form of medication without having 
side effects, it’s impossible that’s the way it works. So therefore if  you’re 
going to take some then you have to balance it with the side effects. If 
you can get through whatever your problem is without taking any drugs, 
then you’ve got no side effects...”
Other patients had fomid an effective drug and shared the view o f Pt 7, who preferred 
taking medication to having a migraine. Pt 3 went as far as describing Sumatriptan as 
‘her lifeline’. Still, the participants, who used medication regularly, did not use them 
lightly. They had specific views on taking medication and on why and when to take 
the different types of medication. The reasons to take medication included pain 
control, restoring the ability to function or the prevention o f headaches. However, 
different medications served different purposes, for example triptans were for ‘severe 
migraines’ only, not for ‘headaches’. Overall, it was the triptans that the participants 
used the most caiefully. Pt 8 described his reasons for using Zomig sparingly:
“ ... the trouble that I was getting with Zomig is, they advise that really 
you take it as soon as you think it’s a migiaine coming. And the two 
problems with that is, one you don’t always know that it’s not just going 
to be a bad headache. So I was reluctant to take Zomig and then just find 
that it’s going to be a bad headache.. .1 only had, I think I only had about 
six of them [Zomig] I think. It was a struggle to get the doctor to 
prescribe them anyway, because they’re quite expensive...”
Pt 7 used Imigran for her severe migraines, otherwise she relied on OTC drugs. She 
also limited her use of Imigran because of the cost, but her personal costs of a 
prescription rather than the cost to the health service:
“ .. .recently, well since ’98, I’ve been on Imigran, so if  I do get a severe 
one, I tend to take that. It actually does seem to work better than the
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Migraleve, but the Imigran is very expensive, it’s a prescription drug. So 
I tend to rely quite heavily on Migraleve... In teims of finances it’s better 
to take Migraleve, because it’s cheaper...”
Similarly, although the participants prefeired not to take drugs every day, 
prophylaxis became acceptable in certain situations. Pt 4, after one particularly 
severe migraine attack, accepted to try beta-blockers:
“ ...I can remember an incident last year. In fact I went to the doctor’s.
And it was three, four days, I had this terrible headache. And I just 
couldn’t get rid of [it], I just felt dreadful. And it was up; across my face 
and then it was just lodged on one side and I felt that I couldn’t bear the 
light etc. And I was just on painkillers, the maximum dose and possibly a 
bit more, which is very silly. I went to the doctor’s in the end on the 
fourth or fifth day. And they prescribed beta-blockers, which helped...”
But when she experienced side effects (hence the circumstances changed), she 
discontinued the treatment.
“ ...beta-blockers made me feel quite light headed..., a little bit 
disorientated I suppose, because I had no sense of urgency or purpose 
about anything. I felt a little bit sort of dizzy. But dizzy in; I don’t mean 
off balance, but just not quite with it... Because to be totally unaware of 
the police chasing you for three miles with a gieat big siren, just indicates 
how spaced out I was... But anyway, they [beta-blockers] did help the 
headaches, but I couldn’t carry on like that because I was out of touch 
with life. So I gave them up ...”
6.4.3.3. Alternative therapies
Although not all the participants had consulted an alternative therapist (such as 
osteopath or chiropractor), they generally expressed an interest in what alternative 
therapies had to offer. Frequently it was cost that prevented the participants from 
trying alternative therapies. The participants, who had consulted alternative 
therapists, compared these consultations to the traditional medical consultations. 
They gave little descriptions on how effective they found alternative therapy, but 
they expressed satisfaction with the time and advice offered by alternative therapists.
181
Chapter 6: The patients’ perceptions of migi aine and CDH management
Pt 13 described her consultations:
...varying [laughter], some people were really helpful, like I found the 
chiropractor pretty helpful. And I guess met my need very much at the 
time and continued to kind of look at a more holistic care, you know, 
thinking of lots and lots of things, like exercise stretching exercise, diet, 
stiess, you know, the whole lot. As did the doctor, the second GP. The 
first GP I felt was very narrow minded and I [was] very much put off by 
him, if  you get the gist. The neurologist was ok, I guess kind of what I 
expected, but quite impersonal...”
Pt 12 also expressed his satisfaction with his alternative therapy consultations:
“ ...the homeopath and the cranial chap [osteopath] were trying to get to 
the cause, whether it was psychological, physical or a bit o f both. They 
addressed that and then tailored what they did to that, rather than the 
other way around. So that’s why I feel I made more progress with 
them...”
The participants also used homeopathic and herbal remedies to treat and prevent their 
headaches. These remedies were compared to the pharmacological agents, and were 
rated as ‘natural’, ‘safer’ and as ‘not leading to side effects’, as Pt 5 reported:
“...I would try those [herbal remedies] you know, so long as they; it was 
natural vegetation and not a drug as such. ...I don’t think they have any 
negative effects...”
Satisfaction or dissatisfaction with homeopathic and herbal remedies was expressed 
less often, and depended on the individual’s perspective. Pt 7 was not impressed by 
alternative therapy:
“ ... I did try a homeopathic thing once, but that didn’t do anything.. .I’ve 
tried Feverfew as well, I didn’t like the smell of those...”
Pt 9, however, had found acupuncture helpful:
“ ...it certainly helped me for a little while, ‘til I stopped. You’ve got to 
keep these things up ...”
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6.4.3.4. Social support
The use of social support was an adjunct to the other management strategies and was 
used to complement or further improve the participants’ headache management. The 
participants received social support from their families, friends, work colleagues and 
other headache patients. Having people to talk to about headaches, and paiticulaiiy 
other headache patients, was considered enjoyable and interesting, as described by Pt 
3:
“...I ’ve been down to my doctor’s, because I had a bit o f blood pressure.
I’ve been seeing a nuise and I was talking to her. And she suffers with 
them, migiaines. And she has the same tablets, she has Imigran and she 
says that’s her lifeline. She feels the same as m e... It’s very interesting, 
because you know you think ‘oh’ you know, ‘I seem to be the only one 
suffering from headache’...”
Talking to people allowed the participants to give and receive support and 
understanding and to exchange information and gain insights into other management 
strategies. For example Pt 10 said:
“ ...I’ve just met a new person, who suffers with headaches. She’s not 
had migraines, but she’s had very bad headaches. We just spent a whole 
hour chatting to one another, and giving one another different ideas. And 
afterwards it was just so nice, she said to me ‘you’ve helped me such a 
lot’. ..”
Also family and friends helped the participants to be more active in their own 
headache management and provided support when the participants had an attack. P 4 
decided to consult her GP, on her husband’s insistence:
“ .. .my husband said ‘oh you must go to the doctor and sort it out’....
Gaining new information about headaches to learn to better deal with them was 
considered important by the participants. New information was sought through 
various sources of social support such as family and friends, work colleagues, other
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headache patients and the media. Particularly charities, such as the Migraine Action 
Association were thought to be useful, since they gave access to the latest 
developments, as outlined by Pt 6:
“ ...They [Migraine Action Association] might have new treatments that 
have been successful with other sufferers, because obviously they are in 
touch with a number; a much larger number of people than probably the 
GP is. So they might have more idea of different treatments that can be 
used and possibly support for the sufferer...”
Although expressing interest in information about migraines, not all the participants, 
however, benefited from social support. Pt 5 for example was not aware of an 
association that can provide information for migraine and said the following:
“...it’s just one of those areas where it’s tucked to one side, there is 
probably something going on in pockets, but for the population as a 
whole; they’re not aware of anything going on, where to go, is there 
anything for it? You know if you had asthma, there are societies for 
asthma and the doctor can put you in touch...You can actually take it as 
far as you want to take it, can’t you. You can stay with the problem and 
just research it. But I am not aware of anything like that for migraine...”
6.4.3.S. Self-help and life-style
Not only did the analysis reveal the patient as having a central role in their 
management, the patients perceived themselves as an essential resource to 
management. The participants often thought it was their responsibility to deal with 
their headaches through self-help and life-style changes. Pt 9 believed that headache 
management was:
“...a  matter of doing most of the work yourself...”
As social support, self-help and life-style were described as adjunctive management 
strategies to health care and medication use. Self-help involved taking initiatives and 
contributing to their own headache management, by gaining infoimation about 
treatments, selecting their own prescription diugs, and convincing their GPs to
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prescribe the dmgs. Pt 8 explained how he influenced the outcome of his GP 
consultations:
“ ...The only way they [migiaines] got better was really by me sort of 
making them better, you know, sort o f talking about Zomig... I just said 
[to the GP] I’d heard about these [Zomig] ‘what do you think of 
them?’... She looked them up ... and said ‘oh, yes’. So I don’t think 
she’s heard of them before and said ‘yeah, we can try these if you 
like’.. .”
Self-help often revolved around triggers and analysis of their own headaches to help 
find a cause and possibly a cure. Pt 2 described looking for a cause of his headaches 
by examining his everyday behaviours:
“ ...I got to the stage where it got so bad I just had to look at everything 
that I was doing in a day. So, where are you in a day? What are you 
doing in a day? Now can this be a cause? No, ok let’s move on to the 
next thing...”
The participants’ life-style management strategies revolved around stress control, 
getting enough sleep and dietary changes. But changes in life-style could be as 
extreme as changing jobs to help control the migr aines, as outlined by Pt 8:
“ ...I’ve sort of resigned myself almost to the fact that it’s now up to me 
to get out o f my job and the shift work to stop my migraines...”
6.5. Discussion
The interviews revealed the wide range of strategies that the participants used to 
manage their headaches. The sampling aimed to recruit dissimilar patients and 
therefore the study gave access to many different perspectives and perceptions of 
migraine and CDH management. The participants adapted headache management to 
suit their needs and preferences, making migraine and CDH management highly 
individual. The participants predominantly talked about the traditional medical 
system, including consultations with doctors and medication use. They reported both
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unsatisfactory and satisfactory consultations with doctors and concerns with 
medications, including low expectations, sometimes low satisfaction, decisions about 
which type of medication to use and worries about medication side effects and costs. 
Similar concerns were revealed in another qualitative study, which used focus group 
to study the perceptions and needs of migraine patients (Cottrell et al., 2002). 
Problems included the implementation of treatment, even when effective treatment 
had been prescribed, dissatisfaction with emphasis on drug treatments (especially 
among women), worries about (long-term) side effects from taking medication and 
the costs of medication.
Poor cormnmiication between the doctor and the patient is thought to be one of the 
underlying causes of migraine under-treatment (Lipton et al., 1994). The participants, 
particularly the lapsed consulters and unsatisfied consulters, in this study reported 
that doctors were not interested enough. The participants were more satisfied with 
consultations when management was shaped to their needs and preferences, and 
when they felt that they were listened to and their concerns were understood by the 
health professional. However, concerns such as low expectations of tieatments and 
the wony of side effects were rarely addressed within consultation and dissatisfied 
patients chose not to consult again. Gaining insight into these issues is important to 
help health professionals to better understand the needs o f headache patients and to 
communicate more effectively with headache patients. This may contiibute to 
improving consultations and consequently treatment of migraine and CDH. Also, 
better understanding of the patients’ preference for tieatment may encourage further 
research into management strategies that the patients express a preference for.
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In view of the new chronic disease paradigm (Bodenheimer et al., 2002), the most 
important finding of the study was the central role the participants assigned to their 
involvement (self-management) in their headache care, including their role in during 
health care consultations and decisions about medication use. Chronic disease has 
become the principal medical problem and it is thought that the patient must become 
a partner, who contributes at almost every decision and action level (Holman and 
Lorig, 2000). The results presented in this chapter and finther results fi*om this study 
(Peters et al., 2003) showed how the patients’ perceptions of themselves as a 
resource to management; and their expectations, preferences and satisfaction with 
management strategies influence their choices for management. They express their 
willingness to be involved indirectly through their actions and directly through their 
interest in learning more about headaches through their social support network.
6.6. Conclusion
Health care is changing towards a greater involvement o f the patients in their own 
care. The Department of Health (UK) advocates the ‘Expert Patient’ as a new 
approach to chronic disease management for the 21®‘ century (Department of Health, 
2001). Therefore it is important to increase miderstanding of the patients’ perspective 
of chronic diseases, including migraine and CDH. Qualitative research, although 
limited in its generalisability, is suitable to gain insight into the migraine and CDH 
patients’ perspective. The results from qualitative studies can be used to inform 
health care professionals of the range of their patients needs and preferences, to 
shape clinical practice, to develop patient education programmes and to further 
research efforts (both qualitative and quantitative) into issues that are important to 
the headache patient.
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7.1. Rationale
The literatur e review (Chapter 2) has described the high prevalence of migraine and 
chronic daily headache (CDH) (12% (Breslau and Rasmussen, 2001) and 3.2% (Lu 
et al., 2001) respectively). It has also described that migraine and CDH patients have 
reduced quality o f life (QoL), with CDH patients being more severely affected than 
patients suffering from episodic migraine (Meletiche et al., 2001).
Migraine patients have been criticised for having a fatalistic attitude towards the 
treatment of their migraines (Henry et al., 1992), and migraine remains under­
diagnosed and under-treated (Lipton and Stewart, 1994). The qualitative study had 
aimed at gaining insight into the patients’ management from the holistic perspective. 
The 13 participants described their active involvement in their headache care. The 
interviews also revealed that the participants’ management strategies included and 
went beyond the traditional health care consultations and medication use. However, 
the qualitative methodology is limited in its generalisability, and a postal survey was 
conducted to study and compare the holistic management used by migraine and CDH 
patients.
To prepare for designing the surwey, previous studies using a surwey design to 
investigate the migraine and CDH patients’ use of management strategies were 
identified. These studies were srumnarised (Appendix 1) to identify which type of 
headache had been studied, which factors had been included and excluded, and 
which time frames and instruments (questionnaires vs. interviews vs. diaries) had 
been used. These issues were used as a guideline for the designing the questionnaire 
used in this study.
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Twenty-four studies, using a survey design, have been earned out between 1991 and 
2003 on the management behaviours employed by migraine and CDH patients. Six 
surveys have used a postal questionnaire only. Seven surveys have used telephone 
interviews and 5 studies have used face-to-face interviews. Only two studies used 
diaries, one of which had used diaries additionally to interviews. A large number of 
studies (n=10) did not specify time frame used, but the most common time frame 
was 12 months (n=9). The studies had been carTied out in a variety of countries. The 
largest number of studies have been conducted in the US (n=9). Two studies have 
been carried out in the UK. One international study also included the USA and the 
UK in their sample.
The Summary Table (Appendix 1) also presents the results of these studies (the 
number of patients using the studied strategies). Most studies focused on the use of 
health care (general practice, specialist care and emergency services) and/or 
medication for migraine (Linet et al., 1991; Edmeads et al., 1993; To and Wu, 1995; 
Michel et al., 1996; Dowson and Jagger, 1999; Adelman et al., 2000; Wang et al., 
2001; Lavados and Tenhamm, 2001; Lipton et al., 2001) and for CDH (Lu et al., 
2001). Predominantly management strategies have been studied in isolation, apart 
from the combined studies on health care and medication use. Some studies 
investigate other migraine management strategies, but usually these remain limited to 
one additional strategy for example triggers (Dowson and Jagger, 1999), social 
support (Michel et al., 1996) and the use of behavioural responses for headache 
(migraine and TTH) relief (Pavâo Martins and Parreira, 2001). One recent 
international study has focused on a wider range of issues including consultations 
with doctors, alternative health care use and self-help strategies such as bed rest and 
trigger avoidance (Brandes, 2002; MacGregor et al., 2003).
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Comparisons of health care behaviours have been drawn between migraine patients 
and controls (To and Wu, 1995; Michel et al., 1996; Lipton et al., 2001). Other 
studies compared management of patients with different headache diagnoses. Most 
comparisons between diagnoses were drawn between migraine and tension-type 
headache (Edmeads et al., 1993; Lavados and Tenhamm, 2001; Pavâo Martins and 
Parreira, 2001). One study compared 4 headache groups: migraine, probable 
migraine, tension-type headache and other headache (Linet et al., 1991). A further 
survey compared migraine patients with non-migraine headache sufferers (Wang et 
al., 2001). Comparisons between migraine and CDH are limited to one study that 
investigated the differences in coping, but not the use of management strategies, in 
migraine and CDH patients (Siniatchkin et al., 1999).
To summarise, few studies have focused on the management strategies employed by 
migraine sufferers. Previous studies on the migraine patients’ management have 
focused on consultations with doctors and medication use. Data on CDH 
management from the patient perspective is even more limited. Furthermore, to date, 
no study has drawn a comparison between the management behaviours employed by 
migraine and CDH patients. Also, the preliminary qualitative study showed that 
migraine and CDH management is more than physicians’ consultations and 
pharmacological treatment.
It is thought that headache management is best when the patient is actively involved 
(Silberstein et al., 2000). Through their use of management, patients indirectly 
express their views on preferences and choices (Kravitz and Melnikov, 2001). The 
limited amount of data on the patients’ behaviours suggests that headache patients 
are often disregarded as a resource to effective management. Increased knowledge of
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the patients’ behaviours, particularly between tire different headache types, may help 
to better understand patients’ preference and decision-making.
Therefore, to increase knowledge about the patients’ use of management and to make 
the qualitative findings more useful for explanation and prediction, a postal survey 
was canted out. The following chapter sets out to describe the aims and research 
questions and design, data collection and analysis of the questionnaire.
7.2. Aim and research questions
The aim of the survey was to investigate and compare the management str ategies 
used by patients suffering fi-orn migraine (M), migraine with aura (MWA) or CDH. 
The survey aimed to compare three groups, rather than the 2 groups (migraine and 
CDH) used for the qualitative phase, because the qualitative data indicated that 
patients with different headache diagnoses and increasing headache severity 
managed their headaches differently. Also, migraine diagnosis has been shown to be 
more likely when certain symptoms are present, including aura and increasing 
disability (Lipton et al., 2001).
The 2 main research questions were formulated according to this aim and were as 
follows:
• Which management strategies do M, MWA and CDH patients use to treat and 
prevent their headaches?
• What are the differences in management employed by M, MWA and CDH 
patients to treat and prevent their headaches?
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7.3. Development of the questionnaire
The questionnaire was developed through the collaboration of the student and her 
supervisors, based on the findings of the qualitative methodology and on the 
literature. As previously described, the studies on the patients’ use of management 
strategies ar e mainly based on telephone and mail questionnaire surveys. Due to time 
limitations and cost, a mail questionnaire was selected as a method of data collection. 
Also a mail questioimaire allowed a wider spread sample and it permitted people to 
confer with other people or think about their answers, which was important in view 
of the retrospective approach of the survey. The questiormaire collected data on the 
management behaviours of migraine and CDH patients in the year prior to the study.
The literature was searched to identify previous studies investigating migr aine and 
CDH management from the patients’ perspective. Few data on the patients’ 
management of headache were available. No studies investigating the holistic picture 
o f either migraine or CDH management (i.e. comprising the 5 themes identified in 
the qualitative study) were identified. Furthermore, there were no comparisons 
between the management of migraine and CDH. Since, past questiormaires to study 
certain aspects of management were either not available or did not exist in English, a 
new questionnaire was developed.
In previous publications, patients’ input into the questionnaire development was not 
described. Only one questionnaire to study the patients’ preferences for migraine 
therapy was based on qualitative findings (Caro et al., 1998). Therefore, it can be 
assumed that the suiveys, although investigating the patients’ behaviours, are 
developed by headache researchers. The questiomiaire used in this survey was 
developed with the patients’ input, based on the previous qualitative findings, as well
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as expert validation by other researchers and pilot work with migraine and CDH 
patients.
7.4. Content
No previous questionnaire had investigated either the holistic management of 
migraine or CDH from the patients’ perspective. Therefore, a new questionnaire was 
developed. The questionnaire contained 4 main parts: 1) headache information 
(section 1), 2) the management strategies (sections 2 to 6), 3) the patients’ opinions 
and beliefs (sections 7 and 8) and 4) biographical information. These four' sections 
will be described below in more detail. A copy of the questiormaire can be fotmd in 
Appendix 11.
7.4.2. Headache information
No validated diagnostic tool in English was available to diagnose the volunteers as 
suffering from migraine, migraine with aura or CDH patients. Therefore, a diagnostic 
tool was designed to be included in the questioimaire. This tool was based on the IHS 
criteria (for migraine and migraine with aura) and on the (Silberstein et al., 1994) 
criteria for CDH.
7.4.3. Management Strategies
Management strategies included in the questiormaire were identified fiom the curTent 
literature (Chapter 2) and the preliminary qualitative study. Five main areas of 
management had been identified and were included in the questiomiaire: 1) health 
care use, 2) medication use, 3) alternative therapies, 4) social support and 5) lifestyle 
and self-help (Table 7.1)
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Table 7.1: The five areas of management for migraine and CDH and their 
definitions, according to the qualitative study.
Health care use Consultations with health care professionals within the 
National Health Service, including GPs, neurologists, 
doctors specialising in headache, nurses, pharmacists, 
physiotherapist and psychologists
Medication use The use of pharmacological agents, including Over the 
Counter and prescription medication, and acute and 
prophylactic treatments
Alternative therapies Consultations with alternative therapists, including 
chiropractors, osteopaths and homeopaths
The use of herbal or homeopathic remedies, such as 
Feverfew or butterbur
Social Support Support sought and given by family, friends and work 
colleagues, support groups.
Information from the media such as the internet, 
newspapers, magazines, books and television.
Self-help and lifestyle Trigger avoidance, avoidance of aggravating stimuli, 
exercise, healthy eating, massage and cold/hot treatment.
These 5 areas of management were rearranged to reflect 4 other themes of 
management: 1) consultations, 2) the use of acute and prophylactic medication and 
herbal/ homeopathic remedies, 3) acute and prophylactic general management and 4) 
social support.
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7.4.4. Opinions
Two sections of the questionnaire (6 and 7) dealt with the patients’ opinions. Section 
6 related to the patients’ opinions about management strategies for dealing with their 
headaches and section 7 related to the patients’ beliefs and attitudes about headaches 
as a health issue.
7.4.5. Biographical information
This section of the questionnaire asking for biographical information reflected the 
data set of the last National Census, which was downloaded fiom the Internet.
7.5. Design of the questionnaire
To increase response rate, the questionnaire was laid out to be simple and to appear 
personal by the use of coloured paper and by directly addressing the respondents. It 
included a blank page for fuither comments, any other information that patients 
might felt that was relevant.
7.6. Cover letter and information sheet
The cover letter and infoimation sheet were designed to appear personal and to 
motivate headache patients to take part in the study. The information sheet was 
printed on University of Smrey headed paper. The cover letter was also printed on 
University of Surrey headed letter paper for the letters sent to the respondents of the 
advertisements. The cover letter sent via the Migraine Action Association was 
printed with the Migraine Action Association logo, to demonstrate that the Migraine 
Action Association was supporting the study. A copy of the cover letter can be found 
in Appendix 12 and the infoimation sheet can be found in Appendix 13.
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7.7. Ethical approval
Ethical approval had been obtained from the University of Surrey Ethics Committee 
(Appendix 14).
7.8. Pilot testing
7.8.2. Experts opinion
The questiomiaire was developed by the researcher and in collaboration with her 
supervisors, who commented on the design and content of the questionnaire. 
Furtheimore, two independent reseaichers with expertise in questionnaire design 
assessed the lay out and feasibility of the questionnaire. The information provided 
was used to revise the questionnaire.
7.8.3. Patients’ pilot study
The questionnaire was administered to 10 headache patients to test the content 
validity and feasibility of the questionnaire. The 10 patients were given an evaluation 
foim (Appendix 15) to assess the Headache Management Questionnaire, the cover 
letter and information sheet. None of the 10 patients had any problems of filling the 
questionnaire in. These 10 patients were selected thiough personal contacts and 
through a Headache Clinic.
7.8.4. Diagnostic Tool-Validity
A further initiative was taken to test the validity of the diagnostic tool within the 
questionnaire. Working together with the research nurse at the Headache Clinic, the 
9 questions relating to the diagnosis were sent to 30 patients who had previously 
been diagnosed by the clinic’s headache specialist. The questionnaire contained a
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code, which allowed the research nuise to identify the patient for comparison of the 
diagnosis. The patients were also sent a letter explaining the procedure (Appendix 
16), and a stamped and self-addressed envelope to return the questions to the 
researcher. Twenty-six (87.7%) questionnaires were returned. The diagnosis was 
made by the researcher and compaied to the clinician’s diagnosis (Appendix 17). The 
questionnaire diagnosis and clinician’s diagnosis concuned in 22 out of 26 cases. 
Thus the validity between the questionnaire and the clinician’s diagnosis was 84%.
7.8.5. Changes to the questionnaire
Following the experts input and the patients’ pilot study, only minor changes had 
been made to the questionnaire. Spelling and labelling mistakes were conected. 
Also, in accordance with the experts’ opinion, the section on biographical 
infoimation was moved to the end of the questionnaire.
7.9. Data Collection/ Administration
7.9.2. Mailing
The volunteers were sent a copy of the questionnaires together with an information 
sheet and a stamped (second class) and self-addressed envelope. The volunteers were 
asked to return the questionnaire within two weeks. Depending on the response rate, 
a follow up letter was to be sent 3 weeks after mailing the questionnaire. However, 
due to the high response rate, it was not necessary to send follow up letters. 
Envelopes were stamped with the University of SuiTey address, and the researcher’s 
name.
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7.9.3. Recruitment
7.9.3.1. Advertisements
Two advertisements were placed (Appendix 18) to recruit volunteers to complete the 
questionnaire. First, an advertisement was placed on the Migiaine Action 
Association web-site (http://migraine.org.uk). This advertisement led to few 
responses and therefore as a second step, the same advertisement was placed in the 
October 2003 issue of the Migraine Action Association Newsletter. Although this 
increased the response rate, the sample size of 400 questionnaires had not yet been 
achieved. A total of 87 responses to the advert on the internet and in the Migiaine 
Action Association Newsletter had been achieved. All questionnaires had been given 
a unique identification number to verify which questionnaires had been returned and 
to send follow up letters if  necessaiy.
7.93.2. Mailing the questionnaire to members of the 
Migraine Action Association
Since the advertisement had not led to the desired response rate, it was decided to 
mail the questionnaire to a random sample of the members (n=800) of the Migiaine 
Action Association. Due to the high response rate that the Migraine Action 
Association achieves when they mail questionnaires to their members, it was decided 
that mailing 800 questionnaires would be sufficient to achieve the desired sample of 
400. A list of the respondents to the adverts was sent to the Migraine Action 
Association to prevent members being asked to fill the questionnaire in twice.
An adapted version of the cover letter was used for mailing the 800 questionnaires. 
The cover letter was jointly written by the researcher and director of the Migraine
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Action Association. The letter was signed by the director of the Migraine Action 
Association. The information sheet was printed on University of SuiTey headed 
paper, the same as for the mailings in response to the advertisement.
The 800 questionnaires, cover letters, information sheets and stamped and self-
addi'essed envelopes were put into prepared envelopes (second class stamp and
University of SuiTey addr ess). These ‘packages’ were boxed and sent by Parcel Force 
to the Migraine Action Association for mailing to 800 members.
7.10. Questionnaire processing
For the questiormaires that were returned in response to the advertisement, the 
identification number was checked and deleted from the address database.
The questionnaires returned from the mailing to Migraine Action Association 
members, were given a unique identification number upon receipt. The identification 
numbers were entered into SPSS to facilitate data checking at a later stage.
7.11. Data checking
7.11.2. Eligibility
Upon receipt the questiomiaires were checked for eligibility (age and diagnosis) by 
the first author. If a definite diagnosis of IHS migraine (with or without aura) or 
CDH were given, the questionnaire (n=422) was entered into the statistics package. 
To check the reliability of the diagnosis, a 10% (n=42) random sample were selected 
and re-diagnosed independently by a headache clinician to assess the reliability of 
the diagnoses. Diagnoses concurred in 40 cases (95.2%).
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Based on this data checking, 65 questionnaires were excluded from analysis, due to 
absence of headaches in the last 12 months (n==9), the respondent being over the age 
limit of 65 years (n=39), missing biographical data (n=5) or missing diagnostic data 
(n=12). The diagnosis of further 50 questionnaires could not be established and was 
discussed between with the headache clinician. This led to the exclusion of further 34 
questionnaires, based on the headaches being unclassifiable (n=7) or the patients 
suffering from headaches other than migiaines (with or without aura) or CDH 
(n=27). The remaining 16 questionnaires were entered for data analysis. Thus, 438 
questionnaires were included in the data analysis.
7.12. Analysis
The questiomiaire data were entered into SPSS 10.1 for analysis. The non-numerical 
data was coded for entry into SPSS. First, codes were assigned for the closed 
questions. Data from open-ended questions were entered as open data initially and 
the coding was developed after the answers had been read and evaluated.
Data were analysed by descriptive statistics to compare the three groups (M, MWA 
and CDH). Chi-square tests were used for to test differences of categorical variables, 
including consultations, medication use. Kruskal-Wallis tests were used for ordinal 
data, including frequency of medication use, general acute and prophylactic 
management and social support. Analysis of variance (ANOVA) and post-hoc 
Scheffe tests were used for continuous variables including headache frequency, pain 
severity, impact and total scores for the use of general acute and prophylactic 
management and social support. The level of significance was set at p<0.05.
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Chapter 8: The Patients’ Management of Migraine and Chr onic Daily Headache
8.1. Abstract
Objectives: This study aimed to compare headache management between migraine 
(with and without aura) and chronic daily headache (CDH) patients over the last 12 
months. Management strategies from 4 areas were studied, including health care 
consultations, medication and alternative remedies, general (acute and prophylactic) 
strategies and social support. The patients’ beliefs and attitudes were also 
investigated and compared.
Methods: A postal questionnaire was sent to members (n=887) of the Migraine 
Action Association. The response rate was 61.2% (n=543), and 438 questionnaires 
were included in the analysis. M (n=117) and MW A (n=239) patients were classed 
according to the EHS (International Headache Society) criteria. CDH (n=83) was 
diagnosed when patients suffered more than 15 headaches days per month. 
Descriptive tests, ANOVAs, Chi-square and Kruskal-Wallis tests were used for 
statistical analysis (p<0.05).
Results: Significant differences in the use of management stiategies were found in 
consultations with headache specialists (p=0.002) and neurologists (p=0.004), the 
number and types of acute medications (e.g. tiiptans, p=0.002), the use of anti­
depressants (p=0.004) and some acute and prophylactic avoidance techniques. 
Although, no significant differences between the gioups were found in the use of 
other health professionals (e.g. GP), alternative health professionals, general acute 
management and the use of social support, they all actively used these strategies. 
Overall, CDH patients were more active than M and MWA patients. For the 
management strategies where no significant differences were found, there was a 
trend towards a gi'eater level of use of management strategies by CDH sufferers.
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Patients with CDH also had more negative beliefs and attitudes than M and MWA 
sufferers.
Conclusion: All the respondents were actively involved in their headache 
management, with CDH patients being more active. Given the initiatives towards 
higher involvement of the patients in the care of their chronic conditions, this reveals 
M, MWA and CDH sufferers as patients who are willing to be involved in their own 
care. The high level of suffering of the respondents suggests the need for more 
effective headache management and that the patients may be used as a resource to 
management. Therefore, patient education progiammes should be developed to help 
the patients to maximise their efforts to achieve the maximum benefit.
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8.2. Introduction
Migraines (with and without aura) affect 12% (15-18% of women and 6% of men) of 
the general population (Breslau and Rasmussen, 2001). On average, migraine 
patients suffer one attack per month, but the condition can progress to higher 
frequency headaches. Headaches with a frequency above 15 days per month, are 
clinically recognised as chronic daily headache (CDH). CDH affects 2.98% (Lanteri- 
Minet et al., 2003) to 4.1% (Scher et al., 1998) of the general population. Migraine 
and CDH adversely affect the patients’ quality of life, with CDH patients being more 
severely affected than episodic migraine patients (Meletiche et al., 2001).
The chronic nature of migraine and CDH require these high impact headaches to be 
managed over a prolonged period of time. The major responsibility for management 
lies with the patient, as most attacks are managed by the patient, in the absence of 
health care professionals. However, few studies have been carHed out to investigate 
the migraine patients’ involvement in their headache care and even fewer data are 
available on CDH patients’ self-management. A qualitative study showed the 
migraine and CDH patients’ involvement in their own headache care and decision­
making for their care (Peters et al., 2003a), but the view that migraine patients are 
passive in their headache management prevails.
It is recognised that headache management is best when the patient is actively 
involved (Silberstein et al., 2000) and that facts known by the physician need to be 
supplemented by facts that are only known by the patients (Sullivan, 2003). 
Therefore, gaining knowledge about the migraine and CDH patients’ perspective is 
important to make resear ch and health care practice more patient-centred and focused 
on the issues that are important to the patients (Sullivan, 2003). This study aimed to
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investigate and compare the management used by migraine (with and without aura) 
and CDH patients in the last 12 months, to gain further understanding of the 
involvement of headache patients in their own care.
8.3. Methods
8.3.2. Questionnaire
No previous questionnaire had investigated the holistic management of migraine or 
CDH from the patients’ perspective. Therefore, based on the findings of a 
preliminary qualitative study (Peters et al., 2003b), a new questionnaire was 
developed to include 4 areas of management: 1) consultations, 2) acute and 
prophylactic medication and herbal/ homeopathic remedies, 3) acute and 
prophylactic general management and 4) social support. Further sections included 
headache information (symptoms and impact) and biographical data.
The questionnaire was developed through collaboration by the authors. Two 
independent researchers with expertise in questionnaire design assessed the layout 
and feasibility of the questionnaire. To test content validity and feasibility, the 
questionnaire was administered to 10 headache patients. To test the validity and 
reliability of the diagnostic tool within the questionnaire, 30 patients who had 
previously been diagnosed by a headache clinician (AD) were asked to complete the 
questions relating to diagnosis. The first author made the diagnosis based on the 
returned questionnaires (n=26). The questionnaire diagnosis and clinician’s diagnosis 
concurred in 22 cases (84%).
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8.3.2.1. Respondents and recruitment
The questionnaire was targeted at adult headache patients (aged 18-65) who had 
either suffered from IHS migraine (M), IHS migraine with aura (MWA) or CDH 
(headache fr equency >15 days per month) in the last 12 months. Only UK residents 
were included in the sample. Ethical approval was obtained from the University of 
Surrey Ethics Committee.
The respondents were recruited through the Migraine Action Association in the UK. 
The questiomiaire was sent to a total of 887 patients and 543 questionnaires (61.2%) 
were returned.
8.5.2.2. Data preparation
Upon receipt the questiomiaires were checked for eligibility (age and diagnosis) by 
the researcher. If a definite diagnosis of IHS migraine (with or without aura) or CDH 
were given, the questionnaire was entered into the statistics package. O f these 422 
questionnaires, a 10% (n=42) random sample were selected and re-diagnosed 
independently by a headache clinician (AD) to assess the reliability of the diagnoses. 
Diagnoses concurred in 40 cases (95.2%).
Based on this data checking, 65 questionnaires were excluded from analysis, due to 
absence of headaches in the last 12 months (n=9), the respondent being over the age 
limit of 65 years (n=39), missing biographical data (n~5) or missing diagnostic data 
(n=12). The diagnosis of further 50 questionnaires could not be established and was 
discussed between the researcher and headache clinician (AD). This led to the 
exclusion of further 34 questionnaires, based on the headaches being imclassifrable 
(n=7) or the patients suffering from headaches other than migraines or CDH (n=27).
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The remaining 16 questionnaires were entered for data analysis. Thus, 438 
questionnaires were included in the data analysis.
8.3.2.3. Analysis
The questionnaire data were entered into SPSS 10.1 for analysis. Data were analysed 
by descriptive statistics to compare three groups: migraine (M), migraine with aura 
(MWA) and CDH. Descriptive statistics, chi-square Kruskal-Wallis, analysis of 
variance (ANOVA) and post-hoc Scheffe tests were used for statistical analysis. The 
level of significance was set at p<0.05.
8.4. Results
8.4.2. Respondents
Based on headache symptoms and headache frequency, of the 438 patients 117 (109 
women and 8 men) were diagnosed as M patients, 238 (211 female and 27 male) as 
MWA patients and 82 (72 female and 10 male) as CDH patients. There were no 
significant differences in gender, marital status, ethnicity, level of education, work 
status, age, age of onset of headaches and years of headache experience between the 
three groups (Table 8.1).
Table 8.1: Characteristics of the respondents by diagnosis
Mean age 49.9 8.86 48.3 9.66 49.9 9.02
Mean age at headache onset 21.58 10.66 19.26 10.07 18.88 10.83
Years of headache 28.63 12.23 28.94 12.34 30.99 13.16
experience
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8.4.3. Headache symptoms
The majority of respondents reported unilateral and pulsating or throbbing pain, 
aggravation of pain by physical activity, photophobia, phonophobia and 
nausea/vomiting (Table 8.2). The mean pain severity was 6.84 (sd 1.64) for M, 7.02 
(sd 3.70) for MWA and 6.70 (sd 1.81) for CDH. No significant differences were 
found for pain severity, location of the headache, type of headache pain, aggravation 
of headache by physical activity and headache duration with medication between the 
3 groups. Headache duration without medication was significantly longer for CDH 
than for M and MWA (p=0.016). Frequency of headaches (days per month) was 
significantly higher for CDH than for M and MWA (p=0.000), with CDH patients 
suffering a mean of 21.9 (sd 5.50) headache days vs. 6.84 (sd 1.64) days for M and 
5.53 (sd 3.70) days for MWA patients. As far as associated symptoms were 
concerned, only phonophobia differed significantly (p=0.017), with CDH patients 
being more affected than M and MWA patients.
Table 8.2: Percentage of M, MWA and CDH patients reporting symptoms
Headache location Unilateral 93.2 88.7 85.4
Bilateral 6.8 11.3 14.6
Type of headache pain Pulsating or throbbing 56.5 53.7 44.9
Steady ache 35.7 30.4 43.6
Tight band 7.8 15.9 11.5
Aggravation by physical activity 65.8 71.6 72.8
Photophobia 94.9 85.6 92.6
Phonophobia 85.5 90.0 86.3
Nausea/ vomiting 83.5 81.8 78.1
Aura symptoms Visual disturbance — 75.8 38.3
Speech disturbance — 59.8 45.6
Numbness — 41.1 38.3
Dizziness — 45.5 61.0
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8.4.4. Headache impact
Overall headache impact, rated on a scale of 0-10 (no impact to a lot of impact), 
significantly differed (p<0.001) between the 3 groups. The mean impact was 5.53 (sd 
2.29) for M, 5.51 (sd 2.40) for MWA and 7.16 (sd 1.13) for CDH. Post-hoc analysis 
(Scheffe test) showed that CDH patients were significantly more affected than M 
(p<0.001) and MWA patients (p<0.001). In terms of areas of life affected (Figure 
8.1), between 64 and 90% of patients reported headache impact on paid work, 
housework, leisure activities, and family and social lives. Fewer patients reported an 
impact on career and education. Apart from paid work, more CDH patients reported 
impact than M or MWA on specific areas, but significant differences were only 
found in the impact on housework (p=0.021) and career (p=0.013). The total number 
of areas of life affected by headaches was significantly different between M, MWA 
and CDH. The post-hoc Scheffe test showed that CDH was significantly different 
from M (p=0.043) and MWA (p=0.03).
Figure 8.1: Impact reported by M, MWA and CDH patients
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8.4.5. Consultations
B.4.5.1. Consultation rates
The total number of health professionals consulted significantly differed between 
groups (p=0.001). On average, M patients consulted 1.71 (sd 1.19) health 
professionals, compared with 1.84 (sd 1.65) for MWA and 2.53 (sd 1.81) for CDH. 
The post-hoc Scheffe test showed that CDH patients had consulted a significantly 
higher number of health professionals than M (p=0.002) and MWA (p=0.004) 
patients. The three groups had consulted a variety of health professionals, including 
medical professionals and alternative therapists (Figure 8.2). The highest 
consultation rates occurred with general practitioners. The pharmacist was the second 
most consulted health professional, whereas psychologists were the least consulted. 
No significant differences were found for the consultations with most health 
professionals, apart from higher consultations rates for CDH with headache 
specialists (p=0.027) and neurologists (p=0.002).
Figure 8.2: Consultations by M, MWA and CDH patients
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Further significant differences in consultations were found when examining the 
consultation frequency of the three groups. Significant differences in the consultation 
frequency were found for consultations with the GP (p<0.001), the neurologist 
(p<0.001), the osteopath (p=0.018) and the psychologist (p=0.011). The mean 
consultation rates for every health professional are presented in Table 8.3 and the 
post-hoc Scheffe test revealed the following differences between the groups. CDH 
patients consulted GPs significantly more frequently than M (p=0.001) and MWA 
(P<0.001). Furthermore, CDH patients had consulted neurologists significantly more 
often than M (0.005) and MWA (p=0.001). The frequency of consultation with the 
osteopath was significantly different between CDH and M patients (p=0.019). 
Consultations with the psychologist were significantly more frequent for CDH 
patients than for M (p=0.036) and MWA patients (p=0.017).
Table 8.3 : Frequency of consultations for M, MWA and CDH
Acupuncturist 0.42 1.32 1.36 10.12 1.54 5.44 NS
Chiropractor 0.19 0.78 1.28 7.91 1.61 5.91 NS
Headache specialist 0.22 0.80 0.24 0.80 0.48 1.08 NS
GP 2.00 2.05 1.93 2.59 3.58 4.44 <0.001
Homeopath 0.17 0.93 0.43 2.05 0.84 3.42 NS
Neurologist 0.18 0.60 0.17 0.51 0.50 1.01 <0.001
Nurse 0.07 0.37 0.27 1.09 0.18 0.66 NS
Osteopath 0.23 1.05 0.51 2.13 1.11 3.13 0.018
Pharmacist 0.40 1.09 0.47 1.20 0.57 1.23 NS
Psychologist 0.03 0.28 0.04 0.25 0.95 5.62 0.011
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When analysing only the data of consulters (those who have had at least one 
consultation with a specified health professional in the last 12 months), consultation 
frequency only significantly differed for GP consultations (p<0.001). The post-hoc 
Scheffe test showed that the frequency of GP consultations for consulters was 
significantly different in CDH patients (mean 4.72, sd 4.55) when compared to M 
(mean 2.58, sd 1.99) (p<0.001) and MWA (mean 2.95, sd 2.70) (p=0.001).
8.4.6. Medication use
8.4.6.1. Acute medication
The majority of the patients (99.1% M, 99.6% MWA and 98.7% CDH) had used 
acute medication in the last 12 months. Acute medication use included the use of 
Over the Counter medications (OTCs) and prescription medications (Table 8.4). The 
use of OTCs differed between the 3 groups (69% M, 75.9% MWA and 81.7 CDH 
patients), but this difference was not significant. However, significantly more 
(p=0.003) of M (86.2%) and CDH patients (82.7%) relied on acute prescription 
medication when compared to MWA (71.4%).
Table 8.4: Percentage of M, MWA and CDH patients using medication and 
other remedies
OTC medication 69.0 75.9 81.7
Acute prescription medication* 86.2 71.4 82.7
Prophylactic medication 45.2 38.6 48.1
Homeopathic/ herbal remedies 31.6 30.0 40.2
Vitamins/ minerals 17.4 20.3 27.5
NB. Significant difference p=0.003
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The patients’ use of OTCs and prescription drugs already indicates that most patients 
had used more than 1 type of acute medication. Indeed, 71.7% M patients, 59.9% 
MWA sufferers and 79.0% CDH patients had treated their headaches with one or 
more types of medication. In terms of number of acute medications used, MWA 
patients had used an average of 1.92 (sd 0.97) types of medication, M patients had 
used 2.22 (sd 1.12) types and CDH had used 2.43 (sd 1.22) types. The number of 
medications used by MWA sufferers in the last 12 months was significantly lower 
than the mean number of medications used by M (p=0.046) and CDH patients
(p=0.001).
CDH patients used both OTC and prescription medication more often than M and 
MWA patients (Table 8.5). Reflecting the difference in number of headaches days 
per month, the frequency of use of acute medications significantly differed for 
prescription (p<0.001) and OTC medication (p<0.001). The median frequency of use 
for OTCs was ‘once a week’ for M and MWA patients, and ‘2-4 times per week’ for 
CDH patients. The median frequency of use for prescription medication was ‘once a 
week’ for M, ‘every 2-3 weeks’ for MWA and ‘2-4 times per week’ for CDH.
Table 8.5: Frequency of use of OTC and prescription medication by M, MWA 
and CDH patients
Frequency of use of 
OTCs
2.64 1.34 2.54 1.43 4.18 1.12 <0.001
Frequency o f use of  
prescription 
medication
2.52 1.32 2.17 1.51 3.70 1.35 <0.001
NB. Level o f significance (p) according to Kruskal Wallis test.
0= ‘less than once a month’; 1= once a month’; 2= ‘every 2-3 weeks’; 3= ‘once a week’; 
4= ‘2-4 times per week’ and 5= ‘5-7 times per week’.
219
Chapter 8: The Patients’ Management of Migraine and Chronic Daily Headache
In terms of specific acute medications, combination medications (including caffeine- 
combinations, codeine-combinations, caffeine and codeine combinations and other 
combination medications) and triptans had been most widely in the last 12 monthg 
(Figure 8.3). Combination medications (p=0.026), and more specifically codeine 
combinations (p=0.040) and caffeine-codeine combinations (p=0.047) were used by 
significantly more CDH than M and MWA patients. Significantly more M and CDH 
patients (p=0.002) used triptans when compared to MWA patients.
S.4.6.2. Prophylactic medication
Although more CDH patients used prophylactics (Table 8.4), no significant 
differences were found between the 3 groups, Beta-blockers were used most 
fiequently for prophylaxis in M (21.7%) and MWA (17.2%). A comparable number 
o f CDH patients (19%) used beta-blockers, but the most common prophylactic used 
for CDH were anti-depressants (25.3%). Of the specific medications, only the use of 
anti-depressants significantly (p=0.004) differed between the groups.
The three groups also relied on herbal/ homeopathic remedies and vitamins/ minerals 
for prophylaxis, but these were used less often than prescription prophylactics (Table 
8.4). Homeopathic/ herbal remedies were used by 31.6% of M, 30% of MWA and 
40.2% of CDH patients, with Feverfew being the most common remedy used. 
Vitamins/ minerals were used by 17.4% of M, 20.3% of MWA and 27.5% of CDH 
patients, with magnesium being the most commonly used. Although more CDH 
patients used herbal/ homeopathic remedies and vitamins and minerals, there were no 
significant differences in the use of either of these sti ategies or in the type of remedy.
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8.4.7. General management
8.4.7.1. Acute general management
Acute general management strategies included avoidance techniques, disability 
behaviours and active management strategies (Table 8.6). All three groups used 
acute general management strategies to treat headaches (Table 8.7). Avoidance 
techniques and disability behaviours were used by the majority of patients. Although 
still used at least sometimes by a substantial proportion of patients, active acute 
management strategies were used by fewer patients. Relaxation was the most used 
active strategy, whereas biofeedback was rarely used. Although all three groups used 
these strategies, no significant differences were found in the respondents’ level of use 
(Table 8.8).
Table 8.6: Areas of acute general management strategies
Areas o f acute 
manafiement
Avoidance techniques
Disability behaviours
Specific acute uiaua^ciueut techui(fucs
Avoid alcohol, avoid bright light, avoid 
certain foods, avoid exercise, avoid head 
movement, avoid noise and avoid tea/coffee.
Avoid housework, leave social events, leave 
work, lie down and slow down.
Active acute management Biofeedback, cold treatment, heat treatment, 
__________________________ massage and relaxation__________________
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Table 8.7: Percentage of M, MWA and CDH patients using acute general 
management strategies at least sometimes
Avoid alcohol 91.2 89.9 93.6 91.6
Avoid bright light 84.1 94.3 91.5 90.0
Avoid certain food 75.6 78.8 82.6 79.0
Avoid exercise 72.9 69 72.4 71.4
Avoid head movement 74.2 80.8 87.5 80.8
Avoid housework 72 70.6 71.6 71.4
Avoid noise 86.8 87.1 90.3 88.1
Avoid tea/ coftee 64.6 68.4 56.9 63.3
Leave social events 79.8 78.4 81.5 79.9
Leave work 62 65 56.9 61.3
Lie down 92.2 90.1 86.5 89.6
Slow down 92.9 92.6 95.1 93.5
Biofeedback 4.4 8.0 5.7 6.0
Cold treatment 48.8 43.2 51.8 47.9
Heat treatment 37.7 33.8 38.7 36.7
Massage 50.9 42.2 45.6 46.2
Relaxation 67.3 69.1 65.4 67.3
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Table 8.8: The level of use of acute general management strategies by M, MWA 
and CDH patients
Avoid alcohol 3.32 1.21 3.23 1.24 3.37 1.08
Avoid bright light 2.88 1.20 3.17 1.01 3.04 0.96
Avoid food triggers 2.48 1.47 2.65 1.40 2.70 1.34
Avoid exercise 2.38 1.42 2.22 1.39 2.23 1.30
Avoid head movement 2.52 1.45 2.45 1.24 2.56 1.18
Avoid housework 2.30 1.43 2.14 1.38 2.20 1.21
Avoid noise 2.90 1.22 2.72 1.17 2.87 0.97
Avoid tea/ coffee 2.16 1.52 2.27 1.46 1.85 1.50
Leave social events 2.28 1.09 2.16 1.02 2.28 0.95
Leave work 1.85 1.20 1.85 1.14 1.72 1.07
Lie down 2.74 0.97 2.72 0.99 2.57 1.04
Slow down 2.90 1.01 2.85 0.99 2.87 0.96
Use biofeedback 0.18 0.59 0.24 0.65 0.30 0.62
Use cold treatment 1.42 1.47 1.24 1.31 1.48 1.44
Use heat treatment 1.11 1.35 0.88 1.13 1.13 1.29
Use massage 1.39 1.22 1.13 1.08 1.23 1.12
Use relaxation 1.81 1.17 1.78 1.14 1.83 1.22
NB. No statistically significant 
0= ‘never’; 1= ‘rarely’; 2=
differences were found, using the Kruskal Wallis test, 
‘sometimes’, 3= ‘often’ and 4 = ‘always’.
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S.4.7.2. Prophylactic general management
Prophylactic general management strategies, including avoidance techniques and 
healthy lifestyle (Table 8.9), were used less often, but apart from avoiding exercise, 
more than 50% of patients used these strategies at least sometimes (Table 8.10). 
Eating regularly to prevent headaches was the most commonly used management 
strategy, whereas avoiding exercise was the least commonly used prophylactic 
strategy. Significant differences in the level of use of prophylactic strategies were 
found between the groups (Table 8.10) for avoidance of bright light (p=0.007), 
exercise (p=0.011), avoidance of noise (p=0.004) and food triggers (p=0.025). 
Avoidance of bright light, exercise and noise were used more frequently by CDH 
patients than M and MWA patients. The avoidance of food triggers was used less 
often by M patients than by MWA and CDH patients.
Table 8.9 Prophylactic general management strategies
Avoidance Avoid bright light, avoid exercise, avoid
techniques noise, avoid stress, avoid food triggers
and avoid non food triggers
Healthy Eat regularly, sleep regularly.
lifestyle prophylactic exercise and relaxation
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Table 8.10 Percentage of M, MWA and CDH patients using prophylactic 
general management at least sometimes
Avoid bright light 56.6 66.8 77.2
Avoid exercise 25.9 33.4 52.4
Avoid noise 52.0 53.9 78.5
Avoid stress 72.3 71.9 77.6
Avoid food triggers 64.8 78.7 76.0
Avoid non-food triggers 70.5 94.5 82.2
Eat regularly 95.6 95.9 98.7
Sleep regularly 93.0 92.8 92.5
Prophylactic exercise 64.3 69.1 64.6
Relaxation 67.2 70.2 66.2
Table 8.11: Level of use of prophylactic general management strategies by M, 
MWA and CDH patients■
Avoid bright light 1.72 1.30 2.03 1.40 2.35 1.26 0.006
Avoid exercise 0.87 1.04 0.96 1.12 1.43 1.20 0.002
Avoid noise 1.54 1.28 1.56 1.30 2.15 1.06 <0.001
Avoid stress 1.90 1.04 1.92 1.08 2.20 1.02 NS
Avoid food triggers 2.00 1.41 2.58 1.39 2.47 1.37 0.025
Avoid non food triggers 2.08 1.34 2.40 1.26 2.63 1.23 NS
Eat regularly 3.35 0.92 3.32 0.91 3.37 0.75 NS
Sleep regularly 3.09 1.04 3.11 0.99 3.05 0.90 NS
Exercise 1.83 1.24 1.97 1.19 1.80 1.20 NS
Relaxation 1.78 1.05 1.92 1.11 1.97 1.22 NS
NB. 0= ‘never’; 1= ‘rarely’; 2= ‘sometimes’, 3= ‘often’ and 4 = ‘always’.
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The individual prophylactic strategies were grouped to give an overall score for 
avoidance strategies and lifestyle strategies. The use of prophylactic avoidance 
techniques was significantly different between the groups (p<0.001). Of a maximum 
score of 24, the mean scores were 9.91 (sd 5.24) for M, 11.36 (sd 5.10) for MWA 
and 13.14 (sd 5.17) for CDH. Post-hoc analysis showed, that CDH used significantly 
more general prophylactic strategies than M (p<0.001) and MWA patients (p=0.043). 
The use of prophylactic general management, consisting of the total score of 10 
strategies (score range 0-40), was significantly different (p=0.003) between groups. 
The mean score was 19.62 (sd 6.69) for M, 21.67 (sd 6.60) for MWA and 23.01 (sd 
6.48) for CDH. Post-hoc analysis showed that M patients had significantly lower 
scores than CDH (p=0.005) and MWA patients (p=0.039).
8.4.8. Social support
Using social support was the least used management stiategy, but most (apart from 
patient support groups and charity help-lines) stiategies were used at least sometimes 
by more than 30% of the patients (Table 8.12). No significant differences were 
found in the level of use of social support between the three groups. Social support 
focused on 3 areas: media (internet, magazines, newspapers, scientific ailicles and 
television); family and friends (family, friends and work colleagues) and patient 
support (charity publications and telephone/ email help-line, other headache patients 
and support groups). Other headache patients and reading, including charity 
publications, magazines, newspapers and scientific articles, were used at least 
sometimes by over 50% of patients. Charity telephone/ email help-lines and support 
groups were used the least often.
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Table 8.12: Percentage of M, MWA and CDH patients using social support at 
least sometimes
Charity publications 73.1 80.7 79.9
Charity telephone/ email help-line 7.5 8.6 14.6
Family 40.5 40.0 31.1
Friends 48.6 47.6 40.5
Internet 39.3 30.8 44.3
Magazines 72.7 72.8 77.2
Newspapers 70.7 72.4 74.7
Other patients 60.0 58.7 60.8
Support groups 10.6 12.4 15.3
Scientific articles 44.8 53.5 57.1
Television 31.9 33.4 35.1
Work colleagues 34 31.8 23.9
8.4.9. Patients’ opinions
The patients’ rated their level of agreement with 18 statements on headaches and 
headache management. The table shows the respondents mean level of agreement 
(and standard deviation) with each statement. Significant differences between the 3 
groups were found for 11 of the 18 statements (Table 8.13). Overall, CDH patients 
had a more negative attitude towards headaches and their management, for example 
they found consultations with the doctor significantly less helpful and were 
significantly less satisfied with their headache management. Even in the statements 
for which no significant differences were found, the trend was towards a more 
negative attitude of the CDH patients.
In terms of effectiveness of management strategies, medication was perceived as the 
most effective way to manage headaches. Self-help, although not considered as 
effective as medication, was thought more effective than alternative therapies.
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Receiving advice from friends and family was not thought as helpful as reading 
about headaches. Interestingly, reading about headache was considered more helpful 
than talking to the doctor or other health professionals. Satisfaction with 
management was low and patients wanted better management for their headaches. 
The respondents knew that headaches are not curable and believed that headache 
treatment had improved in the last 10 years. M and MWA patients tended to agree 
that headaches could be treated successfully, whereas CDH patients tended to 
disagree with this statement.
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8.5. Discussion
Focusing on the holistic management of M, MWA and CDH, this study shows that 
that patients are actively involved in their headache management. Furthermore, 
management is based on a combination from 4 areas including consultations, use of 
medication and alternative remedies, general (acute and prophylactic) management 
and social support. Strategies were highly used, with most strategies being used by 
over 50% of patients. The level of use for some management strategies was 
dependent on the headache diagnosis, whereas other management strategies were 
equally used by the 3 groups.
It was mainly the behaviour o f CDH patients that differed from the behaviour of M 
and MWA patients. CDH patients tended to be more active in their management. 
These differences were not always significant, but for the non-significant results 
there was a frend towards a higher level of activity in CDH patients. This indicates 
that the higher frequency of CDH makes these patients more active in their headache 
management. However, the high headache frequency and the high headache impact 
suggest that, despite the patients’ efforts, CDH management is not effective and/or 
not appropriate. Indeed, the high use of medication is cause for concern. In this 
study, most CDH patients used acute medication several times a week. Since the 
majority of tiansfbrmed migraine patients (62.5%) reported that medication provided 
the main headache improvement factor (Galego et al., 2002), CDH patients may 
believe that using medication is the best approach to treat headaches. In this study, 
CDH patients most strongly agreed that medication was effective to manage their 
headaches, whereas they found self-help and alternative therapies less effective. 
However, over-use o f medication may be a contributory factor in the development of
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CDH (Diener and Katasarva, 2001). Therefore, acute medication use should be 
limited and more emphasis should be put onto prophylaxis. In this study, only 48.1% 
of the CDH patients were using prophylactics. Since the majority of CDH patients 
(75.6%) have consulted their GP within the last 12 months, there is scope to 
prescribe prophylactic medication to these patients and to educate CDH patients 
about the implications of medication over-use in the development o f their CDH.
As far as the respondents’ beliefs and attitudes were concerned, it was also mainly 
CDH patients who differed from the other two groups. Overall, CDH patients had a 
more negative attitude than M and MW A patients. CDH patients disagieed more 
strongly that medication, self-help and alternative therapies were effective to manage 
headaches. Also, they found receiving advice from friends and family, reading about 
headaches and talking to the doctor, less helpful than M and MW A patients. CDH 
patients were more dissatisfied with their management and reported that they knew 
less well how to manage their headaches effectively. Accordingly, CDH patients 
expressed a stronger desire for better headache management. The CDH patients’ 
negative beliefs and attitudes, particularly towards the effectiveness of management 
strategies, may be a barrier towards self-management and lead to passive behaviour. 
Indeed, in the qualitative phase (Chapter 6), low expectations and failed experiences 
with management strategies were barriers to adopting or maintaining a given 
management strategy. However, the quantitative findings show that the CDH 
patients’ beliefs and attitudes did not stop CDH sufferers to be actively involved in 
their headache management. Indeed, CDH patients were more active in their 
management than M and MW A patients, who reported less negatives beliefs and 
attitudes. This may mean that CDH patients benefit from their management 
behaviours, despite their negative beliefs and attitudes. However, this remains
233
Chapter 8: The Patients’ Management of Migraine and Chronic Daily Headache
speculative since the study design does not allow drawing conclusions on the 
effectiveness of self-management on the patients’ outcomes. Another possible 
explanation may be found witliin the qualitative data (Chapter 6), which showed that 
headache severity, in terms of symptoms and perceived suffering, influenced the 
management behaviours of migraine and CDH patients. Thus it may be that the 
patients’ perceptions of headaches have a stronger influence on management 
behaviour than the patients’ perceptions of management strategies. The influences of 
the patients’ perceptions on management behaviour, and predictors for management 
behavioui', are areas of self-management that need further investigation.
In terms of the level of use of individual management strategies, previous studies 
have predominantly focused on health care and medication use in migraine. In this 
study, the GP was the most frequently consulted health professional, both in terms of 
consultation rates and consultation frequency, hi comparison to previous studies, 
more patients in this study relied on consultations with family physicians. Migraine 
studies have shown physician consultation rates of 50% in the US (Brandes, 2002) 
(Lipton and Stewart, 1999) and 29% (family physician) in Taiwan for migraine, 
versus consultation rates with GPs of 67,7% for M and 78.0% for MWA. CDH 
studies have shown consultation rates of 41% with family physician (Wang et al.,
2001) a substantially lower rate than the 75.2% consultation rate found in this study. 
However, neurologist consultation rates for CDH have been reported at the same 
level (28%) (Wang et al., 2001) than those found in this study.
As fai* as consultations with health professionals other than physicians are concerned, 
few data are available and they focus on migraine. The available data do not give all 
the necessary details or the health professionals under investigation differ from those
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in this study. Edmeads and colleagues (1993) reported that many headache patients 
consulted chiropractors, acupunctmists, masseuses, homeopaths and nutritionists. 
However, the authors did not give any details on consultation rates and thus no 
comparisons can be drawn to this study. A fui'ther Canadian study revealed that 
1.51% of migraine patients reported consulting a nurse, 71.4% had consulted a dental 
practitioner, 42.5% an optician, 23.9% a pharmacist, 6.9% a physiotherapist, 14.8% a 
chiropractor and 11.7% a psychologist, social worker or other counsellor (To and 
Wu, 1995). In this study, consultations with a nurse were higher than those found by 
To and Wu (5.3% M, 11.3% MWA and 10.0% CDH patients). Consultations with 
pharmacists were comparable for M and MWA patients (17.7% and 24.4% 
respectively), but higher rates were reported by CDH patients (30.5%). Consultations 
with a chiropractor were reported by 7.8% M, 12.1% MWA and 21.4% of CDH 
patients. Consultations with the psychologist were reported by 0.9% of M, 2.6% of 
MWA and 6.4% of CDH patients. However, due to its design, the study by To and 
Wu did not allow to conclude whether these visits were for migraine.
The number of patients using medication have both been reported at similar and at 
lower levels. In this study, over 98% of patients reported to have used acute 
medication in the last 12 months. This coiTesponds to the levels o f medication use 
(94%) by migraine patients in the UK (Dowson and Jagger, 1999). Other studies 
showed lower levels of medication use, such as 72% of French patients using 
medication (Michel et al., 1996). The use of prescription medication (over 70%) was 
also substantially higher in this study, than in a US study (41%) (Lipton et al., 2001). 
In terms of specific medications, triptans were of particular interest, as they were 
used by the majority of patients (57.7% MWA, 75.2% M and 67.8% CDH). In
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previous studies, only 10-18% (Dowson and Jagger, 1999; Brandes, 2002; Lipton et 
al., 2003) of migraine patients had used tiiptans.
In this study MWA patients had used fewer types of acute medication and few MWA 
patients used prescription medication and tiiptans. This was surprising as a previous 
study showed that symptoms such as aura influence the diagnosis of migraine 
(Lipton et al., 1992) and the use of prescription medication (Celentano et al., 1992). 
The lower use of prescription medication and triptans in this study may be explained 
by the patients’ opinions. MWA patients were more likely to report self-help and 
alternative therapies as effective for the management o f their headaches.
The higher use of GP consultations and medication in this study population may be 
related to the respondents’ membership of the Migraine Action Association. The 
newsletter, which Migraine Action Association members receive four times a year, 
provides information about migraine management, including consultations and new 
treatments. The respondents found reading more helpful in the management of their 
headaches than consultations with the doctor and other health professionals. Thus, 
through their reading, the respondents may be better informed about treatment 
availability, which may make them more pro-active and assertive in their pursuit of 
finding effective treatment. A study in the Netherlands found that 58% of headache 
patients attributed their reduction in headache impact to social support strategies such 
as the support by the Dutch Society of Headache Patients (Vos and Passchier, 2003). 
The Migiaine Action Association newsletter also reports on other strategies, such as 
alternative therapies and general management. Thus the high levels of use of other 
management strategies may also be higher in this study population than in the 
general population.
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This study shows that there is a large group of M, MWA and CDH patients, who are 
actively involved in their headache management. Furtheimore, since the majority of 
respondents have reported to use social support stiategies, this study shows the 
benefits of using patient chaiities and the media in educating the patients about 
headache management in terms of achieving higher levels of activity for the 
management of M, MWA and CDH. Indeed, having better information may have 
been an incentive to consult, since more lapsed (60%) and non-consulters (65%) than 
current consulters (42%) felt that they did not have most cunent infoimation 
(Adelman et al., 2000). Given that most of the patients in this study, and particularly 
CDH patients, still suffered fiom high frequency headaches, it is important that the 
patients’ efforts to manage their headaches are maximised and optimised. The 
differences in management found in this study, in relation to diagnosis, need to be 
taken into consideration when educating patients about headache management.
8.6. Conclusion
This study shows that M, MWA and CDH patients are actively involved in their 
headache management and that management is a combination of 4 areas including 
consultations, use of medication and alternative remedies, general management and 
social support. Most strategies were used by over 50% of patients and the level of 
use was dependent on the headache diagnosis for some, but not all, strategies. 
Overall, CDH patients were more active in their headache management than M and 
MWA patients. Also, CDH patients had more negative attitudes and beliefs towards 
headaches and their management, as well as their own ability to manage headaches 
effectively.
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Health care is changing towards a greater involvement of the patient in his/ her own 
care. The new chronic disease pai'adigm, in which the health professional provides 
the expertise about the disease and the patient provides the knowledge about his/ her 
life and experience (Bodenheimer et al., 2002; Holman and Long, 2000), can only be 
implemented if  the patients are willing to be involved. The patients’ high level of 
involvement in their own care indicates the headache patients’ willingness to 
participate in their care. The high levels of suffering experienced by the respondents 
of this study suggest that these patients’ headache management is not as effective as 
it could be. Education programmes are needed to maximise the patients’ efforts 
towards gaining the greatest benefit for the patients, in terms of reducing headache 
impact and improving quality of life.
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Chapter 9: The patients’ involvement in migraine and clii’onic daily headache
management: a study using qualitative and quantitative methods
9.1. Abstract:
Aim: The aim of this study was to investigate the patients’ perspective of migraine 
and chionic daily headache (CDH) management.
Methods: The study was conducted in two phases in the UK. The sample for both 
phases included adult (aged 18-65) headache patients, who suffered either from 
migraine according to the International Headache Society criteria or from CDH 
(headache frequency >15 days per month). First, a qualitative phase was conducted, 
using semi-structuied interviews that were analysed according to the grounded 
theory methodology. Secondly, a quantitative phase was carried out, based on a 
postal survey that was administered to migraine, migraine with aura and CDH 
patients, who were members of the Migraine Action Association (UK).
Findings: The qualitative findings revealed the patients’ decision-making for their 
headache management, their perceptions of headache and headache management and 
the complete set of management strategies used to treat and prevent headaches. 
Patients were highly involved in their headache management and perceived 
themselves as key resouice to management.
The survey showed the proportion of patients using management strategies from 4 
ai'eas of management including health care consultations, medication use, general 
management and social support. The survey also showed the differences in use of the 
management strategies. Overall, CDH patients were more active in their headache 
management, but not all these findings were statistically significantly different.
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Conclusion: Both the qualitative and quantitative findings showed the patients’ high 
level of involvement in their headache care. Combining the two methodologies 
helped to confirm and reinforce the findings. The results of this study can be used to 
inform and educate health professionals, including headache clinicians and 
researcher to malce research and clinical practice more patient-centred, to set up 
education programmes for patients and to maximise the patients’ efforts to achieve 
successflil headache outcome.
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9.2. Introduction
With chionic disease having become the principal medical problem, the approach to 
the management of clnonic disease has evolved to put more emphasis on the 
patients’ involvement. In the UK, the Department of Health advocates the expert 
patient as a new approach to chronic disease management (Department of Health,
2001). It is time for the patient to become a partner and expert in care and to create a 
new generation of patients who aie empowered to talce action to improve their own 
health (Donaldson, 2003). In clnonic disease, patient self-management is inevitable 
and patients malce decisions about their condition everyday (Bodenheimer et al.,
2002). The patient must become a pai'tner, who contributes at almost every decision 
and action level (Holman and Lorig, 2000). Based on these factors, a new clnonic 
disease pai'adigm has been introduced: the patient and health care professional 
relationship involving collaborative care and self-management education 
(Bodenheimer et al., 2002; Holman and Lorig, 2000).
The chionic disease pai'adigm implies that the health professional is the expert about 
the disease, whereas the patients are the experts about their own lives. Facts known 
by the physician need to be supplemented by facts that aie only laiown by the 
patients to malce research and health care practice more patient-centred and focused 
on the issues that aie important to the patients (Sullivan, 2003). When the patient and 
health caie professional recognise and respect the other’s aiea of expertise, they can 
work together to pool their knowledge and choose the way forwai'd (Kennedy, 2003).
Affecting 12% (Breslau and Rasmussen, 2001) and 3.2% (Lu et al., 2001) of the 
general population respectively, migraine and CDH are chionic diseases that need to
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be managed over a prolonged period of time. It is recognised that headache 
management is best when the patient is actively involved (Silberstein et a l, 2000) 
Headaches generally occur in the absence of the doctor and patients have to make 
their own decisions for management. Patients indirectly express their choices by 
behaving in a certain way, for example by not taking their drugs (Kravitz and 
Melnikov, 2001). Therefore, gaining knowledge into the patients’ involvement in 
their migraine and CDH management is important. However, little is known about 
the patients’ management of CDH. As far as migraine is concerned, studies have 
focused on doctors’ consultations and medication use. Consultation rates for 
migraine remain low (Lipton et a l, 1998) and migraine is under-diagnosed and 
under-treated (Lipton et a l, 1992; Lipton et a l, 2000), with patients predominantly 
using Over the Counter (OTC) medications (Lipton et a l, 2001). Thus it has been 
suggested that migraine sufferers learn to cope and live with their disease, rather than 
actively seek effective treatment (Michel et a l, 1996).
To understand the patients’ involvement in their own care, it is important for health 
service providers to receive feedback from the patients about the care that is offered 
(Edwai'ds and Staniszewska, 2000). Thus, if migraine and CDH patients are to 
become a resomce to headache management, it is important to understand the 
patients’ cunent involvement in headache care. Gaining insight into the patients’ 
perspective may help to identify areas for patient-centred reseaich and health care, 
patient education and self-management. This study aimed to investigate the migraine 
and CDH patients’ perspective of headache management. Four reseaich questions 
had been formulated:
1. How do migraine and CDH patients perceive headaches and headache cai*e?
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2. Which management strategies do migraine and CDH patients use?
3. Wliat ai e the differences in the use of management strategies between different 
types of headache patients (migraine, migraine with aura and CDH)?
4. What is the patients’ involvement in their migraine and CDH caie?
Combining qualitative and quantitative research is required to investigate and 
enliance the study of long-term chionic illnesses (Casebeer and Verhoef, 1997). 
Therefore, this study used a combination of qualitative and quantitative methods to 
address the research aim and questions.
9.3. Qualitative phase
9.3.1. Rationale
A qualitative methodology was chosen for the first part of the study, since qualitative 
methods deal with gaining insight into the pailicipants’ unique experiences and their 
interpretation of these experiences (Soafer, 1999). In qualitative studies, the 
pai'ticipants aie allowed to spealc freely (Edwai'ds and Staniszewska, 2000), thus 
qualitative methods gain access to the participants’ perspective, paiticularly their 
perceptions, beliefs and attitudes. Also qualitative research is suitable to investigate 
aieas that have previously little attention (Pope and Mays, 1995). Qualitative studies 
have been under-used in headache research, but could make an important 
contribution to gaining insight into headache (Peters et al., 2002). Based on the 
research aim and questions, the qualitative phase aimed:
• To gain access into the patients’ perceptions and experiences of headache and its 
management.
247
Chapter 9: The patients’ involvement in migraine and chionic daily headache
management: a study using qualitative and quantitative methods
• To identify which management strategies headache patients use.
• To identify the patients’ involvement in their headache care.
The qualitative phase was carried out according to the grounded theory methodology, 
including theoretical sampling and simultaneous data collection and analysis. Thus 
the aim of the qualitative phase was to gain understanding of the patients’ behaviours 
and to help develop the survey. The aim of the survey was to measure the patients’ 
level of activity in their own headache management and to make the qualitative 
findings applicable to a wider sample. Ethical approval had been obtained by the 
University of SuiTey Ethics Coimnittee.
9.3.2. Methods
9.3.2.1. Recruitment and participants
Based on theoretical sampling, a convenience sample was recruited tlnough personal 
contacts, posters in 2 local supermarkets and letters to 20 members of the Migraine 
Action Association. To be included in the study, the pailicipants, had to be aged 18- 
65 yeais and had to suffer from migraine according to the International Headache 
Society (IHS) criteria (Headache Classification Committee of the International 
Headache Society, 1988). Patients with co-existing headaches or patients who had 
developed CDH were not excluded. A total of 39 patients had been contacted and 15 
dissimilai" cases were recruited. Of the 15 participants, one woman withdrew before 
the interview and the first interview, with a female migraine sufferer, served as a 
pilot interview. Thus the interviews of 13 participants (9 women and 4 men) were 
included in the analysis.
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All 13 pailicipants suffered from IHS migraine. Three patients also suffered from 
tension-type headache (TTH) and based on their headache frequency (>15 days per 
months) 5 patients were classed as suffering or having from CDH. CDH patients 
experienced higher fr equency and lower severity headaches, as well as full migraine 
attacks. One patient had been effectively treated for CDH and did not suffer from 
CDH at the time of the study. One participant (Pt 1) had never consulted for 
migraine, 6 participants had not consulted within the last 12 months and 6 
pailicipants were had consulted within the last year. Four participants (1 lapsed and 3 
current consulters) had consulted either a headache specialist or a neurologist. Levels 
of headache-related disability ranged from no disability to severe disability (as 
assessed by the Migraine Disability Assessment (MIDAS) questionnaire). The 
patients’ chaiacteristics aie presented in Table 4.3. (Chapter 4, p. 132).
9.3.2.2. Data collection
Data were collected by semi-structured, individual and tape-recorded interviews. The 
researcher and her supervisors had devised a flexible interview guide based on recent 
migraine literature. Initial questions focused on migraine experience, physician 
consultations and treatments for migraine and CDH. As interviewing and the analysis 
progressed, the further questions were included in the interview guide to collect 
further data on previously raised issues and emerging concepts. These questions 
concentrated on patients’ preferences, choices and decisions and a more holistic 
approach to management (such as alternative therapies, life-style and self­
management).
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Interviews were carried out to the participants’ convenience, at their home, work 
place or at the University of Smrey. The participants, who all signed the consent 
form, were interviewed once. Interviews lasted up to 2 hours with recording time 
averaging 1 hour (range 50-90 minutes). Interviewing finished with data saturation.
9.S.2.3. Data analysis
Interviews were transcribed verbatim. The transcripts were coded in QSR 
NUD*IST5 (N5), a qualitative sofiware package. To reduce bias of the coding 
scheme and emerging taxonomy, the researcher, her supervisors and an independent 
researcher, were involved in the analysis. A coding guide was devised (by the 
researcher and HAS) to standardise the procedure for triangulation. One by one, the 
first 5 interviews were surmnarised (by the researcher, HAS, VV and independent 
researcher). Then the interviews were coded sentence by sentence to give an initial 
coding scheme (the researcher, VV and independent researcher). No notable 
differences were found between the coding of the different researchers. Codes were 
grouped into a hierarchical taxonomy to form concepts and theories. These concepts 
and theories were based on theoretical memos and discussions between the authors. 
The last 8 interviews, coded according to the same teclmique, were used to verify the 
coding scheme and refine the emerging taxonomy and concepts. First, a summary of 
the concepts and later detailed definitions, descriptions and interpretations of the 
main concepts were discussed by the researcher and all her supervisors.
9.3.3. Qualitative findings
The qualitative findings fitted into 3 main categories, which all played a role in the 
patients’ headache management: 1) the patients’ decision-making (Peters et a l.
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2003a) (Chapter 4, p. 117), 2) the patients’ perceptions of headache (Chapter 5, 
p. 147) and 3) the patients’ perceptions of headache management (Chapter 6, p. 168). 
Underlying these tlii'ee categories were the management strategies used by the 
patients including 1) health care use, 2) medication use, 3) alternative therapies, 4) 
social support and 5) lifestyle and self-help (Table 7.1, Chapter 7, p. 198) (Peters et 
al., 2003b). The 13 participants described using or having used a various and usually 
multiple management strategies and self-help measures. The combination of 
strategies used was individual to every patient.
9.3.3.1. Patients’ decision-making
Patients’ decision-malcing was one of the main thiee categories that emerged from 
the qualitative data. The participants explained their reasons for using or not using 
certain strategies (Peters et al., 2003a). To make decisions about management, the 
pai'ticipants relied on and generalised from their subjective experiences, which they 
perceived as significant. From the participants descriptions emerged 4 stages of 
decision-maldng: headache severity, evaluation, decision and behaviour (Figure 4.1, 
Chapter 4 p. 134).
Headache severity comprised the diagnosis of migraine, CDH and TTH, the 
progressive nature of migraine duiing and between attacks and headache impact. 
Headache severity, particularly at the onset of the headaches, was the starting point 
of decision-malcing. It also served as an end-point, since the participants used it as an 
outcome measm e to assess the efficacy of the management.
Evaluation was the most active, involved and complex stage of decision-making and 
comprised 3 steps including awareness, assessment and balancing options with
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perceptions. Awaieness was when the patients’ stopped believing that their 
headaches will not recur and they started thinking about how to deal with the 
problem. The patients progressed to assess their headache severity, their experiences 
of headache management and the outcome and limitations of the previously 
employed strategies. The third pait of evaluation was balancing options with 
perceptions. The participants learned about management options, which they 
balanced with their individual perceptions (preferences, satisfaction, expectations, 
beliefs, and attitudes) to underpin their decisions.
Based on their evaluation, the participants made their decisions for management, 
both for being active or passive in relation to a specific management strategy. 
Decision was often a compromise between the participants’ options and perceptions.
Behaviour', the final stage of decision-making, described the outcome of the 
participants’ decisions. The participants adopted, maintained or discontinued 
management behaviours to treat and prevent their headaches. Behaviour-, which 
could be active or passive, outlined the participants’ past and current management 
strategies (trials and errors), as well as their individual management combinations.
Decision-making was a complex, dynamic and continuous process that developed 
over time and operated on a justification and consequence system. Every decision, 
behaviour and change in migraine severity added to the experience and perceptions 
of the patients. Drawing on their experiences and perceptions, the patients were the 
key decision-makers for the management of their headaches and thus demonstrated 
their involvement in their headache care.
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9.3.S.2. Patients’ perceptions of headache
The patients’ perceptions of headache was the second main category found from the 
qualitative interviews (Chapter 5, p. 147). Three main themes were identified fiom 
the interviews: 1) headaches, 2) headache impact and 3) headache as a health issue.
The theme entitled ‘headaches’ was fuither divided into ‘pain and other symptoms’, 
‘differentiating between different types of headaches’ and ‘perceptions of headaches 
as baniers and facilitators to care’. For most participants, pain was the dominant 
feature of their headaches. To help assess the severity of pain the participants 
explained their pain severity, their experience of the pain and how the pain 
developed over time (within an attack) and changed over the years (between attacks).
The participants assessed their symptoms to differentiate between headaches. 
Migraines were mostly associated with severe, throbbing pain, nausea and aura 
symptoms. Other headaches were described as not interfering with daily activities 
and as being treatable with simple painldllers.
The participants’ perceptions of their headaches, including pain and other symptoms, 
acted as barriers and facilitators to management. The type of headache and 
particularly pain severity were often perceived as a cue for using pharmacological 
treatment. Thus, differentiating between different types of headaches was important 
in the participants’ decision-making for treatment. Participants who did not accept 
certain headache characteristics (such as headache recurrence or headache severity), 
participants expressed hope or optimism that the headaches would not return or 
resolve without active treatment.
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Impact illustrated the patients’ perceptions of suffering and put the magnitude of 
suffering into the context of the participants’ lives. Headache impact was mainly 
described in terms of disability. All aspects of the participants’ lives had been 
affected by their headaches, including their work, family and social lives (leisure 
activities, holidays). Disability was personal to the patients, and referred to 
limitations to the participants’ everyday activities, such as work and family life, 
because of headaches.
The theme of headache as a health issue related to what headaches meant in terms of 
health. Headache was perceived to be a health issue, although not necessarily an 
illness. By comparing headaches to other illnesses, the participants put headaches 
into a wider health context. The participants related their experience of headaches to 
their own experiences of illnesses other than headaches, other people’s experiences 
of illness or illness in general. Mostly, participants related headaches to illnesses that 
they perceived as more serious. Consequently they played down headaches and 
headache impact, which gave a conflicting view with the participants’ perceptions of 
headache pain and symptoms and headache-related impact.
9 3.3.3. The patients’ perceptions of headache management
The third main category of the qualitative data was the patients’ perceptions of 
headache (migraine and CDH) management (Chapter 6, p. 167). Based on the 
participants’ own, and other people’s, headache and treatment experiences, the 
participants had developed expectations, preferences and satisfaction with 
management. The participants’ described their perceptions on all areas of
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management: 1) health caie use; 2) medication use; 3) alternative therapies; 4) social 
support; and 5) life-style and self-help (Figure 6.1., Chapter 6, p. 176).
The theme of health care use mainly focused on consultations with doctors and 
mainly the GP. Some participants had low expectations of general practice 
consultations and questioned the GP’s ability and interest to treat headaches, to the 
extent that they did not consult for headaches. The participants thought tliat general 
practice consultations, and consequently the role of the GP, was focused on 
phaiinacological treatments and that little importance was given to finding the cause 
of headaches, finding a cure or discussing impact and non-pharmacological 
management. Discussions of issues other than medication led to greater patient 
satisfaction and increased the likelihood of follow-up consultations.
The participants’ perceptions of the medications ranged as widely as the number and 
types of medications they had used. Despite expressing preferences for not taking 
any medication, all 13 pai'ticipants had relied on headache medication in the past. 
Some patients, usually those who had only tried OTC medication and who had 
experienced treatment failures, expressed low expectations and low satisfaction with 
headache medications. Low expectations and the worry of side effects led to some 
participants strictly limiting their medication intake. Satisfied pai'ticipants, however, 
preferred taking medication to suffering a migraine.
Interest was expressed in alternative therapies, although not all the pai'ticipants had 
tried alternative health care. Patients who had consulted alternative therapists gave 
little information on efficacy of these treatments, but expressed satisfaction with the 
time and advice offered within alternative health care.
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Receiving social support was considered important to leaiii about new management 
stiategies and to receive and give understanding about headaches from patients’ with 
similai' experiences. Social support was considered a valuable and helpful 
management strategy that was used by most of the pai'ticipants.
Self-help and life-style focused on issues such as trigger control, dietary changes and 
sti'ess management. This theme showed that the participants’ viewed themselves as 
an essential resource to management. The participants believed they were heavily 
involved in their headache caie, by learning about headache and headache treatments 
and by taking initiatives to obtain the treatments they wanted.
9.4. Quantitative phase
9.4.1. Rationale
The qualitative findings included the areas of management (holistic management) 
used by the patients, as well as their decision-making, perceptions of headache and 
management. The data from the interviews also showed that headache management 
was an individual and complex set of behaviours that was composed from five areas 
of management. Previous studies on the patients’ management behaviour's have 
predominantly focused on two of the management areas, i.e. doctors’ consultations 
and medication use. The qualitative study showed that headache management goes 
beyond doctors’ consultations and medication use. However, although the qualitative 
findings revealed which management strategies are used by the patients to manage 
migraine and CDH, the findings do not inform on how many patients use each 
management strategy. Furthermore, qualitative methods are limited in their 
generalisability, therefore a quantitative phase followed the qualitative phase to
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assess how many patients used any given management strategy and to make the 
qualitative findings relevant to a wider population.
The qualitative phase had also indicated that patients with different headache 
diagnoses and increasing headache severity managed their headaches differently (for 
example CDH patients rather than migraine patients had consulted their General 
Practitioner (GP) within the last 12 months). Migraine diagnosis has been shown to 
be more likely when certain symptoms aie present, including auia and increasing 
disability (Lipton et al., 2001). Studies on migraine management from the patients’ 
perspective have not examined differences in behaviours of patients with different 
migraine diagnoses, neither has a compaiison been drawn to CDH. Therefore, the 
quantitative phase aimed:
• To investigate which management strategies are used by migraine (M), migraine 
with aura (MWA) and CDH patients
• To compare the management used by M, MWA and CDH patients over the last 
12 months.
9.4.2. Methods
9.4.2.1. Questionnaire
The quantitative phase was based on a postal survey. Since no previous questionnaire 
had investigated the holistic management of migraine or CDH from the patients’ 
perspective, the researcher and her supervisors developed a new questionnaire based 
on the 5 areas of management identified in the qualitative phase. The questionnaire 
included 4 sections of management: 1) consultations, 2) acute and prophylactic
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medication and herbal/ homeopathic remedies, 3) acute and prophylactic general 
management and 4) social support. Further sections included headache information 
(symptoms and impact) and biographical data.
Two independent researchers with expertise in questionnaire design assessed the lay 
out and feasibility of the questionnaire. To test content validity, the questionnaire 
was administered to 10 headache patients. To test the reliability and validity of the 
diagnostic tool within the questionnaire, 30 patients who had previously been 
diagnosed by a headache clinician (AD) completed the questions relating to 
diagnosis. The reseaidier made the diagnosis based on the returned questionnaires 
(n=26). The questionnaire diagnosis and clinician’s diagnosis concuiTed in 22 cases 
(84%).
9 4.2.2. Respondents and recruitment
The questionnaire was targeted at the same age group as the qualitative interviews
i.e. adults aged 18-65 years. The participants had to have suffered either from IHS 
migraine, IHS migraine with aura or CDH (headache frequency >15 days per month) 
in the 12 months prior to the study. Only UK residents were included in the sample. 
Ethical approval was obtained from the University of Suri'ey Ethics Committee.
The respondents were recruited through the Migraine Action Association in the UK. 
The questionnaire was sent to a total of 887 patients and 537 questiomiaires (60.5%) 
were returned. Upon receipt the questionnaires were checked for eligibility (age and 
diagnosis) by the researcher. Questionnaires were excluded due to absence of 
headaches in the last 12 months (n=9), the respondent being over the age limit of 65 
year's (n=39), missing biographical data (n=5), missing diagnostic data (n=12), the
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headaches being unclassifiable (n=7) or the patients suffering from headaches other 
than migraines or CDH (n=27).
A total of 438 questionnaires were analysed. A 10% (n=42) random sample of the 
questionnaires included in the analysis were selected and re-diagnosed independently 
by a headache clinician (AD) to assess the reliability of the researcher’s diagnoses. 
Diagnoses concuri'ed in 40 cases (95.2%).
9 4.2.3. Data analysis
The data were entered into SPSS 10.1 for analysis. Data were analysed by descriptive 
statistics and comparisons were drawn between three diagnostic groups: migraine 
(M), migraine with aura (MWA) and CDH. Descriptive statistics, chi-square 
Kr'uskal-Wallis, analysis of variance (ANOVA) and post-hoc Scheffe tests were used 
for statistical analysis. The level of significance was set at p<0.05.
9.4.3. Quantitative findings
9.4.3.1. The respondents
Based on headache symptoms and headache frequency, of the 438 respondents, 117 
(109 women and 8 men) were diagnosed as M patients, 238 (211 female and 27 
male) as MWA patients and 82 (72 female and 10 male) as CDH patients. There 
were no significant differences in gender, marital status, etlmicity, level of education, 
work status, age, age of onset of headaches and years of headache experience 
between the three groups. The patients’ characteristics are presented in Table 8.1. 
(Chapter 8, p. 213).
259
Chapter 9: The patients’ involvement in migraine and chi'onic daily headache
management: a study using qualitative and quantitative methods
9.4.3.2. Patients’ use of headache management
9.4.3.2.1, Health care consultations
The total number of health professionals consulted significantly differed between 
groups (p=0.001). The post-hoc Scheffe test showed that CDH patients had consulted 
a significantly higher number of health professionals (2.53, sd 1.81) than M (1.71, sd 
1.19) (p=0.002) and MWA (1.84, sd 1.65) (p=0.004) patients. The three groups had 
consulted a variety of health professionals, including medical professionals and 
alternative therapists (Figure 8.2., Chapter 8, p.216). The highest consultation rates 
occurred with general practitioners. No significant differences were found for the 
consultations with most health professionals, apart from more CDH patients 
consulting headache specialists (p=0.027) and neurologists (p=0.002).
Significant differences in the consultation frequency were found for consultations 
with the GP (p<0.001), the neurologist (p<0.001), the osteopath (p=0.018) and the 
psychologist (p=0.011) (Table 8.3., Chapter 8, p. 217). The post-hoc Scheffe test 
showed the differences between the groups. CDH patients consulted GPs 
significantly more frequently than M (p=0.001) and MWA patients (p<0.001). 
Furthermore, CDH patients had consulted neurologists significantly more often than 
M (0.005) and MWA (p=0.001). The frequency of consultation with the osteopath 
was significantly different between CDH and M patients (p=0.019). Consultations 
with the psychologist were significantly more frequent for CDH patients than for M 
(p=0.036) and MWA patients (p=0.017).
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9.4.3.2.2. Medication use
The majority of the patients (99.1% M, 99.6% MWA and 98.7% CDH) had used 
acute medication (OTC and prescription) in the last 12 months. The use of OTC 
medications did not significantly differ between the groups, but significantly more 
(p=0.003) of M (86.2%) and CDH patients (82.7%) relied on acute prescription 
medication when compared to MWA (71.4%) (Table 8.4.; Chapter 8, p.218). CDH 
patients used both OTC and prescription medication more often than M and MWA 
patients. Reflecting the difference in number of headaches days per month, the 
fi'equency of use of acute medications significantly differed for prescription 
(p<0.001) and OTC medication (p<0.001) (Table 8.5. Chapter 8, p.219). 
Combination medications (p=0.026), and more specifically codeine combinations 
(p=0.040) and caffeine-codeine combinations (p=0.047) were used by significantly 
more CDH than M and MWA patients. Significantly more M and CDH patients 
(p=0.002) used triptans when compared to MWA patients (Figure 8.3. Chapter 8;
p221).
More CDH patients, than M or MWA patients, used prophylactics (pharmacological 
agent and herbal/homeopathic and vitamins/minerals), but no significant differences 
were found between the 3 groups (Table 8.4., p.218).
9.4.3.2.3. General management
The majority of respondents used acute general management strategies to treat their 
headaches at least sometimes (Table 8.7., Chapter 8, p.224), but no significant 
differences were foimd in the level of use between the groups (Table 8.8, Chapter 8, 
p.225). The majority of respondents used prophylactic general management
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strategies at least sometimes (apart from avoiding exercise) (Table 8.10., Chapter 8, 
p227). Significant differences in the level of use of prophylactic strategies were 
formd between the groups for avoidance of bright light (p=0.007), exercise 
(p=0.011), avoidance of noise (p=0.004) and food triggers (p=0.025) (Table 8.11., 
Chapter 8, p.227).
9.4.3.2.4. Social support
Social support was the least used management strategy, but most (apart from patient 
support groups and charity help-lines) strategies were used at least sometimes by 
more than 30% of the patients (Table 8.12., Chapter 8, p.229). No significant 
differences were foimd between the level of use of these strategies between the 
groups.
9.5. Discussion
The aim of the study was to investigate migraine and CDH management from the 
patients’ perspective. First, the qualitative methodology revealed the management 
strategies used by the participants, the patients’ decision-making for headache 
management, and the participants’ perceptions of headaches and headache 
management. Headache management emerged as a complex and individual process 
of decision-making and set of behaviours to treat and prevent headaches that evolved 
over time as patients gained new knowledge and experiences about headaches and 
headache management. In a second phase, the sur*vey revealed that most management 
strategies, that had been described in the qualitative phase, were used by at least 50% 
of patients. Thus the quantitative findings reinforced the qualitative findings, by 
frirther confirming the patients’ high level of involvement in the headache care.
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Furthermore, the interviews indicated that the participants’ management behavioirrs 
differed according to diagnosis and severity of their headaches. Patients who 
perceived themselves as more severely affected were more likely to be self-directed 
in their headache management. Headaches were perceived as increasingly severe 
with increasing headache frequency. Findings from previous (quantitative) studies 
confirmed that headache severity and symptoms such as aura increase the likelihood 
of diagnosis (Lipton et al., 2001), thus the sirrvey aimed to compare headache 
patients with different diagnoses. Overall, CDH patients were more active in their 
headache management. Significant differences in the management of CDH were 
found for a number of strategies. The use of other strategies was not found to differ 
between the groups, but mostly trend was towards a greater level of activity of CDH 
patients. For some management strategies, M patients were as active as CDH 
patients, such as the use of triptans. These findings showed that the patients’ 
management of headache varies according to diagnosis. The greater level of activity 
of CDH patients within the survey confirmed the findings of the interviews and 
indicated greater need and willingness (self-direction) of CDH patients to be active 
in improving their headaches.
Talcen together, both the qualitative and the quantitative study showed the high level 
of involvement of the patients in their headache management. This is contrary to the 
belief that migraine patients ar e passive and fatalistic in their headache management 
(Michel et al., 1996). Michel et al also concluded that patients want to be informed of 
their treatment options and they want to be involved in decisions when more than 
one alternative treatment exists (Michel et al., 1996), which is more in accordance 
with the findings of this study. The qualitative data showed the patients’ involvement
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in their care, tluough their decision-making, perceptions and behaviours. Indeed the 
participants perceived themselves as a key decision-malcer and resource to 
management and the high level of use of management found in the survey confirmed 
the involvement of headache patients in their own care.
In this survey, despite their involvement in their care, the respondents continued to 
suffer from high frequency headaches. During the interviews, participants reported 
failed treatments and changing treatments due to lack efficacy and treatment side 
effects. Additional to the patients’ behaviours, the interviews also revealed that the 
participants were continuously trying to improve their headache management. 
However, due to the design of the survey, it is not possible to conclude how much if 
any improvement had been achieved tlirough the patients’ management behaviours. 
The considerable suffering of these patients indicates that their headache care is not 
optimal despite the patients’ efforts. Therefore, the importance of the findings rests 
with understanding the patients’ perspective and their willingness to be involved, as 
well as their cmrent involvement in their care. Health care problems can only be 
addressed if the user’s perspective is understood and if health car e professionals and 
patients co-operate (Edwards and Staniszewska, 2000). Understanding the patient 
may help to develop a more patient-centred health practice (Faltermaier, 1997) and to 
empower and educate patients to have the necessary knowledge and skills to seek 
help and to manage their headaches effectively (Diener et al., 2000). The change 
towards greater involvement of patients in their health care is only possible if the 
patients are willing to be involved. Understanding the patients’ current involvement 
helps to gain insight into the patients preferences, which they indirectly express
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through their choices; and may help to develop, implement and carry out patient- 
focused education, self-management programmes and research.
9.5.1. Combining qualitative and quantitative findings
Qualitative and quantitative methods can investigate a similar topic by addressing a 
different research question (Jones, 1995), collecting different types of data and 
producing different sorts of answers (Barbom*, 1999). The aim of this study was to 
investigate the patients’ perspective of migraine and CDH management. Four 
research questions had been formulated:
1. How do migraine and CDH patients perceive and experience headaches and 
headache car e?
2. Which management strategies do migraine and CDH patients use?
3. Wliat are the differences in the use of management strategies between different 
types of headache patients (migraine, migraine with aura and CDH)?
4. What is the patients’ involvement in their migraine and CDH care?
Qualitative research is useful to explore areas that have received little previous 
attention (Pope and Mays, 1995). Few studies have been carried out on the headache 
patients’ perspective and particularly the patients’ perceptions. Furthermore, 
qualitative methods are suitable to answer questions such as “what is ‘x’?”, “how 
does ‘x ’ vary in certain circumstances and why?” and “what is the purpose of ‘x’?”. 
Questions that concern meanings, experience, patterns, relationships and values are 
best addressed by qualitative methods (Miller and Crabtree, 1994). Thus, the 
research questions identifying the management strategies used by the patients and
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questions dealing with the patients’ perceptions and experiences of migraine and 
CDH management were best answered by a qualitative design. The use of qualitative 
methods has added to knowledge by giving insight into the patients’ perceptions and 
decision-making, as well as the complete picture of the patients’ management 
practices.
The qualitative findings provide insight into the subjective reality of the participants. 
The researcher is the main instrument of data collection and analysis, which 
introduces bias into the reseai'ch process. While objectivity is accepted as one of the 
weaknesses of and fundamentally rejected in qualitative research, objectivity is 
nonetheless an important feature of research. Objectivity is achieved through the 
standardisation of the research process (such as collecting data through a 
standardised questionnaire) and contributes to the study findings being relevant to a 
wider population group. In quantitative resear'ch, reality is objective, simple and 
positive and all members of society define reality in the same way. Objectivity is 
employed to minimise personal bias and to guarantee that reality will be presented as 
it is, rather than as it is interpreted by the researcher (Sarantakos, 1998).
The qualitative methods were not able to address all research questions that aimed to 
quantify the proportion of migraine and CDH patients using the described 
management strategies. Also, no comparison between the management behaviours of 
headache patients with a different diagnosis could be drawn from the qualitative 
findings. The primary focus of quantitative studies is to quantify and measure. To 
answer questions such as ‘how many’, ‘how much’, ‘what size’ or numerically 
measurable associations between factors, a survey is appropriate (Miller and
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Crabtree, 1994). Thus, the sui'vey had been chosen as a means to address the research 
questions that could not be addressed by the qualitative methods.
In this study, using both qualitative and quantitative methods served several 
purposes. Qualitative research can be used as a prerequisite to quantitative methods 
to facilitate the development of the quantitative research by identifying the ‘correct’ 
terminology for inclusion in a survey questiomiaire or generating hypotheses (Greene 
et al., 1989). In this study, the qualitative data was used to inform the design of the 
research questions. This contributed to the development of a valid questiomiaire that 
was relevant to migraine and CDH patients. Thus, the respondents answered 
questions, which reflected their views, rather than the views of the researchers.
The second purpose of a combined methodology was methods triangulation. This 
involved compaiing data collection through qualitative methods with data collected 
thi'ough quantitative methods (Patton, 1999). Due to the limited generalisability of 
qualitative data, the survey permitted to reliably quantify issues raised within the 
qualitative phase and to make the findings applicable to a lai'ger population. The 
qualitative and quantitative findings both indicated that migraine (with and without 
auia) and CDH patients aie active in the management of their headaches. Thus the 
findings of one methodology confirmed the results of the other methodology. 
Additionally the findings allowed to draw conclusions on how the patients’ 
management of their headaches (qualitative) as well as investigating and compaiing 
the patients management behaviour (survey).
An increasing number of studies is using a combination of qualitative and 
quantitative methods, and the combination of qualitative and quantitative methods is 
recommended to enhance the study of clironic diseases (Casebeer and Verhoef,
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1997). Previous studies have sho’wn that integrating qualitative and quantitative 
methods emphasise the findings (Claike, 2003; Chan, 2001) or the interpretation of 
findings was facilitated by the simultaneous use of qualitative and quantitative 
methods (Etter and Perneger, 1997). Abu et al (2001) found that qualitative findings 
confirmed the quantitative results and suggest that a combined approach should be 
used in future studies of the patients’ views of health caie.
The use of combined methods allowed the researcher to approach the patients’ 
involvement in their headache care from two different angles. This meant the study 
answered different research questions and provided a fuller pictme of the patients’ 
perspective. Similarly to the experiences in previous studies, it was found that the 
results from the two methodologies confirmed and enhanced each other. However, 
given the various strengths and weaknesses of qualitative vs. quantitative research, 
the reseaidier using different methods to investigate the same phenomenon should 
not expect that the findings generated by those different methods come together to 
produce some nicely integrated whole (Patton, 1999). The qualitative phase has 
raised issues that were beyond the scope of the questionnaire, but that were 
nonetheless important and require further investigation. The headache patients’ 
perceptions and their decision-making aie areas that have received little attention in 
headache research to date, but that are essential given the increasing importance that 
is given to patient expertise and patient-doctor collaboration in health care. Despite 
not being quantified, these findings aie of importance for headache researchers and 
clinicians, and other health professionals to gain better understanding of headaches 
and headache patients.
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9.5.2. Limitations and future research
Qualitative research is suitable to investigate new areas (Pope and Mays, 1995) and 
has been underused in headache research (Peters et al., 2002). Giving headache 
patients the opportunity to spealc freely has raised many issues that were beyond the 
scope of the questionnaire, but that will need further investigation. The holistic 
management of migraine and CDH is a broad and complex topic and individual 
management strategies need to be studied in more detail to gain insight into the full 
picture of migraine and CDH management. The qualitative methodology has 
highlighted the importance of the patients’ perceptions in their headache 
management and how the patients use their perceptions to malce management 
decisions. However, these findings caimot be generalised and quantitative research is 
necessary to identify any predictive power of the perceptions on management.
Migraine is more than a headache and the cuiTent endpoints of clinical trials need 
further development, as for example measuring headache relief as an endpoint alone 
does not capture the complete pictuie about the new treatments (Goadsby, 2000). 
The qualitative study has revealed the patients’ perceptions of the efficacy of 
treatments, but more research efforts need to focus on treatment outcome. Better 
understanding of the patients’ perceptions of treatments and their efficacy, to develop 
more patient-centred outcome measures for clinical trials.
The qualitative study revealed that multiple strategies were used for the treatment of 
individual headaches. Long-term, migraine and CDH management changed over 
time, depending on the patients (and other people’s) knowledge and experiences. The 
quantitative data was also able to show that patients had used multiple strategies
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within the last 12 months, but the study design did not permit to draw any 
conclusions on how management changed over time. Therefore, the changes within 
patient behaviour should be studied prospectively to identify those changes within a 
lai'ger sample. Reasons that explain the changes in the patients’ management 
behaviour would be suitable for fruther qualitative investigation.
The studies to date on the patients’ management have been carried out in different 
countries, but predominantly the USA. This study has solely focused on the 
management used by headache patients who aie residents within the UK. However, 
the health care systems between countries vary and may have an influence on the 
patients’ management behaviour. Therefore, it is important to carry out further 
studies on the holistic management of migraine on an international level to compare 
not only different types of headaches but also the influence of different health caie 
systems and across cultures.
The questiomiaire sample included only headache patients who are members of the 
Migraine Action Association in the UK. It is likely that these patients are more 
interested in their headaches, are better informed about headache management and 
aie more pro-active in their treatments. Therefore the findings of this survey may not 
be applicable to the wider headache population and it would be advisable to conduct 
a survey on the patients’ holistic management within the general population. Still, the 
results of this study should not be dismissed, since the Migraine Action Association 
is a patient group with over 17000 members. If the members of the Migraine Action 
Association aie indeed more active than headache patients within the general 
population, this may be due to the regular information they receive as pai't of their 
membership. Having better information may have been an incentive to consult in an
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international study, since more lapsed (60%) and non-consulters (65%) than current 
consulters (42%) felt that they did not have most current information (Adelman et al., 
2000). Therefore, the patients’ management behaviour' within this study may be an 
indication of the value of patient education, which may trigger fur ther study into the 
patient as a resource to management and may be used to underpin the development 
of patient education programmes.
Finally, since the survey was conducted at only one point in time, it is not possible to 
ascertain how the patients’ management practices influence their headache
development over time and whether the patients’ management practices are
successful or unsuccessful in relieving and reducing headaches and headache-related 
impact. Furthermore, the study design does not allow to draw conclusions on which 
management strategies the patients perceive as most or least helpful. To address 
these questions, it would be necessary to collect a further data set, using the
questionnaire, at a different point in time, as well as using additional questions
(either within the questionnaire or as a qualitative study) to determine which 
strategies the patients find the most or the least helpful.
9.6. Conclusion
The aim of this study was to investigate the patients’ involvement in the headache 
(migraine and CDH) management. The study used both qualitative and quantitative 
methodologies to gain access to the patients’ perspective from two different 
viewpoints. Combining the methodologies was found to be useful, as the qualitative 
findings helped to develop a valid questiomiaire that was relevant to the patients and 
helped to explain the quantitative findings. Furthermore, the quantitative findings
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confirmed issues raised within the qualitative interviews and made the findings 
applicable to a wider population of headache patients.
The findings revealed that headache patients aie actively involved in their headache 
management, both in terms of their decision-making for management and in their 
management behaviours. The qualitative data had indicated that patients who aie 
more severely affected are more self-directed in their search for effective 
management. The comparison of M, MWA and CDH patients within the survey 
confirmed that CDH patients, who have higher frequency headaches than M or 
MWA patients are more active in their management.
The findings of this study can be used to inform headache reseaichers and clinicians 
of the patients’ behaviours to lead to greater understanding of the patients’ 
perspective. Fui'thermore, the patients’ high level of involvement in their care, and 
particularly their perceptions of themselves as the key decision-makers of their 
headache care, indicates that headache patients are interested in being involved in 
medical decision-maldng. Thus, headache care should move towards the new chronic 
disease paradigm, which advocates the collaboration of the health care professional 
and the patient, by the health care professional providing the medical knowledge and 
the patients supplying personal expertise of the disease.
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10.1. Introduction
This study aimed to investigate the patients’ management of migraine and clironic 
daily headache (CDH). To achieve this, the study used a combination of qualitative 
and quantitative methods. This section discusses the contribution of this study to 
research methods in health care, the contribution to theory (including coping, the 
transtheoretical model, and models of problem-solving including Leventhal’s self- 
regulatory model) and the contr ibution of this study to knowledge and understanding 
of headache management.
10.2. Contribution to research methods
Few studies have used a combination of qualitative and quantitative methodologies. 
However, in the context of the study of health, the gap between qualitative and 
quantitative research is narrowing and the combination of methodologies is thought 
to be fruitful for the study of chronic disease (Casebeer and Verhoef, 1997). Recently 
more studies using a combined methodology have been published and these studies 
report positive experiences from using this approach to investigate health issues. 
(Etter and Perneger, 1997) reported that the interpretation of findings was facilitated 
by the simultaneous use of qualitative and quantitative methods. (Clarke, 2003) and 
(Chan, 2001) believe that integrating qualitative and quantitative methods 
emphasised their findings. Abu et al (2001) found that qualitative findings confirmed 
the quantitative results and suggest that a combined approach should be used in 
futur e studies of the patients’ views of health care.
Qualitative and quantitative methods can investigate a similar topic by collecting 
different types of data and producing different sor1s of answers (Barbour, 1999) and 
addressing a different type of research question (Jones, 1995). Questions that concern
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meanings, experience, patterns, relationships and values are best addressed by 
qualitative methods and questions that concern numerically measurable associations 
between factors ar e appropriately addressed by a sur vey (Miller and Crabtree, 1994). 
Patient management of a clnonic health problem, including the management of 
migraine and CDH, is a topic, which can be studied by either qualitative or 
quantitative methods. However, each method is suitable to answer a certain type of 
research question. In view of the research questions formulated for this study 
(Chapter 1), a combined qualitative and quantitative approach was necessaiy to 
provide answers to all the research questions. Thus, combining the two methods 
allowed answering a wider range of questions relating to the headache patients’ 
management behavioms, thus giving a deeper and broader understanding of the 
patients’ perspective of headache management.
The qualitative findings gave insight into and provided explanation of migraine and 
CDH management. The qualitative methodology allowed the patients to speak 
openly and freely about their headache management to gain access to the patients’ 
subjective reality in terms of their experiences of headache management and their 
interpretations of these experiences. Furthermore, the qualitative findings contributed 
to the design of a valid questionnaire that was relevant to headache patients. The 
sm’vey added objectivity to the qualitative findings (the patients’ use of management) 
and made the qualitative findings generalisable to a wider population.
10.3. Contribution to theory
Phase 1 of this study was based on grounded theory methodology, which aims to 
generate theory through compar ative analysis of the data (Glaser and Strauss, 1967). 
From the findings of the qualitative phase, emerged the theory that migraine and 
CDH patients are highly involved in their headache management, and that this
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management varies according to headache type, severity, impact and the patients’ 
perceptions of headache and headache management. Thus, the qualitative findings 
revealed issues related to coping, the tianstheoretical model of change and self- 
regulatory theory.
10.3.1. Coping
Coping has been defined as ‘constantly changing cognitive and behavioural efforts to 
manage specific external and/or internal demands that aie appraised as taxing or 
exceeding the resources of the person’ (Lazarus and Folkman, 1984) or, in other 
words, ‘the attempt to change a stiessor or a stress response’ (Kaplan et al., 1993). 
Methods of coping are important in migraine patients, since patients who employ 
more passive coping strategies, have been shown to have lower quality of life 
(Passchier et al., 2001). There are two main types of coping: problem-focused coping 
and emotion-focused coping (Cohen and Lazaius, 1979; Folkman and Lazaius, 1980; 
Folkman and Lazarus, 1980). Problem-focused and emotion-focused coping can be 
used together and the balance between problem-focused and emotion-focused coping 
depends on the demands of the stressful situation. In this study, migraine and CDH 
were the stressor that the patients had to cope with. The patients employed both 
problem-focused and emotion focused coping to manage their headaches and the 
management behaviours used aimed at reducing headache severity (including pain 
severity, headache fr equency and impact) to improve quality of life.
Problem-focused coping aims to reduce the demands of the stressful event or to 
expand the resouices to deal with the stressful event. In this study, the migraine and 
CDH patients employed a wide range of management strategies, such as 
consultations with health professionals, using medication or social support. These 
management behaviours aimed to reduce their headache severity, either by the
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patients attempting to change their stressor (headache severity) through employing a 
variety of management strategies or by patients expanding their resources to deal 
with their headaches, through seeking social support and educating themselves about 
headaches.
On the other hand, emotion-focused coping aims at controlling the emotional 
response to the stressor without attempting to change the stressful situation. 
Emotion-focused coping involves behavioural approaches, for example seeking 
social support, distracting attention from the problem, and cognitive approaches, 
such as changing the meaning of a situation, denying the problem (Sarafmo, 1994). 
In this study, the patients employed emotion-focused coping in several ways. Either 
they denied their headaches and/or were optimistic that the headaches would not 
return. Alternatively, they came to terms with their headaches and accepted them, 
believing that there was nothing they could do to alleviate the burden of their 
headaches. Finally, the participants also changed the meaning of the situation. 
Although they described and acknowledged that their headaches were painful and 
caused disability; they also argued that suffering from headaches was not so bad, 
since other health conditions are more serious and tlrreatening than headaches.
10.3.2. The transtheoretical model
The transtheoretical model was developed by Prochaska and DiClemente to describe 
and explain changes related to health-related behaviours (Prochaska and DiClemente, 
1984; Prochaska et al., 1992). The model comprises five stages, which people seem 
to move tluough these stages at an orderly sequence at their own pace. Stage I 
(precontemplation) includes the people who are not seriously thinldng about 
changing their health care behaviours. In stage 2, called contemplation, people are 
aware that a problem exists and they ar e seriously starting to consider changing their
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health-related behaviours. Preparation (stage 3) involves people pursuing a 
behavioural goal, within the next month or people who have tried to reach a goal 
within the last year- without being fully successful. Stage 4 (action) spans over a 
period of time (usually 6 months), from start of the person’s successful and active 
efforts to change behaviour. The last stage, maintenance, involves people working to 
maintain the successful changes in behaviour.
The qualitative findings revealed the patients’ decision-making for the management 
of migraine and CDH (Chapter 4). The figure illustrating the patients’ decision­
making included 4 different stages: 1) headache severity, 2) evaluation (including 
perceptions), 3) decision and 4) behaviour. The decision-making process also 
revealed that the patients’ perceptions and behaviours were not static, but evolved 
over time, influenced by a range of baiTiers and facilitators. The decision-making 
process helps to explain the management behaviours of migraine and CDH patients, 
thus the transtheoretical model and the decision-making process revealed in this 
study have been compared to outline their similarities and differences.
The migraine and CDH patients’ process of decision-making is similar to the 
transtheoretical model, in that patients progress tluough the different stages at their 
own pace. The transtheoretical model is a linear' model, although progression thr ough 
the stages does not necessarily occur in a linear fashion. The model proposed in this 
research for decision-making about migraine and CDH management differs from the 
transtheoretical model, since it is a cyclical process. However, the two models share 
the patients’ progress tluough the stages at their own pace and the fact that change in 
health behaviours continues to occur over time.
Fur'thermore, the stages within the two models are comparable. The perception of 
‘headache severity’ could be compared to precontemplation, when the patients,
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although suffering from headaches, have not adopted any health care behaviours yet 
to induce a reduction of headache severity. The ‘evaluation’ stage of the decision­
making model includes features of ‘contemplation’ and ‘preparation’. At this stage, 
the patients weigh up the costs and benefits of a paiticular behaviour, or in case of 
the headache patients, they weigh up their preferences with the available headache 
management strategies to decide which strategies to adopt, maintain or discontinue. 
The ‘decision’ stage within the decision-making model, does not have an explicit 
equivalent within the thranstheoretical model. However, the stages of ‘preparation’ 
and ‘action’ imply that a decision has been made. Finally, ‘action’ and ‘maintenance’ 
of the transtheoretical model aie reflected within the theme of behaviour of the 
decision-maldng model. Thus the decision-maldng model includes ‘action’ and 
‘maintenance’ within one stage, thus not assessing whether the behaviours have been 
adopted over a prolonged period of time. The assessment of maintenance of 
behaviours may be more suitable in prophylactic behaviours (i.e. behaviours that are 
caiTied out over a prolonged period of time, such as trigger avoidance) rather than 
acute behavioui's (i.e. behaviours when the patient suffers from headaches, such as 
taking painkillers).
10.3.3. Problem solving models and Leventhals’ self-regulatory 
model of illness cognitions
Traditional models of problem-solving include thiee stages: 1) interpretation, 2) 
coping and 3) appraisal (Ogden, 2000). In these models, it is assumed that given a 
problem, an individual will be motivated to solve the problem and reinstate 
normality. In case of the problem being an illness or a health issue, the person 
suffering from illness aims to re-establish health. This assumption applies in two 
ways to migraine and CDH patients. Firstly, when suffering fi'om a headache (i.e.
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acutely), migraine and CDH aim to become headache free. Secondly, patients 
suffering from chronic, recuiTing headaches, will also aim to prevent their headaches, 
thus trying to stop suffering from headaches even when they do not actually have a 
headache. The model of decision-making (Chapter 4) incorporates both the migraine 
and CDH patients’ attempts to re-establish normality, both acutely and 
prophylactically. In terms of similarities between migraine and CDH patients’ 
decision-making and traditional problem solving models, ‘evaluation’ relates to 
‘interpretation’ and ‘appraisal’ and ‘decision’ and ‘behaviour’ relate to coping.
LeventhaTs self-regulatory model is based on approaches to problem solving and 
suggests that illness/symptoms aie dealt with by individuals in the same way as other 
problems. Additionally, the model incorporates description of illness cognitions as 
described by Leventhal and colleagues (Leventhal et al., 1980; Leventhal et al., 
1985; Leventhal and Nerenz, 1985; Leventhal et al., 1997). Illness cognitions are 
defined as a patient’s own implicit common sense beliefs about their illness. These 
cognitions provide the patients with a fr amework for coping with and understanding 
then illness and telling the patients what to look out for when they aie becoming ill. 
Leventhal and his colleagues identified five cognitive dimensions: 1) identity (label 
given to an illness), 2) perceived cause of the illness (biological or psychosocial 
causes), 3) time line (patients’ beliefs about how long illness will last), 4) 
consequences (patients’ perceptions of possible consequences of their illness and 5) 
curability and controllability (patients’ beliefs on whether the illness can be treated 
and cured and the extent to which the illness is controllable by themselves or others).
As fai" as migraine and CDH patients in this study were concerned, the patients 
described the importance of identifying their headache type, for example in terms of 
deciding which type of medication was appropriate and to assess whether their
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headaches are serious enough to warrant a consultation with the doctor. The patients’ 
perceived cause of illness mainly related to acute issues, meaning that they reported 
issues that had caused a particular- migraine attack (such as stress), rather than 
describing their thoughts on why they suffered from chronic, recurring headaches. 
The ‘time line’ dimension, however, in these migraine and CDH patients related to 
the chronicity of migraine and CDH rather than their acute features, including denial 
and optimism (‘I will not have any more of these headaches’) or acceptance (‘I will 
at some point have another headache’). In terms of ‘consequences’, the participants 
illustrated the effect that their headaches had on their lives. Headache-related impact 
varied between patients, even in patients with a similar degree of headache severity 
(frequency, pain severity and disability). Finally, ‘curability and controllabilty’ 
issues were apparent in the migraine and CDH patients’ perceptions of their 
headaches, as well as their more self-directed or accepting approaches to 
management behaviorrr s to treat and prevent headaches.
10.4. Contribution to knowiedge and understanding of migraine 
and CHD management
As outlined in Chapter 2, studies investigating the patients’ use of management have 
mainly focused on doctors’ consultations and medication use. These studies have 
shown that migraine is under-diagnosed and imder-treated. The majority of patients 
do not consult their doctor about their condition. Migraine patients rely 
predominantly on Over the Counter (OTC) medications, rather than prescription 
medication, to treat their headaches. This has led to the theory that migraine patients 
aie passive and fatalistic in their headache management (Michel et al., 1996). 
However, anecdotal information suggests that migraine patients use management 
strategies other than doctors’ consultations and medication use. The knowledge about
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the management used by CDH patients is even more limited. Therefore, this study 
aimed to investigate the patients’ perspective of migraine and chr onic daily headache 
(CDH) management. The objectives were to gain insight into the patients’ 
perceptions of headache and headache management; to establish which management 
strategies were used and what proportion of patients used these management 
strategies; and to compare the management used by patients suffering from different 
types of headaches.
This study has contributed to knowledge and miderstanding about headaches in 
several ways. First, the qualitative phase revealed the holistic management of 
migraine and CDH. Previous studies have revealed the patients’ use of isolated 
management strategies (mainly doctors’ consultations and medication use), but they 
give limited information on the combination of management strategies used by 
migraine and CDH patients. Although it is useful to study management strategies in 
isolation; it is also important to study the patients’ management from an holistic 
perspective, to improve imderstanding of the complete pictme of headache 
management. The findings of this study showed that migraine and CDH management 
goes beyond medical consultations and medication use, to also include alternative 
therapies, general acute and prophylactic management and the use of social support. 
In this study, headache management was shown to be individual to the patient and 
was based on the patients’ combination of behavioms from the 5 areas of 
management (health care consultations, medication use, alternative therapies, general 
management and social support). This study showed that management behavioms 
were employed simultaneously to maximise the outcome and effectiveness and that 
although patients may be passive in terms of one specific management behaviom*, 
they are likely to be using a wide range of other strategies for the treatment and 
prevention of their headaches.
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Secondly, the qualitative findings gave insight into the patients’ perceptions of 
headache and headache management. Few studies have focused on the headache 
patients’ perspective, and those studies have predominantly used quantitative 
methods (Chapter 2 and Appendix 1). The patients’ descriptions of their headaches, 
and particularly headache severity, and headache impact indicate that patients 
perceive their migraine and CDH as a serious problem. Headache impact, as outlined 
in the review of the literature, has been an area of interest in headache research in 
recent years. This study confirms previous findings on headache impact, but 
additionally reveals the concept of relativity of headache impact. Furthermore, this 
study gives insight into the patients’ perceptions of headaches within wider context 
of health. The study also shows the patients’ dilemma in terms of the seriousness of 
headaches as a health problem. Migraines and CDH entail suffering and have a 
serious impact on the patients’ lives, but in comparison to other, potentially fatal, 
health problems, migraines and CDH are considered less serious and are given low 
priority. This dilemma may be an important contributor to the patients’ approach to 
management and may help explain the patients’ self-medicating with OTC 
medications rather than seeking medical support.
Thirdly, the interview data explained the patients’ decision-making about migraine 
and CDH management, including how the patients’ experience, knowledge and 
perceptions influenced the participants’ managemerrt decisions and behaviours. Apart 
fr om one qualitative study on the decision-making for the use of sumatriptan (Ivers et 
al., 2000), no studies have focused on explaining how the patients choose their 
headache management. Ivers et al (2000) found that at the onset of head pain, 
participants actively compared their symptoms with a ‘migraine template’ that they 
had developed from past experiences. Factors, included in this personalised and 
complex ‘template’ that aided the participants in judging whether a headache was
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indeed a migraine, were the nature, intensity, location and course of pain, the 
exposure to migraine triggers, presence of associated symptoms and presence of 
associated cognitive factors. The findings of this study also showed how the patients’ 
perceptions of their headaches influenced their headache management. Patients who 
perceived their headaches as more severe or as having a greater impact were more 
determined to find more effective management for their headaches. Patients who 
perceived migraines and CDH as less severe were more accepting towards their 
headaches and less pro-active in their search for effective treatment. Thus, the results 
of this study confirmed the findings of Ivers and colleagues (2000). At the same 
time, since this study investigated management decisions beyond the use of one type 
of pharmacological treatment, the findings of this study extend the findings by Ivers 
et al (2000) to give insight and understand about the patients’ decision-making of the 
complete picture of migraine and CDH management.
Grounded theory aims to generate theory (Glaser and Strauss, 1967) and from the 
qualitative findings emerged the theory that migraine and CDH patients are highly 
involved in their headache management, and that this management varies according 
to headache type, severity, impact and the patients’ perceptions of headache and 
headache management. The survey aimed to further investigate the patients’ 
behaviours, to validate part of the qualitative findings. Thus, the sur'vey aimed to 
investigate the management behaviour (level of involvement) of different types of 
headache sufferers and to compare the management used by the different types of 
patients. Three headache types were included: migraine (M), migraine with aura 
(MWA) and CDH, M and MWA were included as separate headache types, as 
features such as aura symptoms and headache impact have previously been shown to 
influence migraine diagnosis (Lipton et al., 2001), which may influence the doctor’s 
recormnendations and prescriptions for headache management. The quantitative
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findings contributed to knowledge by revealing both the high level of involvement of 
M, MWA and CDH patients in their headache care, as well as differences in 
management depending on the headache diagnosis. The findings showed the 
proportion of headache patients using specific management strategies or their level of 
use of management strategies within the last 12 months. Thus, revealing a high level 
of management, these results confirmed the qualitative findings that M, MWA and 
CDH patients were highly involved in their headache management.
Additionally, the survey also aimed to compare the use of management strategies 
between different groups of headache patients. Previous surveys (Appendix 1) have 
predominantly focused on migraine patients, although not differing between 
migraine without aura and migraine with aura. Four surveys (Ferrari et al., 1997; 
Siniatclîkin et al., 1999; Lu et al., 2001; Lanteri-Minet et al., 2003) have investigated 
the use of management by CDH patients, but 2 of those studies (Lu et al., 2001; 
Lanteri-Minet et al., 2003;) did not draw comparisons to other types of headache. 
Two studies have compared episodic and chronic headaches, but one of these 
focused on psychological coping strategies rather than the use of management 
strategies. In this study, the quantitative results showed that there was a difference in 
the use of management for some strategies (such as the use of prescription 
medication or the use of general prophylactic management). When such a difference 
was found, it was usually a larger number of CDH patients who reported using the 
strategy or CDH patients had a higher level of use of the strategy than either M or 
MWA patients or both. More similarities were found in the management behaviours 
of M and MWA patients. This finding further confirms that there is a difference in 
the patients’ management behaviour* (as had been indicated by the qualitative results) 
and that this difference is related to headache diagnosis. The qualitative findings also 
indicated that it was the more severely affected patients who were more active in
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their management. This finding has been further confirmed by the suivey, since it 
was CDH patients who were more active in their headache management.
Thus the main finding of tliis study was the high level of involvement of migraine 
and CDH patients in their headache care. Contrary to the belief that migraine patients 
are passive and fatalistic in their headache management (Michel et al., 1996), the 
patients perceived themselves to have a central role in their headache management, 
thus indicating the importance of patient self-management. Headache patients were 
willing to be involved and attributed a great importance to themselves, namely as a 
key resource to treat and prevent their headaches, tlirough their perceptions, which 
influenced and shaped management and decisions for migraine and CDH 
management in a way that is unique and individual to every patient. The high use of 
management behaviours found in the survey further showed the patients’ 
involvement in headache care and their willingness to manage their disease.
The patients’ involvement in the care of clrronic disease has been advocated in the 
UK by the Depar tment of Health (Department of Health, 2001) and in the US by the 
Disease Management Association of America (Disease Management Association of 
America, 2002). Although, the Department of Health did not include headaches, 
migraine or CDH, within their report on the ‘ The Expert Patient: A New Approach 
to Chronic Disease Management for the 21®‘ century’; migraine and CDH are 
conditions that are suitable for patient self-management. Due to their chronicity, 
migraine and CDH need to be managed over a prolonged period of time and most 
headaches need to be managed by the patients in the absence of health care 
professionals. These facts, taken together with the patients’ willingness to be 
involved and the high level of involvement in the care of their headaches, as
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indicated by this study, demands that migraine and CDH should not be ignored in 
this new approach to the management of chronic disease.
Migraine and CDH affect a large number of the general population and lead to high 
costs to health services and to society in general (Chapter 2). The management of 
migraine and CDH is not optimal, as shown by the high levels of disability and 
greatly reduced quality of life suffered by these patients (Chapter 2). Thus migraine 
and CDH management needs to be improved. Initiatives to improve migraine and 
CDH management have been taken, but they have predominantly focused on 
facilitating the health care professionals’ role, such as guidelines for health 
professionals on the treatment of migraine, disability assessment tools and different 
approaches to clinical management (Chapter 2). But despite these initiatives, 
migraine and CDH patients continue to experience great morbidity. To date, 
migraine and CDH patients have largely been ignored as a resouice to effective 
management, despite the involvement of the patient being advocated within headache 
literatuie (Silberstein et al., 2000). Thus, rather than only aiming to facilitate 
headache management for health care professionals, research and clinical practice 
should aim towaids developing the patients’ expertise and involvement in their 
headache care. One US study, testing a disease management programme for 
headache patients, has recently shown that educating patients is beneficial to patients 
in terms of reduced headache frequency and to health care in terms of reduced direct 
cost (Maizels et al., 2003).
The information from this study can be used to inform and help develop education 
programmes for headache patients. These programmes can be used to educate and 
empower patients towai ds taking responsibility for the management of their migraine 
and CDH, thus putting more emphasis on patient self-management and helping make
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self-management more effective. In terms of headache practice and health care 
generally, the results from this study can be used to inform health professionals and 
headache clinicians, and to improve the communication between and the 
collaboration of the health care professionals and headache patients. This may help to 
improve, facilitate and maximise headache management towards finding more 
appropriate (preferred) and effective management eaiiier in the course of the disease.
The aim of this study was to gain insight into the patients’ perspective, thus the final 
word is given to one of the respondents of the survey, who added this comment to the 
questionnaire. This view both illusti'ates the pro-active and highly involved attitude 
of this patient, as well as the challenge of finding effective management.
“...I never stop trying to find a cui*e, even though it is like trying to find a 
needle in a haystack...”
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Please inform me when the research has been completed.
Yours sincerely
05 October 2000 
04 October 2005
A C Watson
Senior Assistant Registrar
cc: Professor L J King, Chairman, ACE
Dr M Murphy, Principal Investigator, EIHMS
Dr A Dawson, Co-Investigator, Royal Surrey Hospital
Appendix 3: Poster to recruit voiunteers for interviews
i
Do you suffer from migraine?
If yes, are you willing to take part 
in a study on migraine 
management?
The study will involve interviews during which you will be 
asked to talk about your migraine experience, your 
treatm ents and the medical support you seek and 
receive.
If you have any questions about this study or would like 
to obtain an information sheet or would like to take part, 
please contact
Ms. Michele Peters
European Institute of Health and Medical Sciences 
University of Surrey 
Tel: (01483) 879000 ext. 4537 
Email: M.Peters@surrey.ac.uk
UniS
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Appendix 4: Cover letter (Phase 1)
(sent to 20 members of the Migraine Action Association)
University 
of Surrey
Guildford
Surrey GU2 7XH, UK 
Telephone
+44 (0)1483 300800 
Facsimile
+44 (0)1483 300803
European 
Institute of 
Health and 
Medical 
Sciences
University Campus
Duke of Kent Building 
Stag Hill 
Guildford 
Surrey GU2 7TE
Telephone
+44 (0)1483 876700 
Facsimile
+44 (0)1483 876701
Dear Madam, Sir,
I would like to invite you to take part in a study about Migraine Management in 
General Practice, which I am carrying out as part of my Ph.D. Please find enclosed 
an information sheet about the study, which is carried out under the supervision of 
Professor H. Abu-Saad, Dr M. Murphy (University of Surrey) and Dr A. Dowson, 
(Royal Surrey Hospital). Although the study mainly focused on consulting your 
General Practitioner (GP), you do not need to have consulted or to be currently 
consulting your GP. This study will allow you to voice your opinion, beliefs and 
experiences about both positive and negative aspects of care in general practice to 
help improve migraine management.
If you would like to take part or if you have any questions with regard to this study, 
please contact me by telephone or email (the details can be found on the information 
sheet).
Thank you for your interest.
Yours sincerely.
Michele Peters
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Appendix 5: Information sheet
(Phase 1)
Information Sheet
University 
of Surrey
Guildford
Surrey GU2 7XH, UK 
Telephone
+44 (0)1483 300800 
Facsimile
+44 (0)1483 300803
am, nausea and/ or vomiting,
European 
institu te of 
Health and 
Medical 
Sciences
University Campus
Duke of Kent Building 
Stag Hill 
Guildford 
Surrey GU2 7TE
Telephone
+44 (0)1483 876700 
Facsimile
+44 (0)1483 876701
Migraine is a common condition among adults. The severe p = 
dislike of noise and/ or light and aggravation by physical activity is often a major burden to 
migraine sufferer. The sufferers’ ability to carry out paid work and housework or to fully 
enjoy family and social life can be greatly reduced. Treatments, providing significant relief 
of migraine and its burden, are available, but few migraineurs use these treatments. We need 
to gain insight into the reasons for migraine sufferers not relying on these treatments. These 
reasons will provide the key to improve migraine care, to reduce the burden of migraine and 
to improve the sufferers’ quality of life.
You can take part in this study if you:
1. Suffer from migraine
2. Are aged between 18 and 65
3. Are willing to talk about your migraines, consultation practices and treatments.
You will be asked for an individual meeting with Michele Peters, the interviewer, to ask 
questions, to sign the consent form, for an interview. You may be invited for further 
individual and group interviews. All interviews will be tape-recorded. The tapes will be 
destroyed when the study has been completed.
Personal information gathered during this study will remain confidential. The research may 
be published in the scientific literature, but you will not be identified by name. All records 
will be kept in a locked cupboard and will not be accessible to anyone other than the 
investigators.
After reading this information sheet, you must ask about anything that is unclear before you 
sign the consent form. Your participation in this study is voluntary and you have the option 
not to participate or to withdraw at any time without giving any reasons. If you volunteer to 
participate in this study you should notify your GP and give him/her a copy of this 
information sheet.
If you would like any further information or have any questions, please contact Michele 
Peters at the below address/ telephone number or email.
Ms M Peters, Prof. H Huyer Abu-Saad and Dr M. Murphy
European Institute o f Health and Medical Sciences 
Dr A Dowson
Kings Headache Service and Neurology Research Unit, Royal Surrey Hospital, Guildford, Surrey 
Contact Michele Peters Tel. No.: 01483 87 9000 ext. 4537 Email: M.Peters(a)siirrev.ac.uk
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Appendix 6: Interview guide
(Initial interview guide)
Migraine |
• Describe your migraine.
• When did you stait suffering fi'om migraine?
• How long have you suffered from migraine?
• How severe are your migraines? •
I
• Which symptom do you find the most difficult to deal with? I
• How often do you get migraine?
• How long do your migraines last for?
Migraine impact
• How do youi- migraine affect your everyday life?
• What activities do miss out on because of your migraine?
• How do your migraines affect your work?
• How do your migraines affect your family/ social life?
Treatment
• How do you treat your migraine?
• Which medication/ dings do you use when you have a migraine?
• Are there any other medications that you use/ have used in the past?
• Which medication do you use/ have you used every day to prevent your
migraine?
• Which prescription medication do you use?
• Which Over the Counter medication do you use?
• Which other medication do you use?
• Which alternative therapies do you use?
• What else do you use to help relieve your migraines?
• How does your treatment differ between different attacks?
• How do you decide which treatment to have?
• Wliat are the reasons for using this treatment?
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• Who has chosen this treatment for you?
• How did you chose this treatment?
• How helpful/ good is the treatment that you are using?
• What were the reasons for changing your treatment?
How satisfied/ happy are you with your treatment?
• How good do you think your treatment is?
• What do/ don’t you like about youi* cunent treatment?
• What are the good points about your treatment?
• What are the bad points about your treatment?
• What could be improved about youi' treatment?
• What would you like to be different with your current treatment?
• What aie the differences in response to your treatment for different 
attacks?
• What are the side effects of youi' ti eatment?
• How acceptable do you find those side effects?
Wliat do you expect from migraine treatment?
• What would be the ideal treatment for migraine?
• How quickly would you like your treatment to relieve your migraine?
• What is the longest time you would find acceptable to get relief from your 
migraine?
• What is the main aim of your treatment?
® What other aims are there?
• How important is it that youi' treatment will take away symptoms other 
than the pain/ headache?
• Which part/ symptom of the migraine is the most important to treat?
• How acceptable do you find it if your treatment doesn’t completely 
relieve the headache/ your other symptoms?
What do you hope migraine treatment to do?
How would you go about getting different treatment?
• Who would you ask for help to find a different treatment?
• What are your intentions on changing your treatment?
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Consultation/ advice
• Who gives you advice about your migraines/ who do you consult?
• How often/ when (how regulaily) do you talk to somebody about your 
migraines?
• Why do you talk to somebody about your migraine?
• Who else would you like to talk to/ find it useful to talk to?
• Who else do you think might be able to help you?
• Do you talk with youi* friends and family about your migraines?
• Which health professionals do you consult/ have you consulted?
• Who diagnosed your migraine/ headache?
• How much have you read about migraine?
• How happy are you with the advice you are/ have been given?
• How useful do you find the advice you aie/ have been given?
• Tell me more about talking to your GP about your migraine / your visit to a 
migraine clinic?
• What were the reasons for consulting your GP / going to a migraine 
clinic?
• When did you first talk to your GP about your migraine?
• How often do you talk to your GP specifically about migraine?
• How often do you talk to your GP about your migraine when you see 
him/ her for another reason?
• When did you have a follow up appointment?
• When did you last talk to your GP about your migraine?
• What were you expecting from your GP when you first spoke to him/her about 
your migraine?
• What did you expect from youi' follow up appointment(s)?
• What do you discuss with your GP about youi* migraine?
• What else would you like to discuss with him/ her?
• How satisfied (happy) are you with youi' migraine consultations?
• How helpful do you find consulting your GP?
• Which aspects of the consultation did you find helpful?
• What problems did you have when talking to your GP?
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What do you hope your GP will be able to do to treat youi' migraines?
• What would you like your GP to do to help treat your migraine?
What aie the reasons for consulting/ not consulting your GP?
• What are your intentions to see your GP (again)?
• Which initiatives have you taken to talk to your GP about your 
migraines?
• Wliat would make you go to see your GP about yoiu' migraines?
• Has anybody ever suggested that you talk to your GP?
• How much or how often do you think about seemg youi' GP about your 
migraine?
• What aie your reasons for not seeing youi' GP (anymore)?
• If you went to see your GP, what would you like to discuss with him/her? 
Who/ what else do you think may be able to help?
• What else do you think youi' GP could do to help you?
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Appendix 7: Interview guide
(Interview guide comprising issues raised in previous interviews) 
Migraine Diagnosis
• When, how old were you
• Who made the diagnosis 
Symptoms 
Other headaches
How do yon make the difference between different types of headache 
Treatment/ Management strategies 
Taken, current and previous 
Satisfaction, how well do they work 
Choice, how and who by, why did you change 
Why is that treatment (management strategy) better/ worse 
Expectations, what were you expecting of the treatment (management 
strategy)
Improvements, what could be better
Availability, how easy is it to get the treatment (management strategy) 
Readiness/ happiness to take drugs (other management)
Treatment preferences/ ideal treatment (management)
Cost of treatment 
Consultation
Whom have you spoken to 
Why do you prefer/ choose to speak to 
When, why not immediately 
Reasons/ cues to action
What happened/ what was discussed/ were you diagnosed/ discussed all 
leadache types
What might happen (perceived action)
Priorities, how many illnesses were discussed, did you use term migraine 
Expectations/ hopes, what did you want to achieve through the consultation 
Criteria of a good consultation
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• Satisfaction, did he have enough time, did he help, did he understand/ 
discuss the “right” issues
• Improvements
• Intentions/readiness/ follow-ups
• Barriers to consultation, accepting migraine (living with it), don’t want to 
take drugs, nothing to offer, tried it didn’t work, seen parent/ close person cope 
with it, other people’s experience
GP
• How many different GPs
• How helpful
• How sympathetic
• Satisfaction/ expectations, could he/ she do any more, understanding, 
Imowledge, time
• Ease to book appointment
• Confidence in GP
App-28
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Appendix 8. Consent Form
Migraine Management
University 
of Surrey
Guildford
Surrey GU2 7XH, UK 
Telephone
+44 (0)1483 300800 
Facsimile
+44 (0)1483 300803
European 
institu te of 
Health and 
Medical 
Sciences
University Campus
Duke of Kent Building 
Stag Hill 
Guildford 
Surrey GU2 7TE
Telephone
+44 (0)1483 876700 
Facsimile
+44 (0)1483 876701
I will only participate in this study if all responses to the statements below are
positive:
1. 1 have read the information sheet and 1 understand the purpose and nature of this 
study
2. 1 have had the opportunity to ask questions and I have received satisfactory 
answers to all my questions
3. 1 confirm that 1 am aged between 18 and 65 years
4. I understand that I am free to withdraw from the study at any time without giving 
any reasons
5. 1 have had sufficient time to come to my decision and agree to comply with the 
instructions of the study
6. 1 voluntarily agree to take part in the study on migraine management in general 
practice
1 understand that by signing this form I have not waived any legal rights, which I
would have as a patient in a research study
Name of Volunteer (Block Capitals) 
Signed
Name of Witness (Block Capitals) . 
Signed
Signature of Investigator
Date
Date
Ms M Peters, Prof. H Huyer Abu-Saad and Dr M. Murphy
European Institute o f Health and Medical Sciences 
Dr A Dowson
Kings Headache Service and Neurology Research Unit, Royal Surrey Hospital, Guildford, Surrey 
Contact Michele Peters Tel. No.: 01483 87 9000 ext. 4537 Email: M.PetersCasurrev.ac.uk
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Appendix 9. Interview example.
Interview with 36 yeai'-oid female migraine patient (Pt6).
I: I  usually start with the diagnosis o f  the migraine. So i f  you could Just go through 
describing.
Pt 6: my symptoms?
1: your symptoms.
Pt 6: [clears thi'oat], ok, elim I’ve had them; I can’t really remember when they 
started, but I think it was sort of late teens, early twenties.
1: mm.
Pt 6: and ehm, I get symptoms of like severe pain in my head. I don’t get any sort of 
visual flashing or any of that, although my mother and my grandmother suffer from 
those sorts of migraines, although I suffer fr om the pain type. And the, the area of the 
pain does vary. So, sometimes it’s right behind my eye, sometimes it’s one-sided, 
either side, sometimes it goes down my neck, sometimes, it’s right on top of my 
head. So I have pain that, it is, can be all over my head. It’s not always in one 
specific area. And I always feel sick. And I always have got problems with it, and 
sometimes diarrhoea.
I: mm.
Pt 6: I always feel as though I want to be sick, but I haven’t actually yet been sick 
tlirough them. And eh, mainly you know, I have to sleep. And I do; although I don’t 
get the visual flashings, I do sometimes get sort of slanted vision, slight slanted 
vision. So it does affect my vision, but not it the classical way with the flashing 
lights. What else?
I: maybe i f  you can think about the pain a little bit more, how intense is the pain?
Pt 6: elim [pause] again it depends. Sometimes they’re; they can be relieved by 
painkillers, sometimes they can’t. And they; I just need to sleep through them. So 
sometimes I do get severe pain.
I: mm. And how long do they normally last for?
Pt 6: ehm [pause] anything probably from half a day to tliree days.
/.• and how often do you get them at the moment?
Pt 6: at the moment, they’re about sort of thi'ee times a month, I would say.
I: so that's quite a lot.
Pt 6: yeali.
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I: and ehm, describe the pain a little bit more. You say, it can be quite severe, but is 
it a throbbing sort o f  pain, or constant?
Pt 6: ehm, it can; it can be tlii'obbing and I feel as I can almost touch it, especially if 
it is in my temples. If I press it, it seems to relieve it a bit. So I feel as though I can 
almost touch it. And also when it’s behind my eyes, I feel as though if I press it, it 
would go away. So it is; it is sort of a thumping ache. Eh, but a lot of it, is sort of like 
inside, you feel as though you can’t get to it, it’s all inside your head.
I: mm, ok. Do you get symptoms, eh light, any sensitivity to light?
Pt 6 :1 thinlc I am, yeah I do get sensitivity to light and that increases the pain. And I 
don’t like light, although I don’t usually put myself in a darkened room. I mean it 
might improve it if I do, but eh I am quite sensitive to bright light while I’m having 
one.
I: noise, are you sensitive to that?
Pt 6: elnn [pause], I suppose I am yeah. I become very ratty, definitely. And I 
suppose I am, I haven’t really noticed that I am sensitive to noise, but you know I 
probably go very short-tempered and perhaps it is the noise that affects me, such as 
the children [laughter].
I: [laughter] and when you've actually got the headache, does it get worse when 
you 're physically active, when you walk up the stairs?
Pt 6: ehm, not really. I don’t really notice. Previously, you know, like ten, fifteen 
yeai's ago, when I used to have them, I used to find sometimes, if I did something 
like aerobics, it used to go, whereas other times it used to make it worse. So there 
doesn’t seem to be a constant pattern with physical activity. And, so I mean it; it’s 
something that sometimes relieves it and sometimes it doesn’t, yeah.
I: Do you get any other headaches apart from these?
Pt 6: ehm, I s; I suppose I do get sort of mild forms. As I say some of my migraines I 
can relieve with painkillers and you know I call those headaches, although 
sometimes I know that if I’m not careful about what I do, then they can develop into 
migraines. So... .
I: so what's the difference between what you call a headache and what you call a 
migraine?
Pt 6: oh deal', ehm; I can always tell when it’s going to be a migraine, when it’s 
going to develop further. I don’t know, the pain is [pause] slightly different. Eh, it’s; 
it’s a little bit more intense, I suppose at the stait, and 1 always feel sick and quite 
tired, I think when it’s going to be a migraine. When it’s just a headache, if I; like 
dehydration headache, you know I haven’t drunk enough, then it; it’s not the same 
sort of pain. It’s a bit difficult to explain exactly why it’s different, but I know a 
migraine sort of is, feels like a big weight on my head. And I do always feel sick. 
Whereas with the other headaches, it’s not quite as severe pain at the beginning. Is 
that ok?
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I: yeah, that's fine. Ehm, how often do you get those headaches?
Pt 6: ehm, I; I haven’t really noted the frequency to tell you the truth. I mean 
sometimes I sort of wake up with a slight headache, which often goes after I’m; I 
mean it could just be caffeine withdrawal almost. You know, after I ’ve had my cup 
of tea and had something to drink, ehm, [pause].
I: do you notice them mof'e often than the migraines or less often?
Pt 6: [pause], elim, probably, mild headache, which doesn’t really affect what I do, 
probably more often than the migraines. But then I; it wouldn’t disable me in any 
way, I wouldn’t stop what I was doing or anything with the headaches.
I: that's why you don't pay so much attention to them?
Pt 6: yeah, that’s right, yeah.
I: ok, that's fine, that's that bit sorted out. And now I've got a little bit o f  something 
for you to do.
Pt 6: all right.
I: this is a MIDAS questionnaire, which is meant to measure disability fi'om 
headache and it covers the period o f  the last three months. So i f  you can just go 
through the questions and answer in days for the last three months.
Pt 6: right.
I. and talk about them while you 're thinking.
Pt 6: ok [pause]. With; about missing work; I don’t, although I should perhaps, I 
don’t stop work because of them. Although ehm, my efficiency at work is probably 
very much reduced. So I don’t actually, usually come home [phone rings].
I: do you want to get that?
Pt 6: no, my husband can get it. Ehm, so; so I haven’t actually had any days off 
work.
1: ok, so i f  you just put zero days.
Pt 6: zero.
I: and the next one actually relates to your efficiency.
Pt 6: ok [pause]. Is this specifically about my work place work? ‘cause rather, I do; I 
do sometimes do work at home. I suppose I wouldn’t have done if I had a migraine.
I: but is that work, fo r  your work?
Pt 6: yes.
/.• you 're not talking about household work?
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Pt 6: no. So we’re just talking about.
I: so I  think, even i f  you 're working at home, that’s still your paid work.
Pt 6: so you’re talking about paid work yeali [pause]. Three days [pause].
I: and yo u ’re working part-time?
Pt 6: yeah, I work part-time, three out of five days, but I work every day, but I work 
school hours. So I drop my children off at school, go to work and come back and 
pick them up from school, yeah [pause]. When you count, I mean I know that 1; I 
Icnow that sort of almost, elim, the days that I’m going to have a headache, in that it 
ties in with my cycle. So I know I sort of have one like a week before I’m due, 
probably the day I start and the middle of the month, ovulation. So I can almost sort 
of count back to that, but I can’t remember exactly whether that was right for every 
month. I mean do you want me to just estimate it in that way, when it says how many 
days in the last three months did you have a headache?
I: yeah.
Pt 6: it’s just an estimate.
I: yeah, i f  that is all you can give me.
Pt 6: all that I can give.
I: I  know that it might be slightly different.
Pt 6: then I’ll put nine [pause]. Ok [passes back MIDAS].
I: ok, thanks. I f  you like I  can explain that a little bit later, but I  don't want to have 
all o f  that on the tape.
Pt 6: ok, sure [laughter].
I: I  don’t want to have to type all that [laughter].
Pt 6: it will save you a bit of time.
I: well I  don’t like listening to myself Well, the first thing I  really want to talk about 
is your treatment. What do you do at the moment for your treatment?
Pt 6: I usually just take painkillers and I have Ibuferi, which I find is quite good. I 
usually take; I was; I was advised and I think it’s better for me to take, as soon as I 
know that I am going to get it, even when the pain’s not severe, ehrii, I should take 
tablets and regularly while I still get the pain. And I’ve been; it often does alleviate 
it. However, I’m often not as good as that, and I often just “oh, it’s gomra go away” 
and leave it until it gets to a state where it is so painful that the painkillers don’t 
touch it. So if I’m good then I take them at the beginning and if I’m not then I talce 
when it’s probably too late. And then I; then I have to really just rest and sleep to; to; 
to alleviate it.
App-3 3
I: so who advised you to take it?
Pt 6: ehm, the doctor.
I: so you have seen your GP about it?
Pt 6: yes, I have yeah.
I: eh, so how helpful do you find  them when you first take them? When you say at the 
beginning, how quickly do they work?
Pt 6: eh, probably about an hour, I ’d say. They do; I mean it depends, sometimes, 
you know it can clear it up all together with just one dose. Sometimes if it’s gomia be 
worse for whatever reason, you know I need two doses, or sometimes it doesn’t 
alleviate it at all. But generally if I; if I take them as soon as I think I ’m going to get 
one, then usually one or two doses is enough.
/; mm.
Pt 6: to prevent the really severe pain and having to go to bed really.
I: and how acceptable do you find  that that is? I  mean obviously never knowing 
really i f  i t ’s going to work or not.
Pt 6: yes, I mean it would be better if there was obviously guarantee that it’s going to 
help; that is going to work. It’s that the sort of; is that what you mean [laughter]?
I: yeah [laughter]. Well, i t ’s; lots o f  people are taking things that either take a long 
time to work or that; are not always that good at later stages.
Pt 6: mm.
P. during the migraine, so you either have to take it really early.
Pt 6; ram. Yeah, I mean if I have got my full; you know; if it’s got the pain and the 
sickness and if I take a tablet then, I might as well not bother, because also I thinlc I 
get problems with elim, you know, my gastro-intestinal tract. And I don’t thinlc I 
absorb it, quite honestly, which is another thing. The doctor did actually give me 
some other tablets, which are called Motilin, which aie meant to be anti-nausea 
medication, which are meant to help me absorb the painkillers, which he suggested 
taking one of those every time you have a dose of painkillers. Which, elim I have 
taken, but I have now run out and I haven’t bothered to go back to the doctors to get 
some more. And they did actually help, they did help the nausea and possibly the 
absorption of them. So they were; they were quite good as well.
I: mm. So that made a difference when you took them to the effect o f  the painkillers?
Pt 6: yeali, it did yes. And because also, the nausea and everything was also relieved. 
I think the whole group of symptoms was just must easier to tolerate it.
L so normally with the painkillers the nausea is not relieved?
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Pt 6: no it’s not relieved at all, no.
I: right.
Pt 6: just the pain, the head.
I: but even when you take it early, it just affects the pain or the nausea?
Pt 6: elim [pause] eh [short laughter].
I: [laughter].
Pt 6: I haven’t really thought about it. I suppose it does in a way relieve the nausea, 
but more the pain. Often I am left with the nauseous side of things and I don’t have 
severe, as severe pain.
I: mm and is that ok then?
Pt 6 : 1 can; I can suffer the nausea much better than I can suffer the pain, definitely. 
It’s the pain that really, ehm, it’s much worse for me. I can’t do things when I’ve got 
that really severe pain, whereas I can; I can still carry on almost as normal with the 
sickness.
I: mm, ok. So you Just get your painkillers over the counter, you don’t get a 
prescription?
Pt 6; yeah, no.
I: and you get the anti-emetics as a prescription?
Pt 6 :1 had those; yeah I had those as a prescription, yeah.
I: la m  assuming you can’t buy those over the counter.
Pt 6 : 1 don’t Icnow, I haven’t, I mean my doctor prescribed these particulai* ones and 
he said there was other ones that we can try, but they seemed to work. Ehm, I haven’t 
tried buying them over the counter to tell you the truth.
I: yeah. I ’m just.
Pt 6 :1 don’t know.
I: I  don’t know i f  you can buy them over the counter. Ehm, so what would you say 
are the main reasons for using this treatment?
Pt 6: elim [pause] probably because they; the thing that really affects ehm [pause] my 
working efficiency and just generally affects me, is the pain. And so obviously I 
want to relieve the pain, so therefore I’m taking painkillers. That; the; the anti-nausea 
medication was, as I say the nausea is; or is not; is not good, but I can stand that 
better. But I; the anti-nausea drug, did help me absorb the other ones, I think. So, 
that’s why I talce I suppose [laughter].
I: have you ever taken anything else, apart from that?
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Pt 6: yeah, I have taken the; I have taken other painkillers yeali. Paracetamol don’t 
work, or dispirin or aspirin don’t seem to have the same effect as Nurofen. But I 
usually just get the just the general Boots’ own Ibufen ones. So I need a sort of fairly 
strong one, and I always have to take at least two tablets. Bhm, I did try other 
treatment. Do you want me to talk about that? I have tried other treatment before this.
I: yeah.
Pt 6: yeah, and that was Migraleve, where you have the pink and the yellow tablets. 
Do you know this?
I: everybody talks about the pink and yellow tablets [laughter].
Pt 6: yeali [laughter]. I know it was such a long time ago, I can’t remember which 
one you take first. One when it’s just started and then you take the other ones all the 
way tlu'ough it. It had no effect on my. It didn’t really do me any good. It didn’t seem 
to work with me. Ehm, so that’s the only other treatment I’ve taken.
I: so you ve tried different things?
Pt 6: yes.
I: and ju st went onto something else when it didn’t work?
Pt 6; yes, that’s right. I mean especially painkillers, you loiow. I think; I find Ibufen 
is better. I have had some; I had an operation in hospital and they gave me some, 
ehm codeine and paracetamol, which were very strong. And I have used those, just 
because I didn’t use them for the pain I had from the operation and they seemed, I 
suppose it’s good, but they don’t seem any better. They didn’t seem to relieve it any 
better than the Ibufen, so I; I just get that.
I: ok. Obviously yo u ’ve mentioned your doctor and what he prescribed a little bit 
already. And o f  the main things I  really wanted to talk about, was about advice that 
you get.
Pt 6: right.
I: generally from people, but then more specifically from the GP.
Pt 6: right.
I: where, generally speaking, do you get advice fi'om?
Pt 6: ehm, mainly from the GP. I mean my Mum’s quite concerned about my 
headaches, and she probably is more active than I am. And she wrote to the; the 
Migraine Society. So I’ve got their leaflet on it, which I’ve read. It’s quite general, 
but I haven’t taken it any further than that. Ehm [pause] so main; most of the advice 
is either taken from friends, who tell you about their experiences or from the GP, 
fi'om my doctor. And I have been to, I mean I’ve had these headaches for a while, 
and I went to, when I was an undergraduate student at S, I went to the doctor there, 
who gave me the Migraleve. But my doctor here, he, you know; he’s very good, but 
he’s only, as I said, only suggested these anti-nausea drugs with the painkillers.
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I: right, ok, maybe i f  I  can you trough all the different consultations that you had 
with the doctor.
Pt 6: right,
I: when did you first go to see somebody?
Pt 6: eh.
I: you said as an undergraduate?
Pt 6: yes [pause] eh, was it, so that was probably about; say it was about; perhaps it 
was about ’88, all those many years ago [laughter].
I: do you remember what the reason was that you went to see somebody at that time? 
Pt 6: elim [pause].
I: it sounds like it took you a little bit o f  time before you went to see somebody.
Pt 6: yes, well I just used to sort of just suffer the pain really. And I think it was just 
getting, probably my Mum again saying “you should go and see someone about it, 
they might be able to help you”. I mean I was just thinking it’s just like a headache, 
and you just have to take painkillers and that’s the only; the only relief that you can 
get. But I thought I’d go to the doctor and try and get other treatment to see; ‘cause 
pain relief wasn’t really working that well.
I: mm.
Pt 6: and eh, then I got Migraleve and it didn’t really work, so I just went back to 
painkillers. And then when I was; when I was; had eh, when I was here, after my; I 
didn’t have migraine during my first pregnancy at all, but during my second 
pregnancy I had, I did have a number of very severe migraines, which is quite 
unusual I thinlc during pregnancy they are often alleviated. So after that I went to my 
doctor. It must have been about, ehm, a couple of year s ago, ’99.
I: can I  bring you back to your first consultation.
Pt 6: right.
I: you went a little bit fast.
Pt 6: sorry [laughter].
I: oh no, that’s all right [laughter]. Ehm, what actually happened when you went to 
see the GP? Can you remember a lot about it?
Pt 6: no really [laughter].
P. or just tell me the things that you do remember.
Pt 6: ehm.
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I: how helpful do you think it was or what suggestions did they come up with?
Pt 6: I mean I think, eh the main thing he said was [pause] was; you know; I can’t 
remember. You know he suggested this Migraleve in that, you laiow to take the, this 
medication as soon as I had the migraine. He was probably the person; the first 
person to say that rather than I used to just let it carry on, thinking “oh it’s gonna go” 
and it hardly ever did. And so, he told me to take the medication, this Migraleve 
medication as soon as I had the headache, whether it was a pink or a yellow I can’t 
remember [laughter]. So and then you’re meant to talce then and then obviously the 
subsequent, the other one, the pink or the yellow, through the migraine. And that’s 
all I can really remember.
/.• right. Do you remember him going through the diagnosis, discussing your 
symptoms with youl
Pt 6: not really. I think I just, I can’t really remember, ‘cause I know, I know there is 
sort of certain types of migraines, and I said I had just the pain and not the flashing 
lights. And he did accept that that was a migraine. But I don’t think, I don’t 
remember him going through the; the diagnosis of it, no.
I: so you, ehm, did you actually go in and say to him straight away I  suffer from my 
migraine ", rather than saying ” I  suffer from headaches” and then he had to.
Pt 6: no, I think I said to him “these are my symptoms and I think it’s a migraine”. I 
think he probably said “yes”. So I mean I thought it was a migraine, before I went to 
him. It wasn’t him who told me that.
I: so i t ’s through your Mum?
Pt 6: probably, yeah, yes, yes.
I: did he come up with any suggestions about what you can do apart fi'om 
medication?
Pt 6: ehm, you know I can’t really remember. But I mean I know from somewhere 
that things can affect migraines, like alcohol and chocolate and things like that, so, he 
may have suggested that to me, the fact that they could be triggers for it. Ehm, and I 
think with mine, I found that; it’s not; I don’t find that any food is in particular a 
trigger, but I find that if  I’ve got a headache, I don’t really; I can’t drink alcohol at 
all. And eh, tea and coffee I don’t really want. So I don’t know if it’s related or not. It 
doesn’t seem to bring them on, but while I’m having them, it’s not a; I don’t really...
I: that might probably be more related to the nausea. 
Pt 6: yeah.
I: you go o ff certain things.
Pt 6: yes, yeali.
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I: right and then after you'd seen him and the Migi'aleve didn’t really work, why 
didn Y then go back and see him again to get something else. Why did you just go 
back to painkillers?
Pt 6: ehin [pause] I don’t know really, I just; he didn’t really say that there was much, 
many other treatments. So, I just; I don’t know, I just suffered it, I suppose 
[laughter]. Eh [pause].
I: I  am trying to understand the reasons, why people don Y go back. I t ’s actually 
quite a lot o f  them, they tell me I  just don Y know why.
Pt 6: yeah. I mean although it is very disabling really to have a migraine [pause] 
somehow, you Icnow you just think, you should; it’s just a headache and nothing is 
going to help it really. If painkillers don’t work, then there is probably nothing else 
that is going to work. Once I’ve tried that, Migraleve, I thought that was it, obviously 
the treatment he suggested to me and then it didn’t work.
I: mm. What do you think now then? Are there any other treatments apart from  
painkillers?
Pt 6: [pause].
I: do you know o f any?
Pt 6: ehm [pause] not; not really, not specifically, unless they are things like 
relaxation or trying to determine when certain triggers. But then I don’t know of any 
specific ones, no [laughter].
I: that’s ok, that’s fine [laughter].
Pt 6: good [laughter].
I: as I  say, I  am not testing your knowledge. So, eh after that first consultation, was it 
until that last; or that consultation you were talking about now, a couple o f years 
ago.
Pt 6: yeah.
I: was it that long in between when you didn Y see anybody?
Pt 6: yes, it was really, yes. I mean think every time I re-registered with a doctor, you 
know when you go through your medical history. You know they say “do you suffer 
fi'om anything” and I said “yeah, migraines”. And I remember another doctor saying 
“what do you do” and I said “painkillers”. And he said “is that; is that enough for 
you” and I said “well, it doesn’t always shift the pain”. But he didn’t seem to be that 
interested in it, that’s the trouble [daughter comes to interrupt and is talcen away by 
Dad].
I: why didn’t you take him up; maybe talking about it again to see i f  whether there is 
something else.
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Pt 6: elim, ‘cause I mean; I thought, although it was; although it is; it is [pause] it is 
debilitating for me, I just felt as though, I suppose, I could cope with it. I didn’t sort 
of want to make a fuss or go tlirough any more [pause], I don’t know, any more 
consultations about it, suppose [laughter]. Very difficult questions [laughter].
I: [laughter], yeah, we//, i t ’s just interesting that people don’t really know why they 
didn’t go back.
Pt 6: yes.
I: but then after a while, obviously you went back again. What was the reason that 
made you go back at that time?
Pt 6: ehm, it was getting to a stage where I was getting quite severe, you Icnow; 
severe migraine, quite frequently. They; I mean they come in cycles, I think around 
about my pregnancies I think they relieved them a little bit, being pregnant and 
during lactation and things. Although then they started coming back more frequently 
and more severely and it was affecting me a lot more. And the doctor I’ve got is very 
good, so I thought, and he’s very understanding and he does listen and discuss things 
with you. So I thought it would be interesting to have his opinion on them, to see if 
there is anything that he could suggest.
I: mm. And do you remember a lot about that consultation?
Pt 6: yeah, I mean, om‘ doctor, I mean he’s very I mean; he’s very interested in what 
you say and he got me to list everything, all my symptoms. And he said that, you 
Icnow he explained the different types of migraines to me and he said “yeah, that is a 
migraine” and the possible treatments. I mean because mines are, he thinks; because 
mine’s a cyclical one that is obviously associated with my hormones or my cycles, he 
said, you know, he said that it may be that that is actually the trigger for it. Elun, and 
he suggested, because I suffer from nausea, he suggested the anti-nausea and the 
painkillers, and he said he could give me other stronger painkillers, if I didn’t find 
any that suited me.
I: right.
Pt 6: and also for a while actually, it might have been around the time they started. I 
started on the pill, and I think that, it was during that time, I was having it for quite a 
long time, I think that probably didn’t help. And then I came off the pill for the 
reason of the headaches, which was about; which was quite a long time ago. And eh, 
and he said “perhaps start on a different pill”, you know, oral contraceptive to see if 
that had any beneficial or detrimental effects on it. And eh, it didn’t really make that 
much difference, it didn’t relieve them. I went on the progesterone only pill. It didn’t 
relieve them, but it didn’t seem to make them worse. They don’t seem to have any 
effect on them.
I: mm. So you got the ehm pain, you have the painkillers and you got the anti-emetic 
and you said that that is working quite well.
Pt 6: yes.
I: but now you said yo u ’ve run out o f  them.
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Pt 6: I’ve run out of the, yes [laughter].
I: [laughter], you know what 1 am going to ask. Why didn 'tyou go back?
Pt 6: probably just, because I ’ve been busy. And eh, although it is, it is; it does make 
it easier, having those, elim, recently I suppose; I mean I haven’t really thought about 
it, but recently they’ve been slightly less severe than I have had in the past. So it 
hasn’t been such a problem, because it’s the pain that always really affects me. So if 
I, if I can relieve the pain with the painkillers, as I say, I can sort of suffer the nausea. 
So I haven’t been back and I should. And it’s just because I’ve been, I suppose, not 
that you can ever be too busy, but I feel as though I’m too busy. Or other things to do 
with laziness, perhaps [laughter].
I: priorities [laughter].
Pt 6: yeah, priorities, that’s what it is, that’s better [laughter].
I: ehm, but don 7 you think i f  you ’re going to have the; even i f  they are not as bad at 
the moment; i f  you are going to have the anti-emetic to go with the painkillers, that’s 
going to relieve the pain quicker because you get, it gets absorbed quicker?
Pt 6: yes, yes, it would [laughter] so I should really go [laughter]. I’ll book an 
appointment now [laughter].
I: [laughter] I ’ll stop the tape i f  you like.
Pt 6: yeah [laughter].
I: ehm, did your GP when you were seeing him come up or suggest anything apart 
from painkillers and anti-emetics? Did he talk to you about migraine specific 
medication?
Pt 6: no, not really, not that particular type, because he said “try these and if you find 
that they’re beneficial or if they’re not then come back and we can talk about it 
again”. So I mean I did find that they were better and again if I’m good and I take 
them bef; just as my headache starts then I thinlc it definitely improves the outcome 
of the treatment, rather than leaving it.
I: how do you actually decide when yo u ’re going to take the medication?
Pt 6: [pause].
I: because you don’t seem to be very consistent.
Pt 6: no, not really. Well, I don’t; I don’t like taking medication for starts, so really if 
I can get away with not taking medication then I prefer not to. And I think this is why 
I always leave it too late, because I think “oh well, it’s going to go” and it never; 
very rarely; well it never does. But every time I kind of thinlc “well, I just leave it, 
this one might go”. But nowadays, I think recently ehm, I am more likely to talce it 
when it’s just coming on. Ehm, which is; gives me better relief really.
I: so you have learnt from past experience [laughter].
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Pt 6: oh, yes it’s taken me a long time [laughter]. So and also if I’ve got; you Icnow, 
if I’m going out or something and I’m starting a headache then I take it earlier. 
Whereas if I’m just staying in the evening, it doesn’t really make any difference, it’s 
not going to affect what I am going to do. Then I ’m more likely to leave it.
I: so what worries you about taking the drugs?
Pt 6 :1 mean, nothing really [short laughter], I just feel as though it’s better if I don’t 
have to take medication.
I: ok, fine. I f  you think maybe about, again, seeing the GP and obviously you ve had 
some help, but is there anything else you ’d  think you ’d like to discuss with the GP or 
maybe another health professional about the migraine that might help you?
Pt 6: ehm [pause].
I: to prevent getting so many or being so severe.
Pt 6: yes I mean, if; if I thought that there was a treatment out there that would 
relieve them completely then I would make the effort to go. But I just; I have; 
speaking to other people, and probably because they are the same as me and don’t go 
back to the doctor, they say there is nothing really that has ever helped them 
completely. And they just alleviate the symptoms, rather than actually getting at the 
reason why they are having them.
I: mm.
Pt 6: so if I could be confident in a treatment, then I would probably seek more help. 
I: right, so i f  anybody told you noMK 
Pt 6: [laughter].
I: there is actually something, that also work at later stages o f  the migraine.
Pt 6: right.
I: that you could take. It takes, I  mean in a lot o f  people, it doesn’t work for  
everybody, but it takes away the nausea as well.
Pt 6: yes.
I: and lots o f  the symptoms.
Pt 6: yes, I would.
I: then I  think you should go back.
Pt 6: [laughter] is there a treatment?
I: yeah, there are some things, I  can tell you a little more about.
Pt 6: ok.
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I: I  have got some reading for you as well 
Pt 6: ok.
I: so, is there anything else, apart from medication that you could, any other advice 
that you ’d  like, or more information about certain aspects o f  it?
Pt 6: ehm, I mean I have ehm, I mean I know of work that’s been done on looking at 
the dietary triggers for it and if you’ve got perhaps an underlying food allergy, then I 
Icnow that that can affect yoiu migraine. And you need a trigger food. And I did 
some work on food allergy. But knowing how awful it is to go on an exclusion diet, I 
have never pursued that side of things, the dietary side of things. And being a 
nutritionist I possibly should have done [laughter] searching into allergies as I did.
I: I  don‘t agree with that [laughter].
Pt 6: no [laughter], it’s awful, it’s, we never do the right thing as us nutritionists. But 
I haven’t, because I know how horrendous exclusion diets are. Ehm, and they are not 
always conclusive anyway. So, ehm another thing that I; I; that does affect it, my 
migraines, is stress, either a relaxation or a stress. If I do for any reason get ehm, you 
Icnow, an acute stress, for whatever reason, I got a deadline that’s like tomorrow and 
I have only just heard about it, then I can feel the migraine coming on. And often I 
used to have migraines on a Friday, especially when I was a student. Eh, and 
especially when I went home and I think that is often a relaxation thing. So perhaps 
to control, you know, this stress and relaxation may help.
I: have you heard about anybody that you can go and see about relaxation?
Pt 6: not really.
I: are there other treatments that you might have?
Pt 6: no, I haven’t had, not specifically for migraines, no.
I: and have you ever read anything, I  mean you know about the food  triggers, where 
do you know about those? Just from being a nutritionist?
Pt 6: yeah, I did; I did some research into food allergies, so I learned just from doing 
literature surveys.
I: but you haven’t read in magazines or?
Pt 6: elim, I don’t; I don’t really get magazines, but I mean I have; I have seen them 
in a few magazines, when they talk about migraines. And obviously if there is a 
magazine there and I am waiting in the doctor’s siugery or the dentist’s, I would read 
the one that is about migraine. It’s just because it’s, you know, of particular interest, 
but I don’t read an awful lot of magazines. Although I know that they are written in 
there a lot about conditions like migraines.
I: mm. A lot o f  people say that and I  never see anything.
Pt 6: oh really [laughter].
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I: [laughter] in fact there was something on TV the other day as well, and I  missed 
that.
Pt 6: [laughter], I didn’t see that.
I: ehm, i f  you could maybe think about an ideal treatment fo r migraine. What would 
that be? What would that do?
Pt 6: it would completely take away, well it would prevent me having them, I think, 
rather than treating them. Just taking take away having them completely. Is that what 
you mean?
I: well, la m  just trying to work out what would be the ideal thing fo r  you.
Pt 6: yes.
I: and obviously i t’s different fo r different people.
Pt 6: you know, when I think really never to have a migraine, would be great, if there 
was anything that could be taken. Again if they said “if you take this drug every day, 
this medication and you’ll never get a migraine”, I would again think twice about 
that. Because although migraines are bad, again I don’t know if I’d want to take 
medication every day and there might be side effects. A friend of mine had, you 
know, severe migraines and they put her beta-blockers, you know, for a long period 
of time, which controlled her migraines. And now she just takes one when she’s 
getting a migraine. But again, I know about beta-blockers, I wouldn’t like to be on 
them long-term.
1: mm.
Pt 6: so, it depends, you know, on what you have to actually do to get no migraines. 
I’d have to consider, if it’s not medication, possible side effects.
I: ehm, probably thinking about the GP again, a little bit more. They; so they haven’t 
really told you about any more specific medications for migraine?
Pt 6: no, only the Migraleve.
I: or mainly painkillers?
Pt 6: yes, yeah.
/.• how encouraging were they to come back, i f  what they prescribed or i f  what they 
suggested to you wasn ’t working?
Pt 6: ehm, I mean, my recent GP, he always says “do come back and talk about it 
again, if it’s not relieving your symptoms”. As I say, I haven’t really been, I mean I 
did go back and say that they were working and I got a repeat prescription of those. 
And he did say, you know, “is that, is the treatment ok for you”? [daughter comes in. 
Dad takes her away]. We’ve got a busy house [laughter].
I: don’t worry [laughter].
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Pt 6: soiTy about that. So, he has been; he has been very understanding, and he would 
probably discuss it more with me and be happy to do that. It’s just me, that I haven’t 
gone back to him and said “look, it’s not working, I want more treatment”.
I: mm, when you actually go in and see him about it, or the times that you have been, 
do you only go in to specifically discuss the migraines? Or did you also discuss 
something else?
Pt 6: something else as well, yeali. So, I; it’s; yeah; I mean I’m probably when I went 
the first time with the migraine, I didn’t; I waited until there was a few other things I 
had to tell him about, before; I didn’t go in specifically for the migraine. There was 
at least another reason why I went in to see him.
I: but they were still quite happy to discuss things, because there is a lot o f  people 
who mention the migraine with something else and then it gets sort o f  pushed in the 
background.
Pt 6: yes.
I: and he deals with one problem, but not with the other.
Pt 6: but not witli the other, yes. Ehm [pause], yeali, I mean he did; yeah; he probably 
dealt with the first problem, which seemed more immediate then he did with the 
migraine. And he did give me treatment for it, as I said, but elun, I suppose it wasn’t, 
he didn’t seem that much more concerned about the migraine as he did about the 
other thing.
I: yeah, ok. But it seems though, I  mean you say that you need to have something first 
to go and see him.
Pt 6: [laughter] yeah.
I: it just doesn 7 seem very high priority to get it sorted out.
Pt 6: no. I Icnow, I really don’t know why it is. In my mind I don’t put my priority, 
because it’s probably the thing that causes the most effect on my work, out of 
everything is the fact that I’ve got a migraine. And it is weird that people don’t go 
back and I don’t go to seek more help. And I really; I just don’t Icnow why. And your 
research would be interesting [laughter].
I: [laughter].
Pt 6: to determine why we don’t go back [laughter].
I: well, they just say they don 7 know why they don 7 go back [laughter].
Pt 6: I know [laughter], that’s no good, is it for you? Have you done men as well? I 
mean aie men different to women? Perhaps it’s just that us women think that this is 
what we get every month, especially when it’s with the menstrual cycle and this is 
what we’ve got to suffer.
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I: no, i t ’s the same thing. I  think women go and see the GP more often, but 1 think 
that’s generally speaking and for headache that’s true as well.
Pt 6: yes.
I: but women suffer more frequently than men.
Pt 6: yes.
I: but I  do get the same responses.
Pt 6: yes.
I: I  mean not even thinking about the GP helping, why haven’t you taken more 
initiatives to find  out more like going to the Migraine Association?
Pt 6: [cleai's throat], well the thing is when you haven’t got a migraine, you kind of 
think, you sort of hope that you are not going to get another one for a while. 
Although as I say. I; I; it was only recently, again talking to my friend who was; was 
prescribed these beta-blockers, she said that it was very cyclical hers. And I thought 
mine was, but I hadn’t really written down exactly when I had them, and I hadn’t 
really taken any mental note. And it was when she was talking about it that I decided 
that I’d try and see if  there is any pattern to mine. I found there seemed to be a 
pattern. Ehm, so [pause] I; I sort; when you haven’t got one, as I said, you don’t feel 
as though you’re going to get one, or you just hope that it’s not going to come again. 
And because it’s a thing that I feel as though, you know, can’t be treated, except with 
painkillers, or that’s the impression you get from other people, unless you going to 
go onto something like beta-blockers or something like that. You feel as if it’s almost 
not worth going to the doctor’s.
I: mm, because you can just buy them over the counter?
Pt 6: yes, that’s right, yes.
I: well, that does make sense. I  mean i f  you don’t think that the GP can do anything 
to help you any further, then you are not going to go.
Pt 6: mm.
I: that’s why I ’d really like to know what other things people think that the GP might 
be able to do for them.
Pt 6: imn.
I: have you ever thought about seeing a headache specialist? Do you think there is 
such a thing as a headache specialist or somebody else apart from a GP?
Pt 6: no, I didn’t know there was necessarily a headache specialist, but after I have 
got the; the Migraine Society’s leaflet, so obviously I could go to them and they 
would possibly put me in touch with other sort of treatments. Again, I haven’t done 
that [laughter] as yet. Yeah, I mean I didn’t know there was any specific headache 
specialist.
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I: does that sound like a good idea to have somebody more specific, I  mean even a 
GP with a special interest, who’d really know a little bit more. There are other 
treatments apart fi'om just painkillers, whether it is that GPs don 7 want to prescribe 
them.
Pt 6: yeali or don’t know, yes.
I: it is difficult knowing exactly what’s going on.
Pt 6: yes, I mean; I think with a lot of GPs, I mean they have such a broad range of 
conditions that they need to know about. I mean, you can’t often blame them for not 
knowing tlie up to date treatment for everything, but as you say you can around that 
with possibly having people that are interested in a certain conditions. And you 
know, it would help; help the patient.
I: ehm, maybe just mentioning the treatment again. We ve have spoken a little bit 
about the aims o f your treatment, but what it is that you expect from the treatment?
Pt 6: ehm, what I’d like is, you know, if  I’m obviously going to get migraines, is that 
as soon as I get a migraine, then to have the pain relieved immediately. That would 
be great. And not to feel sick.
I: what is immediately. What’s the acceptable length o f  time?
Pt 6: ehm [pause], eh, half an hour* or something [short laughter], half an hour after 
taking the medication, if  that’s what you’re doing.
I: how important is it that, obviously taking the pain away, but how important is it 
that it treats the other symptoms?
Pt 6: ehm [pause], it is, I mean it is important. It is important, I don’t like going 
around feeling sick or having diarrhoea or anything like that. But the pain is the most 
thing, without a doubt. And if it could relieve everything that would be great. I mean, 
ideally, yes to relieve everything, pain and nausea and everything. Ehm, but to 
relieve the pain is almost sort of good enough, because that’s so awful.
I: mm. What would you not find  acceptable?
Pt 6: ehm, if it doesn’t relieve the pain I suppose. Is that what you mean, yeah?
I: well, some people say that they wouldn 7 like something that they ’d have to take 
every day.
Pt 6: oh I see what you mean, oh. Yeah, I wouldn’t like; I wouldn’t like to have to 
take something every day. You know, especially because I don’t particularly like 
taking medic; I mean I’m not completely adverse, of course I take things if they are 
prescribed to me and I; they; I need them. But ehm, I would prefer not to talce 
medication, if I can help it.
I: so have you tried any other forms o f  relief when y o u ’ve actually got a migraine, 
apart from taking medication. And what do you do at the times that you are not 
taking any medication?
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Pt 6: ehm, I do sometimes, I mean if you, you can almost; sometimes when I’m not 
taking the medication, if I concentrate and try and sort of shift the pain myself 
almost, I can do that for a bit. You have to; you know; concentrate and you; we 
learned some things when I; when we went to the National Childbirth Trust for 
labour pains. You can concentrate on the pain and try and shift it and move it up your 
body and things like that. And it does work for a bit, but quite honestly it t^ e s  so 
much effort, that it doesn’t work all the time. And you’re going to keep that up for a 
while, I mean things like not looking at bright lights and, you know, and if I sleep 
than that helps. And to drink, you Icnow to drink fluids, water, does relieve; it doesn’t 
relieve it, but you know, I think it’s better to drink water than not. Because you don’t 
want to be dehydrated, those sort of things.
I: when you actually sleep, because you ’re saying that you can get them for up to 
three days, so you can go to sleep.
Pt 6: and still wake up with them, yeah. I mean that is quite unusual, three days. It is 
unusual, but I mean they do sometimes. I mean sometimes I sleep and you still got it 
the next day. And as the day progresses it sort of gets worse and then, you have to, 
you know, you sleep. Sleep usually does relieve it, but not always.
I: right, so when you wake up with it the next morning, is it actually, do you feel a 
little bit better or does it?
Pt 6: sometimes it does. As soon as you wake up, it does feel better, and you Icnow if 
you get up and as you go through the day, then it gets worse again.
I: what do you do then.
Pt 6: the trouble is, I always try and cany on and not, you know, not sort of put 
myself in a dark room, and perhaps that might help. So I mean I try and carry on a 
bit, but sometimes I just lay on the sofa all day, just sort of sleeping. I don’t usually 
sort of go to bed. But eh, you know; I usually try and rest, I would say.
9.1. I: ok, where [end o f tape]
Pt 6; besides the GP you mean?
1: well i f  you just think about it, or go through the procedure, the process that would 
have to happen fo r  you to go and see somebody, who would you ask then. I  mean, i f  it 
suddenly got worse would you talk to your Mum?
Pt 6: oh I see yes.
I: or go to the GP.
Pt 6 :1 mean you always discuss things with your friends. I mean I would probably go 
to the GP or even write or phone up the Migraine Society, those, yeah those two 
roads.
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9.2. I: what do you think the Migraine Society could do for you?
Pt 6: [clears tliroat]. They might have eh new treatments that have been successful 
with other sufferers, because obviously they are in touch with a number; a lot; much 
larger number of people than probably the GP is. So they might have eh, more idea 
of different treatments that can be used and possibly support for the sufferer.
I: mm, so yeah think about it, they might have more o f different treatments that might 
work better.
Pt 6: yes.
9.3. I: does that make you want to write to them or get in touch with them?
Pt 6: [short laughter], yes.
I: [laughter] I  know I ’m always going back to the same thing.
Pt 6: why are you so lazy? That’s what you’re trying to say. Yeah, I suppose so. The 
thing is while I can sort of stand the; you know; the pain even after, when using the 
painkillers, when it’s to a sufferable level than I sort of live with that. Although as 
you say, ideally I’d prefer it to go away completely. So yes, perhaps I should go 
there, be pro-active in looking for treatment.
I: how do you deal with other problems, because a lot o f  people put dealing with 
things off, unless it’s really acute.
Pt 6: mm.
I: more or less an emergency, then they do something about it, but how pro-active 
are you?
Pt 6: ehm, other problems you mean?
I: I  am just wondering generally, some people are very get up and go and get this 
sorted out, and others haven’t got time, maybe it will go away.
Pt 6: yeah, I do a bit, a little bit of maybe it will go away. So I do leave things, I 
mean other sort of medical conditions you mean or possibly just life.
I: yeah.
Pt 6: well, I mean I do often, you know, if I have a medical; a symptom or 
something, I often leave it a little bit. I don’t run immediately down to the doctor’s 
until it gets to a stage where I think “well it’s not going to go away and I probably 
need help”. Then I do go to the doctor’s.
9.4. I: so you still think your migraine is going to go away?
Pt 6: well people do say that you grow out of them. I mean this is. I’m always hoping 
that I will eventually grow out of them.
I: yeah, but that might not be for twenty years.
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Pt 6: no, I know [laughter], I’m hoping.
I: is that enough? It may take years.
Pt 6: yes, ever hopeful me [laughter]. Yes, perhaps I ought to go and get some more 
help.
I: what are your intentions at the moment to get some help. I  mean, don’t let me 
influence you in thinking you should go, i f  you don’t think you want to go at the 
moment.
Pt 6: I mean before; you know before this interview then I probably wouldn’t have 
done. I would have probably gone to the doctor’s when I could be bothered to get 
some more Motilin. Ehm, but then I mean possibly I should go and get more help. 
And I’d like some ideas for me to go [laughter], which I’m sure you can tell me.
I: well I  can tell you a few  things or you can read about them. Ok, well, has it 
actually only been tM>o times that you have spoken to your GP about the migraine?
Pt 6: I’ve spoken to my GP at the moment at least twice about it.
I: oh yeah, you did say that.
Pt 6: yes. And yeah, and this, the first one I thinlc, I might have mentioned it when I 
went on the pill, but he wasn’t very good, the doctor at the health centre at the 
university wasn’t particularly good from what I remember. And I mentioned it to him 
and he wasn’t interested. And then it got to a state where I thought I want to do 
something about again, and he mentioned this Migraleve. And then I didn’t go back 
to him after that. It didn’t work, but I lost interest.
I: so there were times where you actually mentioned it where you didn’t really get 
the response you wanted.
Pt 6: yes, fr om the medical; from the health centre, one when I was a student.
9.5. I: and was that only that once, or did you try and mention it to somebody 
else?
Pt 6: no, just I think, just that once from what I can remember, just him.
I: ok. Right, well I  think that’s about all I  wanted to talk about, unless there is 
anything that you wanted to add about consultations, or treatment.
Pt 6: no, I don’t think so. I mean as I say I haven’t gone to anything more specific 
than the medication that I said.
I: ok, thank you very much.
Pt 6: that’s ok.
[tape off, duration 54.43 mins]
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Appendix 10: Coding instructions
General hints
• Codes are labels for assigning units of meaning to units of text o f various sizes
• Codes have to
• fit into a structure (need to relate to or be distinct from other codes in
meaningful, study-important ways)
® be defined to enable other analysts to understand the definitions and identify, 
quickly and easily, a segment fitting the definition
• be neither too specific nor too broad
• remain flexible (they are likely to change and develop during the coding
procedure) and to be reviewed continuously
• Sub-sections and coded units of text can overlap, hence one sub-section may be 
labelled by one or more master codes and units of text may be labelled by one or 
more codes
® Not all units of text need to be coded
Developing a code list by coding one interview
® Read through the whole inteiTiew to familiaiise yourself with the information
contained in the inteiwiew
• Re-read interview and write down key issues to give list o f master codes
• Give broad explanation/ definition of each master code (use no more than 10 
master codes)
® Re-read interview and give sub-headings to different sections using master codes,
thus creating sub-sections
» Read each sub-section and identify descriptive (sub)code(s) for each unit of text
(using one or multiple sentence units)
• Code the unit of text (clearly identify the unit of text and write code into left hand 
margin of the transcript)
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• Write code (label) with explanation/ definition down on a separate sheet of paper
® Continue coding the document by using identified codes or by creating new 
codes
• For example: master code MIGRAINE DIAGNOSIS
® (Sub)codes: pain (including location, intensity, quality, any pain 
increasing/ reducing strategies such as walking up stairs or lying 
down), nausea and vomiting (presence), phobias (presence), other 
symptoms, frequency (how often do the migraine occur, both 
previous and current experience) and duration (how long do the 
migr aines last from, previous and curTent experiences)
Reviewing codes
• After coding the an interview, review the (master and sub) codes by comparing 
codes and their descriptions
• Codes may have to be re-grouped into broader codes or split into more specific 
codes
• Codes may also have to be deleted or newly created 
Coding further interviews
• Write this start list (without explanations) onto single sheet of paper for reference 
during further coding
• Code further interviews by reading interview, giving sub-headings according to 
master codes, labelling units of text in the sub-sections according to list of codes, 
identifying and defining new codes and reviewing codes
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Appendix 11: Copy of the questionnaire for the postal
survey
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Appendix 12: Cover letter for survey
November 2002 
Deal' Member
Michele Peters, a PliD student at the University of Sun’ey is writing her thesis on the 
management of migraine and chronic daily headache and would appreciate it if  you 
could help by completing the enclosed questionnaire. Evaluation of the 
questionnaires will provide infoiination on the strategies patients use to treat and 
prevent attacks and will give us valuable information for initiatives to manage the 
condition.
The study is caiiied out under the auspices o f the European Institute of Health and 
Medical Sciences (University of Smi'ey) and has been approved by the University of 
Suney Ethics Committee.
Enclosed you will find an information sheet, that will tell you more about the study 
and what is expected of you, the questionnaire and a stamped and self-addressed 
envelope in which to retui'n the questionnaire.
If you have any more questions or any difficulties filling in the questionnaire, please 
contact Michele by telephone on (01483) 684537 or by email:
M.Peters@suney.ac.uk
Thank you in anticipation for taking the time and trouble to participate in this study. 
Yours sincerely
te. *
Ann Turner (Mrs) 
Director
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Appendix 13: Information sheet
Headaches, particularly migraine and chronic daily headache, can be a great 
burden to a sufferer. Many different forms of treatments are available to the 
patients, but little remains known about the strategies that patients employ to 
treat and to prevent their headaches. This study will look into the management 
strategies that migraine and chronic daily headache sufferers have used within 
the last 12 months. The findings of this study will help to assess the needs and 
the preferred methods of treatment of headache patients. It will also inform us 
whether there is a difference between the management used by patients with 
different types of headache.
To take part in this study you will need to be an adult (aged 18-65) headache 
sufferer who is a resident in the UK. You will not be able to take part if you are 
pregnant. The study involves filling in a questionnaire. At the end of the 
questionnaire you will find a blank page, which you can use to give any other 
information that you may feel is relevant.
When you have completed the questionnaire, you will need to return it to the 
researcher in the provided stamped and self-addressed envelope. We would be 
grateful if you could return the questionnaire within two weeks. Your 
participation in this study is voluntary and you have the option not to participate 
or to withdraw at any time without giving any reasons.
The research may be published in the scientific literature, but you will not be 
identified by name and personal information gathered during this study will 
remain confidential to the researchers.
After reading this information sheet, please contact Michele Peters (contact 
details below) if you have any questions or would like any further information.
Ms M Peters, Prof. H Huyer Abu-Saad, Dr V Vydelingum and Dr M. M urphy
European Institute o f Health and Medical Sciences 
Dr A Dowson
Kings Headache Service and Neurology Research Unit, Royal Surrey Hospital, Guildford, Surrey
Contact Michele Peters Tel. No.: 01483 684537 
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E-mail: M.PetersCasurrev.ac.uk
Appendix 14. Ethical approval for Phase 2 (survey)
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Unis
25 June 2002
Ms Michele Peters
EfflMS
Level 5
University of Surrey
University 
of Surrey
Guildford
Surrey GU2 7XH, UK 
Telephone
+44 (0)1483 300800 
Facsimile
+44 (0)1483 683811
Registry
Dear Ms Peters
Management of migraine and chronic daily headache: a questionnaire study 
tACE/2002/36/EIHMS)
I am writing to inform you that the Advisory Committee on Ethics has considered the 
above protocol (and the subsequent information supplied) and has approved it on the 
understanding that the Ethical Guidelines for Teaching and Research are observed and 
the following condition is met:-
1, That in the Instructions Sheet for the questionnaire the sample box is marked 
accordingly, as this has been omitted.
2. That the Section 4: Medication Use is amended to make it clearer whether you are 
asking about doses for a single episode or treatment for separate episodes.
For your information, and future reference, the Guidelines can be downloaded from 
the Committee’s website at http://www.surrev.ac.uk./Surrev/ACE/.
This letter of approval relates only to the study specified in your research protocol 
(ACE/2002/36/EIHMS). The Committee should be notified of any changes to the 
proposal, any adverse reactions, and if the study is terminated earlier than expected, 
with reasons.
Contd ....
oo
I should be grateful if  you would confirm in writing your acceptance of the condition 
above, forwarding the amended documents for the Committee’s records.
Date of approval by the Advisory Committee on Ethics: 25 June 2002
Date of expiry of approval by the Advisory Committee on Ethics: 24 June 2007
Please infoim me when the research has been completed.
Yours sincerely
Catherine Ashbee (Mrs)
Secretary, University Advisory Committee on Ethics
cc: Chairman, ACE
Dr M Miuphy, Supervisor, EIHMS
Prof H Huyer Abu-Saad, Principal Investigator, EIHMS
Dr V Vydelingum, Co-Investigator EIHMS
Dr A Dowson, Co-Investigator, RSH Guildford
0 \ C2
Appendix 15. Headache Management Questionnaire 
Evaluation Form
Please read the cover letter and information sheet and then fill in the sections below. 
Circle your response and add any comments in the space provided or on the cover 
letter and/or information sheet.
Cover letter
Does the cover letter contain all the necessary information? Yes No
If no, please comment:
Is the cover letter clear? Yes No
If no, please comment:
Information sheet
Does the information sheet contain all the necessary information? Yes No
If no, please comment:
Is the information clear? Yes No
If no, please comment:
Is there any additional information that you would like? Yes No
If yes, please specify:
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Once you have read and commented on the cover letter and information sheet, 
proceed to fill in the questionnaire. When you have completed the questionnaire, 
please complete the section below. If you have any specific comments while 
completing the questionnaire, please write the comments onto the questionnaire.
Questionnaire
Were you given enough instructions on how to fill in the questionnaire? Yes No 
If no, please comment;
Is the questionnaire presented nicely (layout, font size)? Yes No
If no, please comment:
Did you understand all the questions? Yes No
If no, please give the number of the questions you found uncleai* and comment:
Did you find the questions relevant to the management of headache? Yes No 
If no, please comment:
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Are there any additional questions that you would like to be included? Yes No 
If yes, please specify:
Did you like the order of the questions? Yes No
If no, how would you prefer the order of the questions:
Was the questionnaire too long? Yes No
If yes, please comment:
Do you have any other comments?
Thank you for taking the time to fill in the questionnaire and this assessment form.
If you have any questions, or fiirther comments, please contact Michele Peters, 
M.Peters@surrev.ac.uk. Tel: 01483 68 45 37.
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Appendix 16: Cover letter for testing
of diagnostic tool within the questionnaire
Dear Madam/ Sir
I am writing to you with regards to a questionnaire study on headache management, 
which is currently being carried out at the European Institute of Health and Medical 
Sciences, of the University of Surrey. The questionnaire will inform us on the 
strategies that headache patients use to treat and prevent your headaches and will 
give us valuable information on their initiatives to manage their condition.
An important aspect of this study is to diagnose the volunteers correctly. I would be 
grateful if you could help with the evaluation of this part of the questionnaire. 
Enclosed, you will find section 1 of the questionnaire, which aims to collect 
information about the headaches of the study volunteers. Could you please complete 
this section (questions 1 to 9) and return the form in the provided stamped and self- 
addressed envelope within the next two weeks.
If you have any questions, please do not hesitate to contact me via email: 
M.Peters(g),surrev.ac.uk or telephone: 01483 68 45 37.
Thank you in advance for your help.
Yours sincerely,
Michele Peters
T h e  Q u e e n ’s 
4NIVERSARY P R IZ E S
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2002
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Appendix 17: Diagnosis validity
Patient number Diagnosis (questionnaire)
_ . . 1
Diagnosis (clinician)
2 Migraine without aura Migraine without aura
3 Migraine without aura Migraine without aura
4 Migraine without aura Migraine without aura
5 GDH GDH
6 Migraine with aura Migraine with aura
7 CDH Migraine with aura
8 GDH GDH
9 CDH CDH
10 Migraine with aura Migraine with aura
11 Migraine with aura Migraine with aura
12 Migraine ?aura Migraine, inconsistent aura
i 13 Migraine with aura Migraine with aura
14 Migraine with aura Migraine with aura
16 Migraine with aura Migraine with aura
17 Migraine with aura Migraine with aura
18 Migraine without aura Migraine without aura
19 Migraine with aura Migraine with aura
20 I Migraine with aura Migraine with aura
22 GDH CDH
23 Migraine with aura (? Non­ CDH
migraine headaches?)
24 Migraine without aura Migraine without aura
f 25 Migraine without aura Migraine without aura
26 GDH CDH
28 GDH CDH
29 Migrainous headache Migraine without aura
Migraine without aura
26 patients- 22 valid diagnosis- 84% validity
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Appendix 18: Advert for recruitment
(For Migraine Action Association web-site and newsletter)
The Management of Migraine and Chronic Daily Headaches
Researchers at the European Institute of Health and Medical Sciences from the 
University of Sun'ey are looking for Migraine and Chronic Daily Headache patients 
who would be willing to fill in a questiomiaire on the management of their 
headaches. The questionnaire collects information on strategies that patients employ 
to treat and to prevent their headaches, including aspects of care such as medical 
consultations, use of medication and alternative therapies, support from friends and 
family and self-help measiues.
To participate in the study you will need to be aged between 18 and 65 years and you 
will need to be a UK resident. You cannot take part in the study if you are pregnant.
If you have any questions about the study or would like any further information, 
please contact Ms Michele Peters.
If you are interested to take part in the study, please email, fax or telephone your 
postal addi ess to Ms Michele Peters by November 2002 and copy of the 
questionnaire and information sheet will be sent to you.
Contact: Ms Michele Peters
Email: M.Peters@surrev.ac.uk 
Address: EIHMS, University of Surrey, Guildford, Surrey, GU2 7TE 
Fax Number: 01483 68 25 41 
Telephone number: 01483 68 45 37
Ms M Peters, Prof. H Huyer Abu-Saad, Dr V Vydelingum and Dr M. M urphy
European Institute o f  Health and Medical Sciences 
Dr A Dowson
Kings Headache Service and Neurology Research Unit, Royal Surrey Hospital, Guildford, Surrey 
Contact Michele Peters Tel. No.: 01483 684537 Email: M.Petersdùsiirrev.ac.uk
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